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Introduction: A recommended strategy to influence energy balance, which may influence body 
weight regulation, is to eat breakfast regularly.  Purpose: The purpose of this study was to 
examine the impact of breakfast consumption versus a non-breakfast condition on concentrations 
of the appetite-regulating hormones acylated ghrelin (AG) and glucacon-like peptide 1 (GLP-1), 
daily energy intake, and subjective ratings of hunger in women.  Methods: This randomized 
crossover trial recruited a total of 18 normal weight, overweight, and obese women (age 26.3 ± 
6.0 years; BMI 26.8 ± 5.9 kg/m2).  Each participant reported to the research center on two 
mornings following a minimum 12-hour fast to undergo one of two experimental condtions: 
breakfast consumption that provided 20% of their estimated daily energy needs, or a waiting 
period with no breakfast.  Study visits were separated by at least 3 days.  At each experimental 
session, participants provided blood samples to measure plasma AG and GLP-1 concentrations 
and visual analogue scale (VAS) questionnaires to measure subjective hunger and satiety ratings 
prior to each testing condition (baseline) and at 30, 60, and 120 minutes after each testing 
condition.  Participants also self-reported discretionary intake for the remainder of each testing 
day in a food and physical activity diary.  Results: Following breakfast consumption compared 
to the non-breakfast condition, AG was significantly lower and GLP-1 was significantly higher 
at the 30-, 60-, and 120-minute time points (P < 0.001, each), but there was no difference in total 
daily energy intake between conditions (P = 0.199).  In addition, subjective ratings of hunger 
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significantly correlated with energy intake following the breakfast consumption condition (P < 
0.05) but not following the non-breakfast condition.  Subjective ratings of hunger did not 
correlate with AG or GLP-1 concentrations. Conclusion: Even though a significant acute 
hormonal response was observed following breakfast consumption when compared to a non-
breakfast condition, total daily energy intake between conditions was not significantly different.  
Thus, further studies are needed to understand the influence of breakfast consumption on energy 
balance and body weight regulation.   
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1.0  INTRODUCTION 
Rates of overweight and obesity (body mass index (BMI) = 25.0-29.9 kg/m2 and ≥ 30.0 kg/m2, 
respectively) continue to increase in industrialized countries, especially the United States (U.S.).  
Ogden et al. reported that the prevalence of overweight in the U.S. in 2003-2004 was 40% in 
men and 29% in women and the prevalence of obesity was 31% in men and 33% in women [1].  
Between 1980 and 2004, the prevalence of obesity in the U.S. increased by 140% in men and by 
87% in women [1, 2].  This is important because as obesity rates increase so do rates of related 
chronic diseases, such as type 2 diabetes mellitus, cardiovascular disease, cerebrovascular 
disease, and some types of cancer [2, 3].  These diseases are the major cause of morbidity and 
mortality in the United States today and are the leading cause of  70% of all deaths annually [2, 
3].  It is likely that with a reduction in the prevalence of overweight and obesity there will be a 
concomitant decrease in the prevalence of these chronic diseases.   
The increasing availability of inexpensive foods that are energy-dense, high in fat, and 
low in unrefined carbohydrates coupled with increasingly sedentary lifestyles have followed 
similar trends with the increasing prevalence of overweight and obesity, particularly in 
industrialized countries [4, 5].  Weight gain results when energy intake exceeds energy 
expenditure over a period of time, creating a state of positive energy balance.  This occurs when 
more calories are consumed than are required to fuel metabolic processes and physical activity, 
resulting in excess energy storage, predominantly in adipose (fat) tissue.  To induce weight loss, 
either energy intake needs to be reduced through limiting calorie consumption or energy 
expenditure needs to be increased through additional physical activity, creating a state of 
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negative energy balance.  To maintain weight, energy intake must equal energy expenditure, 
creating a state of energy balance [7-10].  Although past research has examined methods for 
inducing weight loss and maintaining a healthy weight, rates of overweight and obesity continue 
to rise [1, 2].  Thus, additional research may be required to understand the physiological and 
metabolic mechanisms of weight regulation, and also how lifestyle factors such as eating and 
physical activity behaviors contribute to the paradigm of energy balance.   
1.1 CORRELATES OF SUCCESSFUL BODY WEIGHT MAINTANENCE 
A variety of lifestyle approaches for weight loss have been examined, and these have typically 
included variations of diet and physical activity that theoretically affect energy balance.  
However, only a few components of lifestyle interventions for weight loss have consistently been 
shown to be associated with long-term weight loss maintenance.  The National Weight Control 
Registry (NWCR) is an observational prospective study to examine successful long-term weight 
loss and weight maintenance strategies in adults who have lost at least 30 pounds and kept it off 
for at least one year [6].  Based on data from the NWCR the three strategies most commonly 
used for maintenance of weight loss among participants are: 1) consuming a low-fat/high-
carbohydrate diet, 2) frequent self-monitoring of weight and energy intake, and 3) regular 
physical activity [6].  More recently data from the NWCR has supported regular breakfast 
consumption as an important lifestyle behavior for weight loss maintenance [7].   
 Additional support for the importance of breakfast consumption to improve energy 
balance and regulation is found in data from several published studies that examined an 
association between increased breakfast consumption and decreased body weight in normal 
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weight, overweight, and obese adults [13-18].  However, other studies have shown the effect of 
breakfast consumption on body weight may be limited to select population groups or with certain 
types of foods consumed for breakfast.  For example, Song et al. reported an association between 
breakfast consumption and body weight only in women [8], and Cho et al. found an association 
between breakfast and lower body weight in those individuals who regularly consumed cereal or 
quick breads for breakfast, but not in those who regularly consumed meat or eggs for breakfast 
[8, 9].  Moreover, one additional study failed to find a significant association between daily 
breakfast consumption and lower body weight in adults [10].  Given these mixed results, further 
examination of the association between breakfast consumption and factors that may affect body 
weight appears to be warranted.  The first step in this process may be to identify the 
physiological mechanisms affected by breakfast that may contribute to hunger, satiety, and 
eating behavior. 
1.2 BREAKFAST AND BODY WEIGHT 
1.2.1 Pathways Explaining the Impact of Breakfast on Body Weight 
Select hypothesized physiological/metabolic pathways by which breakfast may impact body 
weight are shown in Figure 1.  One potential pathway may be that breakfast consumption 
influences food choices throughout the day and this may influence energy intake and energy 
balance.  Studies supporting this idea have demonstrated that individuals who consume breakfast 
consume more nutrient-dense foods throughout the day compared to those individuals who do 
not consume breakfast [11-13].  Nicklas et al., for example, reported the odds of dietary 
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inadequacy were 2 to 5 times higher in individuals who did not consume breakfast compared to 
individuals who consume breakfast [13].  Nutrient-dense foods often have fewer calories than 
foods that are not nutrient-dense.  Therefore, it is possible that those who consume breakfast may 
consume fewer calories throughout the day and have an overall lower daily energy intake.         
 
Figure 1. Theoretical pathways by which breakfast consumption may impact body weight 
 
A second hypothesis is that breakfast consumption may be associated with a higher level 
of daily energy expenditure through increased physical activity and an increase in the thermic 
effect of food (TEF), or the amount of energy expended to digest consumed food, which may 
influence energy balance and affect body weight.  Some studies have reported that individuals 
who consume breakfast are more physically active in general than individuals who do not 
consume breakfast [14-16].  Carels et al. reported that exercise duration was significantly longer 
and total energy expenditure was significantly greater on days when individuals ate breakfast 
than on days when breakfast was not consumed [15].  Some research has also suggested that 
increases in TEF could lead to higher energy expenditure throughout the day.  Significant 
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associations have been demonstrated between larger meals [17], more frequent meals [18], or 
protein-rich meals [19] and greater postprandial energy expenditure, with Johnston et al. showing 
significantly increased postprandial thermogenesis following a high-protein, low-fat breakfast 
compared to a high-carbohydrate, low-fat breakfast [19]. 
It has also been hypothesized that breakfast consumption may stimulate physiological 
processes that reduce hunger and increase satiety, and this may impact total daily energy intake 
[20].  Eating breakfast may stimulate hormonal responses, such as decreased levels of ghrelin 
and increased levels of insulin, leptin, peptide-YY, and glucagon-like peptide 1 (GLP-1).  These 
factors have been shown to decrease hunger and increase satiety, which theoretically may 
influence total daily energy intake and ultimately influence body weight.  Conversely, skipping 
breakfast may result in a reversal of these hormonal responses, which may result in increased 
feelings of hunger and decreased satiety, and this may result in an increase in daily energy intake 
(Figure 2).  Farshchi et al. reported that individuals who regularly ate breakfast had a 
significantly lower total daily energy intake compared to individuals who did not eat breakfast, 
which may lead to the promotion of weight gain when breakfast is not consumed [21].   
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Figure 2. Theoretical pathways by which breakfast consumption and non-breakfast may impact body weight 
 
1.2.2 Appetite Regulating Hormones 
This study will focus on the hormonal response to breakfast consumption, as this has been 
hypothesized as a plausible mechanism to explain the impact of breakfast consumption on body 
weight [22-52].  However, results of studies examining the influence of breakfast consumption 
on selected orexigenic peptides (peptides that stimulate appetite) and anorexigenic peptides 
(peptides that suppress appetite) have been mixed, mostly due to differences in research 
methodology.  Thus, the pathway highlighted in Figure 2 will be investigated in this study.  
Specifically, this study will focus on the acute effect of breakfast consumption on ghrelin, an 
orexigenic peptide, and glucagon-like peptide 1 (GLP-1), an anorexigenic peptide.  Ghrelin and 
GLP-1 are of special interest in the hormonal response pathway linking breakfast consumption to 
body weight, as each has been reported to be particularly responsive to food intake [23, 34]. 
Ghrelin is a 28-amino acid residue peptide that has been reported to be involved in 
multiple physiological processes, including the: stimulation of gastric motility and acid secretion; 
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promotion of adipogenesis; slowing of the metabolic rate; regulation of somatic growth; 
metabolism of glucose; and the stimulation of growth hormone release [22, 39-41, 53-56]. 
However, its predominant role is in the stimulation of appetite and food intake [25, 27, 57].  
Ghrelin exists in two forms: acylated ghrelin (AG) and des-acyl ghrelin (DG).  Research shows 
that only the acylated form of ghrelin is capable of binding to the growth hormone secretagogue 
(GHS) receptor in the hypothalamus to stimulate appetite and food intake [35, 55, 56].  Recent 
studies support this in showing that only ghrelin in its acylated form is significantly associated 
with increased appetite and decreased energy expenditure, especially during periods of fasting 
[38-41, 57].   Only two of these studies, though, examined the impact of breakfast on plasma 
levels of AG [38, 57].  Unfortunately, the scope of these studies was not specific to breakfast and 
AG and each included fewer than nine participants.  Because AG has been reported to play a 
large role in the stimulation of hunger and initiation of energy intake, and because of a lack of 
research examining the association between breakfast consumption and AG, additional research 
is needed to investigate the impact of breakfast consumption on AG. 
GLP-1 is noteworthy for its role in mediating hyperglycemia in diabetic individuals 
through its influence on glucose-dependent insulin secretion [28, 34].  GLP-1 receptor agonists 
are currently marketed as pharmacological agents that have proven effective in the regulation of 
glucose homeostasis in individuals with type 2 diabetes mellitus [28, 34].  GLP-1 is also 
influential in reducing appetite and energy intake in animals and humans [22, 58].  Only two 
studies have examined the impact of breakfast consumption on GLP-1 [42, 51].  However, the 
focus of these studies was to examine the effect of the macronutrient composition of meals on 
GLP-1 and a fasting control condition was not part of the research design.  Also, both studies 
used only young, normal weight participants (mean age 23.3 ± 0.5 and 22 ± 1 y; mean BMI 22.1 
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± 0.4 and 23.9 ± 0.3 kg/m2, respectively).  Due to the reported role of GLP-1 in the regulation of 
energy balance and limited research examining the association between breakfast consumption 
and GLP-1, further investigation is needed to examine the impact of breakfast consumption on 
GLP-1. 
1.3 SPECIFIC AIMS 
The primary aims of this study are: 
1. To examine the effect of breakfast consumption compared to a non-breakfast 
condition on the acute response of plasma AG concentrations over a two-hour period.   
2. To examine the effect of breakfast consumption compared to a non-breakfast 
condition on the acute response of plasma GLP-1 concentrations over a two-hour 
period.   
3. To compare the effect of breakfast consumption and a non-breakfast condition on 
self-reported total daily energy intake. 
4. To examine the effect of body mass index (normal weight, overweight, obese) on the 
acute response of plasma AG and GLP-1 over a two-hour period following a 
breakfast and non-breakfast condition.   
Exploratory aims of this study are: 
1. To examine the effect of breakfast consumption and a non-breakfast condition on 
subjective ratings of hunger and satiety over a two-hour period.   
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2. To examine the association between subjective ratings of hunger and satiety with 
plasma AG and GLP-1 concentrations over a two-hour period following breakfast 
consumption and a non-breakfast period.   
1.4 HYPOTHESES 
The primary hypotheses of this study are: 
1. Plasma AG concentrations will be significantly lower for two hours following 
breakfast consumption than for two hours following a non-breakfast condition.  
2. Plasma GLP-1 concentrations will be significantly higher for two hours following 
breakfast consumption than for two hours following a non-breakfast condition.  
3. Self-reported levels of total daily energy intake will be significantly lower following 
breakfast consumption than following a non-breakfast condition.  
4. Plasma AG levels will be significantly higher and GLP-1 levels will be significantly 
lower in obese participants than in overweight participants for two hours following 
breakfast consumption than for two hours following a non-breakfast condition.  
Plasma AG levels will be significantly higher and GLP-1 levels will be significantly 
lower in overweight participants than in normal weight participants for two hours 
following breakfast consumption than for two hours following a non-breakfast 
condition. 
Exploratory hypotheses of this study are: 
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1. Subjective ratings of hunger will be significantly lower and subjective ratings of 
satiety will be significantly higher for two hours following breakfast consumption 
than for two hours following a non-breakfast condition.  
2. Subjective ratings of hunger will correlate with plasma AG concentrations and 
subjective ratings of satiety will correlate with plasma GLP-1 concentrations for two 
hours following breakfast consumption and a non-breakfast period. 
1.5 SIGNIFICANCE 
Overweight and obesity are important public health concerns in the United States today, mostly 
due to the impact they have on chronic disease.  Effective strategies to maintain body weight 
have been reported, but the mechanisms behind their actions have not been thoroughly 
examined.  One recommended strategy for successful weight loss is to eat breakfast regularly.  A 
proposed mechanism to explain the effect of breakfast consumption on body weight is that eating 
breakfast initiates a hormonal response that improves feelings of hunger and satiety.  Improved 
feelings of hunger and satiety following breakfast may lead to decreased energy intake later in 
the day which may, in turn, lead to a decrease in body weight over time.     
 Limited research has been conducted on appetite-regulating hormonal responses 
following breakfast consumption and results have been mixed.  This is due, in part, to differences 
in research methodology.  This study proposes to examine the impact of breakfast consumption 
on two key appetite-regulating hormones, acylated ghrelin and GLP-1.  Acylated ghrelin was 
chosen to be examined because it is the only known orexigenic gut hormone in humans and has 
been shown to induce hunger and act as an initiator of energy intake [22, 34].  GLP-1 was chosen 
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because in addition to increasing satiety and decreasing energy intake, it contributes to the 
regulation of blood glucose homeostasis and energy balance [28, 34].  It is hypothesized that 
eating breakfast will stimulate a hormonal response that will improve feelings of hunger and 
satiety, resulting in a reduction in daily energy intake significant enough to favor weight loss 
maintenance over time.  However, because hunger and satiety are controlled by many factors 
other than hormones, it is possible that any changes in daily energy intake may not be significant 
after controlling for the other factors.  If a significant, objective relationship between breakfast 
consumption and AG and GLP-1 levels is demonstrated, it would support the observational data 
that shows breakfast consumption to be an effective strategy in maintaining body weight as 
reported in the NWCR. 
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2.0  REVIEW OF LITERATURE 
2.1 INTRODUCTION 
Overweight and obesity significantly increase the risk for illness from high blood 
pressure, high cholesterol, type 2 diabetes, heart disease and stroke, and certain types of cancer 
[59].  Each of these is directly associated with the leading causes of morbidity and mortality in 
the United States [2, 3].  Weight loss and maintenance of a healthy body weight, however, 
reduce these risks for chronic disease [60].  Research has shown that an average weight loss of 
22 pounds achieved by dietary interventions was positively associated with significantly lower 
systolic blood pressure by an average of 7 mm Hg and diastolic blood pressure by an average of 
3 mm Hg in overweight hypertensive individuals [60].  Also, weight loss of between 5-13% of 
body weight was associated with significant improvements in blood cholesterol by as much as    
–18% for total cholesterol, –22% for LDL-cholesterol, +27% for HDL-cholesterol, and –44% for 
triglycerides.  In addition, weight loss averaging 11 pounds through diet was associated with a 
2% decrease in HbA1c over 6 months in overweight diabetic individuals [60].  To reduce the 
risks for chronic disease, effective strategies are needed to help people lose weight and maintain 
a healthy body weight.  Since individuals are often more successful at maintaining a healthy 
weight than trying to lose significant amounts of weight and keep it off once obesity is 
established, these strategies should be initiated as early as possible.   
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2.2 THE IMPACT OF BREAKFAST ON BODY WEIGHT 
Since being established in 1994, the NWCR has followed over 5,000 participants who have 
maintained at least a 30 pound weight loss for at least 1 year [6].  Wing et al. reported that 
breakfast consumption was a common behavior among registry participants to maintain weight 
loss [6].  However, results of other research examining the association between breakfast 
consumption and body weight have been mixed.  There are several studies that support the 
findings of Wing et al.  For example, in a randomized crossover study on normal weight, 
overweight, and obese women (mean age 29.5 ± 5.9 y, BMI range 23-37 kg/m2) involving two 6-
week trials, Keim et al. demonstrated that when 70% of the participants’ daily calories were 
consumed in two morning meals, significantly more weight was lost than when 70% of daily 
calories was consumed in two afternoon and evening meals (–3.90 ± 0.19 vs. –3.27 ± 0.26 kg/6 
wk, P < 0.01) [61].  In a prospective cohort study on men (mean age 57.3 y, mean BMI 25.6 
kg/m2), van der Heijden et al. showed that breakfast consumption was significantly associated 
with a 13% lower risk of 5 kg weight gain over a 10 year follow-up period, independent of 
lifestyle and BMI at baseline (multivariate HR = 0.87) [62].  This inverse association was even 
stronger in men with a baseline BMI ≤ 25 kg/m2 (multivariate HR = 0.78) [62].  Similarly, in a 
prospective observational study that monitored adults over one year (mean age 48 y, mean BMI 
27.6 kg/m2), Ma et al. reported that individuals who did not consume breakfast had 4.5 times the 
risk of obesity as those who regularly consumed breakfast (95% CI 1.57-12.90), and subjects 
who skipped breakfast at least once during the study had 1.34 times the risk of obesity (95% CI 
0.81-2.20) [63].   Finally, in a prospective cohort study on adolescents (mean age 15.9 ± 0.1 y, 
mean BMI 22.9 ± 0.1 kg/m2), Niemeier et al. supported the need to begin interventions earlier 
rather than when obesity is established by reporting that decreased breakfast consumption during 
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the transition from adolescence to adulthood was significantly associated with increased weight 
gain in early adulthood (P < 0.01) [64].   
 However, there is additional research that does not support the findings of Wing et al., 
reporting either no relationship between breakfast consumption and body weight or reporting 
mixed results.  For example, in a cross-sectional parallel group study that examined differences 
in eating behaviors of normal weight (mean age 49.6 ± 7.2 y, mean BMI 23.8 ± 3.1 kg/m2) and 
obese (mean age 47.7 ± 5.9 y, mean BMI 41.0 ± 3.4 kg/m2) Swedish women, Berteus Forslund et 
al. found no significant difference in the frequency of breakfast consumption between weight 
groups (mean ~1.25 vs. ~1.35 meals/person/day at traditional breakfast time, respectively) [10].  
In another cross-sectional study on 4,218 adults ≥ 19 years old, Song et al. reported that an 
association between increased breakfast consumption and BMI < 25 kg/m2 was not significant in 
women (P = 0.1300) or men (P = 0.7544) [8].  However, participants of the study were surveyed 
only once.  In the final model of a retrospective analysis of an observational study, Affenito et al. 
reported that frequency of breakfast consumption did not predict BMI in pre-adolescent girls as 
they transitioned to early adulthood (P = 0.38) [11].  Finally, mixed results were reported in a 
cross-sectional study that examined the body weights and breakfast consumption practices of 
U.S. adults.  Cho et al. reported that those who ate ready-to-eat cereal (mean BMI 26.03 kg/m2), 
cooked cereal (mean BMI 25.46 kg/m2), or quick breads (mean BMI 26.16 kg/m2) weighed 
significantly less than those who did not consume breakfast (mean BMI 26.92 kg/m2), but that 
those who ate meat and eggs for breakfast (mean BMI 27.04 kg/m2) did not weigh significantly 
less [9].    
The discrepancies in these results are mostly due to differences in research methodology.  
Most of the reviewed studies that reported an association between increased breakfast 
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consumption and lower body weight used stronger research designs than those that found weak 
or no relationships, with Keim et al. [61] using a randomized crossover design and Niemeier et 
al. [64] and van der Heijden et al. [62] using prospective cohort designs.  Studies finding a weak 
or no association used either cross-sectional [8-10] or retrospective analysis designs [11].  
Further research is needed to clarify the methodology examining the association between 
breakfast consumption and body weight in an effort to better explain why breakfast may impact 
body weight as reported by Wing et al [7].       
2.3 THE IMPACT OF BREAKFAST ON ENERGY INTAKE 
One hypothesis to explain how breakfast may impact body weight is that breakfast consumption 
may stimulate physiological processes that lead to decreased total daily energy intake [20].  
Consuming breakfast may blunt the insulin response and maintain it at a constant low level.  This 
in turn may lead to reduced appetite between meals which potentially may lead to decreased 
energy intake later in the day [20].  The limited research investigating this association in adults, 
though, has come to differing conclusions.  In a randomized crossover trial on lean women 
(mean age 25.5 ± 5.7 y, mean BMI 23.2 ± 1.6 kg/m2), Farshchi et al. reported that following two 
weeks of daily breakfast consumption participants had significantly lower daily energy intake 
than when following two weeks of skipping breakfast (6.97 ± 0.59 vs. 7.35 ± 0.65 MJ/day, P = 
0.001).  It was concluded that increased energy intake when skipping breakfast could lead to 
weight gain [21].  On the contrary, in a cross-sectional study of 504 young adults (mean age 23 
y) involving one 24-hour diet recall, Nicklas et al. reported that participants who did not 
consume breakfast had a significantly lower daily energy intake than those who consumed 
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breakfast (1990.4 vs. 2558.1 kcals, P < 0.0001) [13].  However, differences in lifestyles between 
those who consumed breakfast and those who did not were not explored.  For example, the 
socioeconomic status and physical activity behaviors of participants were not considered.  In 
another study, Schusdziarra et al. examined food diaries recorded over 10 days by 280 obese 
participants preparing for a weight loss program (male/female ratio 75/205, mean age 45 ± 0.85 
y, mean BMI 36.6 ± 0.2 kg/m2) and diaries recorded over 14 days of 100 normal weight control 
participants (male/female ratio 33/67, mean age 42 ± 0.2 y, mean BMI 32.5 ± 0.1 kg/m2).  The 
researchers reported that obese participants significantly increased total daily energy intake by 
approximately 400 calories and normal weight participants significantly increased total daily 
energy intake by approximately 500 calories on days when breakfast was consumed versus days 
it was not consumed (P < 0.05) [65].  Although the well-designed research study by Farshchi et 
al. found a significant association between increased daily breakfast consumption and decreased 
total daily energy intake, a physiological pathway to explain the results was not explored [21].  
There is a need to further investigate mechanisms that explain how regular breakfast 
consumption can lead to energy balance and impact body weight.  A plausible mechanism to 
explain the impact of breakfast consumption on body weight involves the response of appetite 
regulating hormones to breakfast consumption. 
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2.4 PRIMARY OUTCOME MEASURES 
2.4.1 Appetite Regulating Hormones 
To regulate energy intake and energy balance, the body produces peptides that stimulate appetite, 
known as orexigenic peptides, and peptides that suppress appetite, known as anorexigenic 
peptides.  These peptides often interact with one another and modulate feelings of hunger and 
satiety to control feeding [22, 34].  The main orexigenic peptides associated with increased 
appetite and energy intake are the hormone ghrelin and the polypeptides neuropeptide Y (NPY) 
and agouti-related protein (AgRP).  Ghrelin has been reported to influence the expression of 
NPY and AgRP and each responds to food similarly; increasing to the point of meal initiation 
and then decreasing following meal consumption [22, 34].  The main anorexigenic peptides 
associated with decreased appetite and energy intake are the hormones insulin, leptin, 
cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1), and peptide YY (PYY) [22, 34].   
Each has been reported to inhibit food intake, with PYY and leptin inhibiting the action of NPY 
and AgRP [22, 34]. The gut-based hormones CCK, GLP-1, and PYY work together to reduce 
food intake over several hours as each is secreted in a different part of the gastrointestinal tract, 
with CCK being secreted in the duodenum and jejunum, GLP-1 being secreted predominantly in 
the ileum and colon, and PYY being secreted in the rectum and colon.   
 The interaction between these peptides is complex, especially since concentrations of 
some of them have been reported to change with changes in body weight [22, 34].  For example, 
concentrations of ghrelin, GLP-1, NPY, AgRP, insulin, leptin have been found to be lower in 
obese individuals, while obesity has no effect on concentrations of PYY and CCK [22, 34].  Of 
all the orexigenic and anorexigenic peptides, ghrelin and GLP-1 are of special interest in the 
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hormonal response pathway linking breakfast consumption to body weight, as each has been 
reported to be particularly responsive to food intake [23, 34].  In fact, it has been suggested that 
changes in ghrelin and GLP-1 after gastric bypass surgery may contribute to the weight-reducing 
effect of this procedure [27, 36].    
2.4.1.1 Ghrelin 
Ghrelin is a 28-amino acid peptide that is mainly produced by the X/A-like endocrine cells in the 
oxyntic glands of the stomach and upper gastrointestinal tract and, to a smaller degree, in the 
arcuate nucleus of the hypothalamus [29, 41].  Plasma ghrelin has been observed to correlate 
with hunger [58].  It increases during periods of fasting, rises further just before spontaneous 
feeding, and then quickly falls again after eating [22, 54, 58].  Therefore, it has been suggested 
that ghrelin plays a role in meal initiation [22, 54], and there is data to support this [25, 53, 66].  
For example, in an intervention study that followed normal weight and overweight adults (age 
range 29.1-63.7 y, BMI range 22.0-30.0 kg/m2) over the course of one day, Cummings et al. 
demonstrated a mean 78% increase in plasma ghrelin concentrations in the two hours prior to 
eating each meal and a decrease to baseline levels within one hour after food was consumed [53].  
Blom et al. specifically examined plasma ghrelin concentrations with respect to breakfast in a 
randomized crossover study on normal weight and obese men (mean age 33.2 ± 4.8 and 40.8 ± 
4.7 y, mean BMI 23.2 ± 0.5 and 33.2 ± 0.8 kg/m2, respectively) [25].  The investigators 
monitored changes in total plasma ghrelin concentrations following a three-day energy restricted 
and a three-day energy-balanced diet and reported several interesting results.  First, following 
breakfast consumption mean total plasma ghrelin concentrations, averaged across diet type and 
weight-class, fell to 88.0 ± 5.7% of fasting levels and then returned to 105.8 ± 7.1% of pre-
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breakfast fasting levels by the time lunch was requested by participants [25].  Second, the 
intermeal interval (IMI) between a set breakfast time and a participant-chosen lunch time 
significantly decreased as the area under the curve (AUC) of the ghrelin response increased (r = 
–0.42, P < 0.01).  However, this association was found only in normal weight participants.  
Finally, lunch preprandial plasma ghrelin concentrations significantly increased as IMI increased 
(r = 0.51, P < 0.05).  However, this significant correlation only occurred following the three-day 
energy restricted diet and it was not influenced by BMI.  These data demonstrated that plasma 
ghrelin concentrations increased the longer participants went without eating, and the greater the 
ghrelin response, the sooner participants started eating, which supports the suggestion that 
ghrelin plays a role in meal initiation.  However, results from the Blom study also suggest that 
the association may be affected by energy restriction [25].  Unfortunately, a non-breakfast 
control condition was not part of the study design.  Consequently, additional research is needed 
to investigate the impact of a non-breakfast condition on the association between increased 
plasma ghrelin concentrations and increased energy intake.     
 The above studies investigated the association between eating and total plasma ghrelin 
concentrations [25, 53].  Total plasma ghrelin consists of two major molecular forms, acylated 
ghrelin (AG) and des-acyl ghrelin (DG).  It has been reported that less than 10% of total plasma 
ghrelin exists as AG [57, 67], with Lucidi et al. reporting that AG accounts for 3-4% of total 
ghrelin circulating in the blood [57].  Activation of AG by way of acylation of the serine 3 
position with an octanoyl group allows it to attach to growth hormone secretagogue (GHS) 
receptor-1 in the hypothalamus [35, 41, 55, 56, 67].  There it enacts an orexigenic cascade that 
results in a release of growth hormone, increased appetite, stimulation of food intake, and a 
decrease in energy expenditure, especially during fasting [41, 54, 68].  Des-acyl ghrelin is not 
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capable of binding to the GHS receptor and, therefore, does not initiate the orexigenic effect of 
AG [35, 41, 55, 56, 67]. 
 Acylated-ghrelin is the only peripheral signal hormone that increases food intake [68].  
Studies have demonstrated the effects of AG on energy intake when administered either 
subcutaneously or intravenously.  In a randomized controlled trial on normal weight adults 
(mean age 25.4 ± 2.9 y, mean BMI 22.5 ± 1.5 kg/m2), Druce et al. reported significantly greater 
energy intake and perceived palatability of food at breakfast following subcutaneous 
administration of AG prior to breakfast when compared to saline administration (5076 ± 691 vs. 
4230 ± 607 kJ, P = 0.04, and 81.1 ± 3.6 vs. 70.0 ± 4.4 mm on VAS scale, P = 0.03, respectively) 
[69].  Similarly, in a randomized crossover trial on normal weight and overweight adults (mean 
age 25 ± 1.1 y, mean BMI range 19.8-26.8 kg/m2), Wren et al. reported significantly greater 
energy intake and subjective hunger ratings at lunch following intravenous infusion of AG prior 
to and after breakfast when compared to saline infusion (5997 ± 413 vs. 4713 ± 344 kJ, 
respectively, P < 0.001 and 16 ± 10% greater increase in hunger ratings at 120 min. and 46 ± 
20% greater increase at 240 min. after breakfast, P < 0.05) [70].  These studies, though, did not 
examine the association between endogenous AG and energy intake [68-70]. 
Only two studies have specifically examined the effect of breakfast consumption and 
fasting on endogenous plasma AG concentrations, but neither was appropriately powered [38, 
57].  In a randomized crossover study involving eight young, normal weight and mildly 
overweight men (mean age 24.5 ± 3.7 y, mean BMI 24 ± 2.1 kg/m2) comparing the temporal 
profile of AG concentrations over 26.5 hours following consumption of a standard mixed 
breakfast and a non-breakfast condition, Liu et al. reported that AG concentrations quickly 
decreased to nadir levels within one hour post-breakfast and then increased to exceed breakfast 
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preprandial levels within two additional hours.  This was similar to the total plasma ghrelin 
response following breakfast consumption as previously discussed [38].  In a similar randomized 
crossover study that monitored AG concentrations for four hours following a breakfast 
consumption condition and non-breakfast condition in six normal weight adults (mean age 36 ± 2 
y, mean BMI 23 ± 0.7 kg/m2), Lucidi et al. [57] reported a pattern similar to the study by Liu et 
al. [38] following consumption of a standard mixed breakfast.  However, results of the two 
studies differed regarding the non-breakfast condition.  Liu et al. [38] reported that during four 
hours of monitoring, plasma AG concentrations stayed fairly flat, at a level similar to nadir levels 
in the fed condition.  Lucidi et al. [57] reported that during four hours of monitoring, plasma AG 
concentrations, though fairly flat, were significantly higher in the non-breakfast condition 
compared to the breakfast consumption condition (P < 0.01).  However, in the study by Liu et al. 
[38] AG monitoring during the fasting condition began after the participants had been fasting for 
37.5 hours of a 61.5 hour fast, while in the study by Lucidi et al. [57], monitoring began after an 
overnight fast.  Due to a limited number of studies, with differing results and methodologies, that 
examined the association between breakfast consumption and endogenous AG concentrations, 
additional research is needed to explore this relationship.       
 Des-acyl ghrelin accounts for over 90% of total plasma ghrelin [57, 67], and until 
recently it was believed to be biologically inert.  However, research shows that certain actions of 
DG inhibit actions of AG.  For instance, in a randomized controlled trial on mice that monitored 
energy balance following intracerebroventricular (ICV) injection of AG, DG, or artificial 
cerebrospinal fluid, Asakawa et al. reported that DG had a significant inhibitory effect on energy 
intake (P < 0.01) and gastric emptying rate (P < 0.05) over a two hour period [71].  Also, 
transgenically created mice designed to overexpress DG gained less weight with reduced fat 
  22 
mass compared to unaltered mice (33.90 ± 0.631 vs. 37.69 ± 1.673 g at 44 weeks, P < 0.05) [71].  
Results of another randomized controlled animal trial showed that DG significantly inhibited 
energy intake in goldfish over a 60 minute period after ICV injection of AG, DG, or saline (P < 
0.05 at 15 and 60 min., P < 0.01 at 30 and 45 min.) [40].  It is possible that the relationship 
between increased DG concentrations and decreased energy intake is the result of the effect DG 
has on the insulin response.  As evidence, Qader et al. reported that DG compromises the 
appetite regulating effect that AG has on the secretion of pancreatic hormones.  In comparing the 
effects of AG alone or in combination with DG, Qader et al. reported that the presence of DG 
ameliorated the effect of AG on the secretion of insulin, pancreatic polypeptide, somatistatin and 
glucagon (P < 0.001) [72].  Due to the impact that DG may have on the appetite-regulating 
actions of AG, and due to the limited research examining the response of AG to breakfast 
consumption, additional investigation of the relationship is warranted to explain the impact of 
breakfast consumption on body weight.   
 The appetite-regulating effects of AG and DG may be impacted by fasting.  Research has 
shown that the ratio of DG to AG may change with long-term fasting [38, 56].  In a randomized 
controlled trial on rats, Toshinai et al. reported that the DG to AG ratio was markedly increased 
following a 42 hour fast (1.3:1 in fed rats vs. 3:1 in fasted rats) while the total plasma ghrelin 
level did not change [56].   Similarly, in a randomized crossover trial on young, normal weight 
and overweight males (mean age 24.5 ± 3.7 y, mean BMI 24 ± 2.1 kg/m2), Liu et al. showed a 
significant increase in the DG to AG ratio following a 61.5 hour fast, with an increase in DG by 
19% (102.2 ± 13.4 vs. 121.9 ± 11.8 pg/ml, P = 0.040) and a decrease in AG by 58% (27.9 ± 3.9 
vs. 11.8 ± 1.7 pg/ml, P = 0.0025) while total plasma ghrelin did not change (130.1 ± 13.7 vs. 
133.7 ± 12.5 pg/ml, P = 0.66) [38].  However, the impact of fasting on the DG to AG ratio may 
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only be evident following long-term fasting.  In a randomized crossover trial on normal weight 
adults (mean age 36 ± 2 y, mean BMI 23 ± 0.7 kg/m2), Lucidi et al. found the DG to AG ratio 
did not change following an overnight fast, with AG accounting for similar amounts of total 
plasma ghrelin following both breakfast consumption and non-breakfast conditions (range 3.4-
3.9% vs. 2.8-3.0%, respectively, P = NS) [57].  Due to the reported effects of, 1) fasting on 
changes in the ratio of DG to AG, and 2) DG on inhibition of the appetite-regulating actions of 
AG, additional research is needed to further explore the impact of breakfast consumption and a 
non-breakfast condition on plasma AG concentrations.   
2.4.1.2 Glucagon-Like Peptide 1 
Unlike ghrelin, which is the only known appetite-stimulating hormone found in the gut, GLP-1 is 
one of many gut peptides associated with appetite suppression and regulation of satiety.  The 
sensation of satiety is dependent upon a cascade of physiological responses, in which the gut 
hormones CCK, GLP-1, and PYY play a primary role [54, 73].  Cholecystokinin is produced in 
the duodenum and upper jejunum and is released quickly into circulation after ingestion of food, 
peaking within 30 minutes of meal initiation.  Its main role is to induce meal termination [34, 54, 
74].  GLP-1 and PYY are produced and released by the L-cells of the distal gut, ileum, colon, 
and rectum in response to intestinal nutrients [34, 58, 73, 74].  Levels of circulating GLP-1 peak 
approximately 60 minutes after meal initiation [73] and levels of PYY peak in the second hour 
after meal initiation [34].  Therefore, it is believed that GLP-1 and PYY do not play a significant 
role in meal termination but instead impact intermeal satiety, leading to decreased energy intake 
at subsequent meals [73].  This occurs through several actions.  For instance, GLP-1 and PYY 
have been shown to slow gastric emptying [52, 75-77], leading Blundell et al. to conclude that 
prolonged gastric extension would lead to release of other satiety-related gastrointestinal 
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hormones and extended vagal stimulation of receptors involved in the control of food intake 
[73].  In addition to slowing gastric emptying, GLP-1 has been reported to reduce gastric acid 
secretion in humans and elicit symptoms of visceral illness in rats, including conditioned taste 
aversion, all of which contribute to feelings of satiety between meals [34, 46, 58, 73, 74, 78].  
However, the main reason GLP-1 is unique as a component of the satiety cascade relates to its 
role in glucose homeostasis. 
 GLP-1 is classified as an incretin, meaning it stimulates insulin secretion from the 
pancreas [28, 73, 79].  It also inhibits glucagon secretion [79, 80].  In addition to being released 
from the distal gut, GLP-1 is also expressed by the alpha cells of the pancreas [81].  As evidence 
of the role of GLP-1 in glucose homeostasis, Edwards et al. reported a significant increase in 
postprandial hyperglycemia following IV infusion of exendin 9-39, a known antagonist of GLP-
1 receptors, compared to infusion of saline (plasma glucose concentrations 8.67 ± 0.35 vs. 7.67 ± 
0.35 mmol/L, respectively, P < 0.005) in a randomized crossover trial on young, normal weight 
adults (mean age 25.5 ± 0.9 y, mean BMI 23 ± 1 kg/m2) [82].  The effect of GLP-1 on glucose 
metabolism coupled with the previously reviewed effect of DG on the secretion of pancreatic 
hormones [72] could help explain the association between regular breakfast consumption and 
decreased energy intake.  The effects that GLP-1 has on increased satiety and glucose 
homeostasis may lead to decreased energy intake at subsequent meals.   
 Three randomized crossover trials examined the effects of IV infusions of GLP-1 versus 
a placebo on energy intake, appetite, and glucose homeostasis [77, 79, 83].  In all three, energy 
intake was significantly lower following GLP-1 infusion compared to the placebo.  Naslund et al. 
[77] reported a mean 21 ± 6% decrease in energy intake in a study on eight obese men (mean age 
35.0 ± 3.8 y, mean BMI 45.5 ± 2.3 kg/m2) (907.6 vs. 1,027.0 kcals at lunch and 549.3 vs. 740.4 
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kcals at dinner, respectively, P = 0.05 for both), while Flint et al. [79] reported a mean 12% 
decrease in a study on 20 young, normal weight men (mean age 25.5 y, mean BMI 23 kg/m2) 
(883.7 ± 72 vs. 1,003.2 ± 48 kcals, P = 0.002).  Gutzwiler et al. reported a dose-dependent 
relationship between increased IV infusions of GLP-1 and decreased energy intake in a study on 
16 young, normal weight men (mean age 23.6 ± 0.5 y, mean BMI not reported) using doses of 
0.375, 0.75, and 1.5 pmol/kg/min (1520 ± 95, 1451 ± 101, and 1107 ± 84, respectively, vs. 1627 
± 97 kcals, P < 0.001 overall).  However, differences in energy intake between the GLP-1 
condition and placebo condition were significant only at the 1.5 dose and the 0.75 dose of GLP-1 
(P < 0.001 and < 0.05, respectively) [83].   
 With respect to subjective ratings of appetite, results were also similar.  In all three 
studies, ratings of hunger were significantly lower and ratings of satiety were significantly higher 
following infusion of GLP-1 compared to the placebo.  Naslund et al. reported significantly 
smaller increases in ratings of hunger and prospective consumption and a significant decrease in 
ratings of fullness between breakfast and lunch (P < 0.05 for each) [77].  Also, between lunch 
and dinner there were significantly smaller increases in ratings of hunger (P = 0.01) and desire to 
eat (P < 0.05) [77].  Flint et al. [79] and Gutzwiler et al. [83] reported significantly greater 
ratings of fullness (P = 0.028 and P < 0.01, respectively) and significantly lower ratings of 
hunger (P = 0.012 and P < 0.05, respectively).  Flint et al. also reported significantly higher 
ratings of satiety (P = 0.013) and significantly lower ratings of prospective food consumption (P 
= 0.012).  However, in the Gutzwiler study, differences were only significant following the 
highest GLP-1 dose.  This association between increased plasma GLP-1 concentrations and 
reduced hunger and increased satiety may be evidence of the fact that gastric emptying was 
significantly delayed by 50% (P <0.001) after breakfast and lunch following infusion of GLP-1 
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compared with placebo as reported by Naslund et al. [77].  Finally, Naslund [77]  and Flint [79] 
also examined changes in ratings of palatability of the test meals and neither found significant 
differences between testing conditions, challenging research that demonstrated symptoms of 
conditioned taste aversion and visceral illness in rats following infusion of GLP-1 [46, 78].   
 Although postprandial hyperglycemia was attenuated following GLP-1 infusion 
compared to placebo infusion in all three studies [77, 79, 83], differences were significant in only 
two of them.  Naslund [77] and Flint [79] reported significantly lower plasma glucose 
concentrations following infusion of GLP-1 compared to placebo after all meals (P < 0.001 and 
0.0001, respectively), but in both studies plasma insulin concentrations were significantly lower 
following GLP-1 infusion after breakfast only (P < 0.001 and 0.002, respectively).  Flint et al. 
also examined glucagon levels and reported that serum concentrations were significantly lower 
following GLP-1 infusion compared to placebo after breakfast only (P < 0.001) [79].  The 
possible reasons for the decrease in insulin and glucagon concentrations following breakfast only 
were not discussed by the investigators.  Lastly, Gutzwiler et al. reported that although the 
insulin response dose dependently increased following infusion of GLP-1, the differences 
compared to placebo infusion were not significant.  This could have occurred because glucose 
was used as the control placebo [83].   
 Verdich et al. conducted a meta-analysis of nine studies examining the effect of IV 
infusion of GLP-1 versus a placebo on energy intake, appetite, and glucose homeostasis in 147 
participants [52].  The investigators reported a mean reduction in total energy intake of 173.1 
kcals (P < 0.001) or 11.7% (P < 0.001) following IV infusion of GLP-1 compared to a placebo.  
The reduction in energy intake was higher in normal weight participants than overweight 
participants, but the difference was not significant (205.5 vs. 132.4 kcals and 13.2 vs. 10.5%, 
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respectively).  Also, the reduction in total energy intake significantly correlated with the 
increasing GLP-1 infusion rate (r = 0.40, P < 0.001) and was similar between weight classes, 
suggesting a dose-dependent relationship between GLP-1 concentrations and subsequent energy 
intake that is not impacted by BMI.  Verdich et al. also reported that differences in plasma GLP-
1 concentrations significantly correlated with differences in ratings of fullness (r = –0.38, P = 
0.013) and prospective consumption (r = 0.40, P = 0.008), but not with hunger (r = 0.26, P = 
0.09).  However, differences in subjective ratings of satiety and hunger did not significantly 
correlate with the reduction in energy intake.  The investigators also reported that a reduction in 
gastric emptying rate significantly correlated with increases in GLP-1 concentrations but not 
placebo (P < 0.01).  However, the three studies of the meta-analysis examining gastric emptying 
rate involved only overweight participants.  Finally, there were no significant differences in 
ratings of visceral illness following IV infusion of GLP-1 when compared with placebo, further 
challenging the research that demonstrated symptoms of conditioned taste aversion and visceral 
illness in rats following infusion of GLP-1 [46, 78]. 
 Since each of these studies involved exogenous infusions of GLP-1 [52, 77, 79, 83], it is 
difficult to conclude that similar responses in energy intake, ratings of hunger and satiety, and 
glucose homeostasis would be realized following increases in normal endogenous concentrations 
of GLP-1.  To complicate comparisons further, these studies used supraphysiological doses of 
GLP-1 to elicit responses in participants.  As seen in the dose-dependent study by Gutzwiler et 
al., significant results were only realized following infusion of supraphysiological doses of 0.75 
and 1.5 pmol/kg/min.  Results following dose levels of GLP-1 that reflected normal endogenous 
concentrations (0.375 pmol/kg/min) were not significant [83].  Another weakness noted is that 
all of the individual studies included only men as participants and none were statistically 
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powered, including only between 8 and 20 men [77, 79, 83].  However, the meta-analysis study 
by Verdich et al. pooled data from 147 participants for its analysis and reported similar results 
[52].  Unfortunately, all of the participants were men also, making it difficult to generalize 
results.  Together these studies demonstrate the physiological effect that GLP-1 has on energy 
intake, appetite, and glucose homeostasis.  The significant results support the need for additional 
research to examine the response of endogenous GLP-1 to breakfast consumption in an effort to 
explain the impact of breakfast consumption on body weight.   
 Only one research study specifically examined the effect of breakfast consumption on 
endogenous plasma GLP-1 concentrations [84].  However, this between-subjects study was 
designed to examine differences in outcomes in obese male participants before and after weight 
loss (mean BMI before 38.7 and after 33.0 kg/m2) as compared with normal weight controls 
(mean BMI 23.1 kg/m2).  Also, a non-breakfast control condition was not part of the study 
design, so the effect of breakfast consumption compared to a non-breakfast condition on the 
acute response of endogenous plasma GLP-1 concentrations can not be assessed.  In the study, 
Verdich et al. reported no correlation between plasma GLP-1 concentrations and subsequent 
energy intake or gastric emptying rate measured scintigraphically in either population, and only a 
weak correlation was seen between GLP-1 concentrations and subjective appetite ratings (r2 = 
0.25, P < 0.03 in obese subjects, r2 = 0.43, P = 0.02 in normal weight subjects) [84].  However, 
the study did report an inverse correlation between decreased AUC of GLP-1 and increased AUC 
of insulin in obese subjects (r2 = 0.31, P < 0.02), which is contrary to the response reported in the 
previously reviewed studies [77, 79, 83].  The investigators felt that the inverse correlation was 
the result of the obese state of the participants in which fasting plasma insulin concentrations are 
often increased and plasma GLP-1 concentrations are decreased when compared to normal 
  29 
weight individuals.  The impact of BMI on pre- and postprandial plasma GLP-1 concentrations is 
reviewed below.  The results of this between-subjects study helped to shed light on the response 
of GLP-1 to breakfast consumption.  However, additional investigation of within-subject 
differences following breakfast consumption and non-breakfast conditions is needed to clarify 
why breakfast consumption may have an impact on body weight.  
 Although they did not specifically examine the effect of breakfast consumption on 
endogenous plasma GLP-1 concentrations, several other studies included postprandial changes in 
GLP-1 concentrations as part of the outcome measures [26, 37, 42, 85, 86].  In addition, 
subjective appetite ratings were measured in two studies [26, 42] and postprandial changes in 
plasma insulin and glucose concentrations were monitored in three studies [26, 85, 86].  As with 
the study by Verdich et al [84], a non-breakfast control condition was not part of the research 
design in any of the studies, so within-subject differences in the response of endogenous GLP-1 
to breakfast consumption versus a non-breakfast condition can not be fully assessed.  Results 
demonstrating the postprandial temporal pattern of the GLP-1 response to breakfast consumption 
differed among the studies.  In three studies, plasma GLP-1 concentrations peaked at 
approximately 30 minutes following breakfast consumption and trended toward baseline levels 
within 120 minutes [37, 85, 86].  However, in two other studies, plasma GLP-1 concentrations 
peaked at approximately 60 minutes or later and trended back toward baseline levels after 120 
minutes following consumption of high-protein or high-carbohydrate dairy breakfasts [26] or 
breakfasts rich in protein, carbohydrate, or fat [42].  The aim of each of these studies, though, 
was to examine the impact of different macronutrients on the GLP-1 response.  It is likely that 
the differences in temporal patterns of the GLP-1 response are the result of the macronutrient 
composition of the test meal used.  The impact of the macronutrient content of foods on 
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postprandial plasma GLP-1 concentrations is reviewed below.  The only outcome in the above 
studies to be correlated with endogenous plasma GLP-1 concentrations was subjective appetite 
ratings.  Adam et al. reported that subjective ratings of satiety significantly increased in relation 
to increased concentrations of GLP-1 at 60 minutes (r = 0.42, P = 0.02) and 90 minutes (r = 0.39, 
P = 0.03) following breakfast consumption [85].  This is in agreement with the research 
reviewed above that showed an association between exogenously infused GLP-1 and decreased 
appetite [77, 79, 83].  Finally, even though postprandial changes in plasma insulin and glucose 
concentrations were not correlated with changes in GLP-1 concentrations, a comparison of 
temporal trends of the hormones following breakfast consumption supports the following 
research studies reporting a positive association between GLP-1 and the insulin response.  In two 
studies [26, 42], glucose levels peaked and returned to preprandial baseline levels by the time 
plasma GLP-1 concentrations peaked, while in another study [86] glucose levels remained flat 
during the entire course of monitoring even though plasma GLP-1 concentrations peaked at 60 
minutes.  This may have been due to the use of a high-protein gelatin test meal that was 
artificially sweetened [86].  In all three studies, insulin levels peaked approximately 30 minutes 
prior to the peak of plasma GLP-1 concentrations and then trended to baseline levels at rates 
similar to GLP-1 [26, 42, 86].  These trends support research demonstrating an association 
between increased plasma GLP-1 concentrations and glucose homeostasis that was reviewed 
above.  An examination of the response of plasma GLP-1 concentrations to breakfast 
consumption is needed due to the lack of research investigating differences in the response of 
GLP-1 between breakfast consumption and non-breakfast conditions.  A better understanding of 
this association may help to explain the relationship between breakfast consumption and body 
weight.   
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 In reviewing the existing literature, there is evidence to support the hypothesis of a 
response in plasma AG and GLP-1 concentrations to breakfast consumption as a plausible 
mechanism to explain the impact of breakfast consumption on body weight.  However, because 
the results of the literature have been mixed, mostly due to differences in research methodology, 
this study will examine the acute effect of breakfast consumption on plasma AG and GLP-1 as 
part of the pathway that links breakfast consumption to a healthy body weight.   
2.5 BREAKFAST MEAL CONSIDERATIONS  
2.5.1 Defining Breakfast 
An important factor in the discrepancies in results of research investigating the association 
between breakfast consumption and body weight is differences in how each research team 
defined the variable breakfast.  In a paper that reviewed the impact of breakfast consumption on 
weight loss, Ruxton and Kirk concluded that conflicting results arose from lack of a standard 
definition of breakfast [87].  Due to the fact that breakfast consumption and a non-breakfast 
condition are independent variables in the proposed study, a clear definition of breakfast is 
important to ensure that outcome measures are comparable between study conditions.  Of the 
research studies reviewed in sections 2.2, 2.3, and 2.4, only three specifically defined the 
variable breakfast [8, 11, 88].  Song et al. allowed the participants to identify breakfast in self-
reporting their daily intake [8].  The other two studies, though, provided more objective 
definitions.  Affenito et al. considered breakfast as any eating between 5:00 a.m. and 10:00 a.m. 
on weekdays and between 5:00 a.m. and 11:00 a.m. on weekends [11], and Siega-Riz et al. 
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considered breakfast as any food or beverage consumed between the hours of 5:00 a.m. and 
10:00 a.m. [88].   
 Of all the research studies reviewed for this paper, only five others defined breakfast.  
Like Song et al., two allowed the participants to identify what breakfast was [9, 15].  A study by 
Haines et al. used guidelines similar to those of Affenito [11] and Siega-Riz [88] in considering 
breakfast as any consumption between 5:00 a.m. and 9:00 a.m. [12].  Nicklas et al. did not take 
the timing or frequency of meal consumption into consideration and instead defined breakfast as 
food or a mixture of foods that were at least equal in macronutrient values to that of one serving 
of milk [13].  Also, in considering studies for a review article, Timlin et al. accepted those that 
defined breakfast as the first meal of the day that was consumed within two hours of waking or 
before the start of daily activities and typically no later than 10:00 a.m. and was of a calorie level 
between 20% and 35% of total daily energy needs [20].  In the proposed study, the definition of 
breakfast will follow criteria used in the studies by Haines et al. [12], Affenito et al. [11], and 
Siega-Riz et al. [88] since their criteria were based on results from the Nationwide Food 
Consumption Survey and the Continuing Survey of Food Intakes by Individuals, two large 
national surveys established by the U.S. Department of Agriculture (USDA).  The definition will 
also include criteria used in the study by Nicklas et al. since it considered a minimum caloric 
content [13].  In the proposed study, breakfast is defined as consumption of a food or mixture of 
foods that equals or exceeds the kilocalorie content of one serving of milk (approximately 120 
kilocalories) between the hours of 5:00 a.m. and 10:00 a.m. on weekdays and between 5:00 a.m. 
and 11:00 a.m. on weekends [11-13, 88].   
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2.5.2 Macronutrient Composition of the Breakfast Meal 
Another factor that may have contributed to the discrepancies in results of research investigating 
the association between breakfast consumption and body weight is differences in the 
macronutrient content of the breakfast meal used in each study.  The macronutrient content of the 
breakfast meal needs to be considered as it may mediate a relationship between breakfast 
consumption and plasma AG and GLP-1 concentrations, ratings of hunger and satiety, or energy 
intake.  Three macronutrients provide nearly all of the energy for the typical person: 
carbohydrate, fat, and protein [89].  Carbohydrate and protein provide 4 kilocalories per gram 
while fat provides 9 kilocalories per gram [89].  Based on the USDA Food Guide from the 
Dietary Guidelines for Americans, 2005, it is recommended that a healthy diet is comprised of 
approximately 55% carbohydrate, 30% fat, and 15% protein [2]. 
Previous research has demonstrated that each of these macronutrients may impact plasma 
AG and GLP-1 concentrations, ratings of hunger and satiety, and subsequent energy intake 
differently.  However, results have been mixed.  Johannes Erdmann and colleagues have 
investigated the impact of macronutrients on plasma ghrelin concentrations, ratings of hunger 
and satiety, and subsequent energy intake following breakfast through several randomized 
crossover trials on normal weight and obese adults [30-33].  Erdmann and his research associates 
came to several conclusions with respect to carbohydrate.  First, total plasma ghrelin 
concentrations significantly decreased following carbohydrate-rich meals for up to four hours, 
with the exception of potatoes, after which total ghrelin concentrations significantly increased 
[30-33].   Second, even though total plasma ghrelin concentrations significantly decreased 
following most carbohydrate meals, feelings of hunger and satiety did not always correlate to 
levels of total plasma ghrelin [30, 31, 33].  Third, in one study subsequent energy intake 
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following carbohydrate-rich foods (790 ± 77 kcals) was significantly greater than subsequent 
energy intake following protein- and fat-rich meals (721 ± 79 and 613 ± 75 kcals, respectively).  
One exception pertained to fruit and vegetable sources of carbohydrate which resulted in 
subsequent energy intake (988 ± 86 and 972 ± 85 kcals, respectively) greater than that of the 
carbohydrate-rich foods [33].  However, in another study comparing carbohydrate- and protein-
rich foods, subsequent energy intake was not significantly different following consumption of 
each meal (597 ± 39.6 and 621 ± 44.5 kcals, respectively) [31]. 
With regard to fat, Erdmann et al. found that total plasma ghrelin concentrations 
remained flat and then significantly decreased following a fat-rich meal in one study (nadir 415 ± 
45.2 pg/ml at 180 min.) [32], while in another study ghrelin significantly increased (peak 509 ± 
77 pg/ml at 45 min.) [33].  Erdmann  et al. observed ratings of hunger and satiety and subsequent 
energy intake following a fat-rich meal in only one study and found no significant correlation 
between total plasma ghrelin concentrations and hunger and satiety ratings, but did find that 
subsequent energy intake following a fat-rich meal (613 ±75 kcals) was significantly less than 
subsequent energy intake following meals rich in protein, carbohydrate, fruit, and vegetables 
(721 ± 79, 790 ± 77, 988 ± 86, and 972 ± 85 kcals, respectively) [33]. 
Finally, in investigating outcomes following meals rich in protein, Erdmann et al. came to 
several additional conclusions.  First, total plasma ghrelin concentrations significantly increased 
following protein-rich meals for as much as four hours [31-33].  Second, feelings of hunger and 
satiety did not correlate to levels of total plasma ghrelin and were similar to those following 
carbohydrate-rich meals [31, 33].  Third, as above, subsequent energy intake following a protein-
rich meal was significantly greater than following a fat-rich meal [33], and either similar to or 
significantly less than following a carbohydrate-rich meal [31, 33]. 
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Summarizing the outcomes from Erdmann’s research, it appears that, with exceptions, 
total plasma ghrelin concentrations generally decrease following consumption of carbohydrate-
rich foods and increase following consumption of protein-rich foods, ratings of hunger and 
satiety do not correlate well with total plasma ghrelin levels among all of the macronutrients, and 
subsequent energy intake varies following consumption of each of the macronutrients.  It should 
be noted that Erdmann examined changes in total ghrelin and not AG which could explain the 
lack of correlation between levels of plasma ghrelin and ratings of hunger and satiety. 
Other research reported different results.  In a non-randomized crossover study on young, 
normal weight men (mean age 20.5 ± 2.5 y, mean BMI 21.6 ± 1.9 kg/m2), Blom et al. reported 
that although the total AUC of the ghrelin response was a significant ~45% greater following a 
protein-rich breakfast than following a carbohydrate-rich breakfast (P <0.01), the total AUC of 
the AG response was not significantly different.  They also found the AUC of GLP-1 to be ~66% 
greater following the protein-rich breakfast than following the carbohydrate-rich breakfast, but 
the difference was not significant (P = 0.10).  In addition, subjective ratings of hunger and satiety 
did not correlate with AG or GLP-1 concentrations and no significant associations were found 
between the AUC of the ghrelin response and energy intake at lunch.  Examining an association 
between the AUC of GLP-1 and subsequent energy intake was not within the scope of the study 
[26].  In another randomized crossover adult study (mean age 55.3 ± 2.9 y, mean BMI 29.2 ± 2.2 
kg/m2), Greenman et al. reported that total plasma ghrelin levels significantly decreased 
following a high glucose breakfast (P < 0.0001),  significantly decreased following a high fat 
breakfast, but only in women (P = 0.029), and had no significant change following a high protein 
breakfast.  Finally, in another randomized crossover study on young, normal weight adults (mean 
age 23.3 ± 0.5 y, mean BMI 22.1 ± 0.4 kg/m2), Raben et al. found no significant differences in 
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the AUC of GLP-1, in subjective ratings of hunger and satiety, or in subsequent energy intake 
following protein-rich, carbohydrate-rich, and fat-rich breakfasts [42].  Summarizing these 
studies, plasma AG concentrations responded similarly following carbohydrate consumption and 
protein consumption even though total plasma concentrations differed, GLP-1 concentrations 
trended higher following protein consumption in one study but not in another, and subjective 
ratings of hunger and satiety and subsequent energy intake were similar following consumption 
of carbohydrate, protein, and fat.   
Based on the equivocal results of the above research studies, the macronutrient 
composition of the breakfast meal needs to be considered in the proposed study as it may impact 
stimulation or inhibition of AG or GLP-1, subjective ratings of hunger and satiety, and 
subsequent energy intake.  To control for the macronutrient content of the breakfast meal, a 
mixed meal will be used and comply with the macronutrient profile recommendations for a 
healthy diet suggested by the USDA Food Guide of the Dietary Guidelines for Americans, 2005 
[2].  The meal will consist of approximately 45-55% carbohydrate, 30-35% fat, and 15-20% 
protein. 
2.5.3 Energy Content of the Breakfast Meal 
One last factor that may have contributed to the discrepancies in results of research investigating 
the association between breakfast consumption and body weight is differences in the energy 
content of the breakfast meal used in each study.  The energy content of the breakfast meal has 
been shown to impact plasma ghrelin concentrations proportionally.  In a three-stage randomized 
crossover trial on normal weight adults (mean age 22.5 y, mean BMI 22.6 kg/m2), Callahan et al. 
demonstrated significantly increasing plasma ghrelin responses to breakfast meals that provided 
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7.5%, 16%, and 33% of the participants’ estimated daily energy expenditure (nadir levels 80.2 ± 
2.8, 72.7 ± 2.7, and 60.8 ± 2.7% of baseline, respectively, P < 0.001) [90].  Therefore, in the 
proposed study it will be important to provide a breakfast meal that contributes a standardized 
percentage of the estimated daily energy expenditure of participants to control for the effect of 
the energy content of the meal on the ghrelin response. 
 Cross-sectional studies, intervention studies examining free-living conditions, and 
retrospective analysis studies have demonstrated that breakfast contributes approximately 10% to 
22% of the total daily energy intake of U.S. adults, with an average range of approximately 15% 
to 20% [8, 12, 13, 15, 51].  In an intervention study examining eating patterns following a 
behavioral weight loss program, Carels et al. reported that breakfast contributed 14.6% of total 
daily energy intake in overweight adults [15].  Also, in a retrospective analysis of U.S. adults 
who were NHANES 1999-2000 respondents, Song et al. reported that 9.9% to 18.6% of total 
daily energy came from breakfast [8].  Finally, in a review paper Ruxton and Kirk reported that 
breakfast contributed from 6% to 20% of total daily energy intake in children worldwide and that 
the contribution of breakfast to total energy intake in adults was often lower than or similar to 
that of children.  However, the paper did not give a specific range for adults [87].  Based on these 
sources, breakfast contributes approximately 14% of total daily energy intake in adults. 
  Other sources, though, reported a larger contribution from breakfast.  Haines et al. 
reported in a trends analysis pool of three cross-sectional studies on breakfast consumption by 
U.S. adults that breakfast contributed from 18% to 22% of total daily energy intake [12].  
Similarly, Nicklas et al. reported a 19% contribution [13], and Siega-Riz et al. reported a less 
than 25% contribution in U.S. adults in their cross-sectional studies [88] 
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.  Finally, in a Dutch randomized controlled trial investigating the effects of a high and normal 
soy protein breakfast on satiety hormones, ratings of satiety, and energy intake, Veldhorst et al. 
used a breakfast meal for an intervention that contained 20% of daily energy requirements 
because it was the average reported for the general population of the Netherlands [51].  The 
mean contribution of breakfast based on these results is approximately 21%.  Based on the above 
research and to ensure adequate intake for statistical comparisons, the proposed study will 
provide participants with a breakfast meal that will account for 20% of their estimated daily 
caloric needs. 
2.6 ADDITIONAL FACTORS THAT IMPACT APPETITE REGULATING 
HORMONES 
2.6.1 Age 
There is some research that demonstrates changes in fasting and postprandial ghrelin 
levels with age.  In a pre-test, post-test intervention study that compared fasting and postprandial 
ghrelin levels in older and younger adults (mean  age 75.2 ± 1.8, BMI 21.1-28.3 kg/m2 vs. 28.1 ± 
0.7 y, BMI 18.9-24.5 kg/m2), Di Francesco et al. reported that fasting AG levels were 
significantly lower in elderly participants (42.5 ± 4.8 vs. 62.8 ± 9.5 pg/ml, P = 0.04).  Also, 
following breakfast consumption AG levels stayed flat in elderly participants while they 
significantly decreased and then rose to preprandial levels in younger participants (time × age 
interaction effect P = 0.03) [91].  In a cross-sectional study comparing younger and older (mean 
age 24.2 ± 2.6 vs. 39.4 ± 6.9 y) lean (mean BMI 21.4 ± 0.31 vs. 21.9 ± 0.48 kg/m2), overweight 
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(mean BMI 27.1 ± 0.47 vs. 27.4 ± 0.30 kg/m2), and obese (mean BMI 34.7 ± 1.30 vs. 37.1 ± 1.0 
kg/m2) women, Schutte et al. showed that decreased fasting plasma ghrelin concentrations 
significantly correlated with increased age (r = –0.20, P < 0.05) [92].  Makovey et al. also 
showed a correlation, but not a strong one [93].  In a cross-sectional study that examined total 
ghrelin concentrations in younger and older participants (mean age 37.48 ± 8.97 vs. 59.15 ± 5.85 
y, mean BMI 26.4 ± 4.9 vs. 27.3 ± 3.7 kg/m2), it was reported that increased age significantly 
predicted decreased ghrelin levels after adjusting for gender, fat mass, and body size, but it only 
accounted for 15-20% of the variance (P < 0.05) [93].  However, in a randomized crossover trial 
on adults ranging in ages from 26 to 74 years (mean age 55.3 ± 2.9 y, mean BMI 29.2 ± 2.2 
kg/m2) that examined total plasma ghrelin concentrations following breakfast consumption 
versus a non-breakfast condition, Greenman et al. found no correlation between ghrelin levels 
and age [94].  Makovey et al., however, reported that lack of a significant correlation in the 
Greenman study was likely due to lack of power [93].  Greenman et al. included 24 participants 
in their study while Makovey et al. included 158 participants.  Due to the fact that three studies 
did find a significant association between age and plasma ghrelin concentrations, particularly one 
in which AG concentrations were compared [91], recruitment for the proposed study will be 
limited to adult participants between the ages of 18 and 40 years.  The upper limit of 40 years 
was chosen because it is the approximate median of 30 years and 51.2 years, the upper age limits 
used for the younger groups in the studies by Schutte et al. and Makovey et al., respectively. 
2.6.2 Activity Level 
Research has reported an effect of exercise on plasma ghrelin concentrations.  It will, therefore, 
be important to consider activity level as a factor that potentially could impact appetite regulating 
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hormones.  As evidence, two studies involving non-trained adults that compared changes in 
ghrelin concentrations between exercise and non-exercise conditions reported a positive 
association [95, 96].  Cheng et al. examined the acute effects of 50 minutes of moderate intensity 
exercise on appetite regulation in a randomized crossover trial [96].  In the study, young men 
(mean age 24.6 ± 4.8 y, mean BMI 25.4 kg/m2) completed three trials: breakfast consumption 
followed by exercise, exercise followed by breakfast consumption, and breakfast consumption 
only.  It was reported that pre-breakfast fasting plasma ghrelin concentrations significantly 
increased and pre-breakfast subjective hunger ratings significantly decreased one hour after 
exercise in the exercise followed by breakfast condition (P ≤ 0.05 for both).  Also, plasma 
ghrelin concentrations were significantly greater and subjective ratings of hunger were 
significantly lower after the breakfast consumption followed by exercise condition when 
compared with the breakfast consumption only condition (P ≤ 0.05 for both) [96].  This study, 
though, investigated the acute effects of exercise on total plasma ghrelin.  Only two studies have 
specifically investigated the acute effects of exercise on AG.  In a randomized crossover trial on 
young men (mean age 21.2 ± 0.7 y, mean BMI 22.2 ± 0.7 kg/m2), Broom et al. reported that the 
total AUC for AG concentrations was significantly greater following exercise than following the 
sedentary control condition (mean 510 vs. 317 pg/ml/3 h, P = 0.021; and mean 1401 vs. 917 
pg/ml/9 h, P = 0.033) and that hunger ratings during the first three hours of the trials were 
significantly higher during the control condition than the exercise condition (mean score 32 vs. 
24, P = 0.013) [95].  However, in another randomized crossover trial, Unick et al. reported that 
AG was unaltered by exercise (time × condition interaction effect P = 0.16), as were subjective 
hunger ratings (AUC for hunger scores, exercise: 395.5 ± 164.5 vs. resting: 391.7 ± 192.6, P = 
0.94) [97].  None of the above studies, though, examined the long-term effects of exercise on 
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fasting plasma ghrelin concentrations.  Therefore, it is difficult to conclude that the AG 
concentrations of sedentary individuals would respond to breakfast consumption differently than 
AG concentrations of individuals who regularly exercise.   
 Although there have been several research studies demonstrating the effects of exercise 
on GLP-1 concentrations in trained athletes and children [98-100], only the study by Unick et al. 
has examined the effects on non-trained adults [97].  The investigators reported that although the 
overall condition × time interaction effect was not significant (P = 0.41), the AUC for GLP-1 
over the entire testing day was significantly lower after exercise (exercise: 402.4 ± 98.8 vs. rest: 
422.8 ± 103.2 ng/mL × 120 min., P < 0.05).  As with AG, though, no studies have examined the 
long-term effects of exercise on fasting GLP-1 concentrations, thus making it difficult to 
conclude that GLP-1 concentrations would respond to breakfast consumption differently between 
sedentary and active individuals.  Regardless, research has demonstrated a significant association 
between physical activity and AG, GLP-1 and subjective hunger ratings.  Thus, the level of 
physical activity of participants will need to be controlled in the proposed study so that an 
association between breakfast consumption and plasma AG and GLP-1 concentrations can be 
appropriately examined.  To control for the effect of physical activity on plasma AG, plasma 
GLP-1, and subjective hunger ratings, recruitment will be limited to sedentary participants who 
engage in less than 30 minutes of moderate-intensity exercise per week.  Physical activity will be 
estimated for both testing days.  It will be self-reported by participants in a food and physical 
activity diary.  
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2.6.3 BMI 
Research shows that fasting levels of plasma ghrelin and GLP-1 are different between normal 
weight, overweight, and obese individuals [27, 49, 84, 85, 94, 101, 102].  Plasma ghrelin levels 
are negatively correlated with BMI [49, 94, 102].  In a cross-sectional study and a randomized 
crossover trial on lean (mean BMI 25.4 ± 2.3 kg/m2), overweight (mean BMI 29.2 ± 2.2 kg/m2), 
and obese (mean BMI 38.2 ± 4.8 kg/m2) adults (mean age 42.0 ± 5.6 y), Tschop et al. and 
Greenman et al., respectively, reported similar inverse correlations between increased BMI and 
decreased fasting total plasma ghrelin levels (r = –0.50, P < 0.01 and r = –0.47, P = 0.02, 
respectively) [49, 94].  In obese individuals, fasting levels of plasma ghrelin are lower and 
postprandial decreases are often attenuated when compared with normal weight individuals [49, 
101-104].  In cross-sectional studies on normal weight (mean BMI 23.2 ± 0.8 kg/m2), overweight 
(mean BMI 29.2 ± 2.2 kg/m2), and obese (mean BMI 33.7 ± 2.7 kg/m2) adults, both Tschop et al. 
and Shiiya et al. reported fasting plasma ghrelin concentrations in obese adults to be 32% lower 
than in normal weight adults (P < 0.01 and < 0.05, respectively) [49, 101].  Additionally, in an 
observational trial that examined differences in plasma ghrelin concentrations following 
breakfast in normal weight (mean BMI 22 ± 2.2 kg/m2) and obese (mean BMI 33.8 ± 5.7 kg/m2) 
adults, Erdmann et al. reported that the postprandial decrease in plasma ghrelin concentrations in 
obese participants was attenuated when compared with normal weight participants (–137.6 ± 107 
pg/ml vs. –214.8 ± 247 pg/ml, respectively, P < 0.001) [103].  Plasma ghrelin levels also change 
with weight loss.  In a weight loss intervention trial on adults, Cummings et al. demonstrated a 
24% increase in the AUC for the 24-hour ghrelin profile following diet-induced weight loss of 
17% of initial body weight over six months (2772 ± 334 pmol-days/L pre-weight loss vs. 3429 ± 
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429 pmol-days/L post-weight loss, P = 0.006) [27].  Shiiya et al. have proposed that ghrelin 
concentrations are inversely correlated with BMI and change with weight loss as part of a 
negative feedback mechanism to maintain energy homeostasis [101].  This would theoretically 
occur through up-regulation of ghrelin expression under conditions of negative energy balance, 
such as in times of starvation or high energy expenditure, and down-regulation under conditions 
of positive energy balance, such as obesity [101].  The reviewed studies have examined the 
effects of body weight on total plasma ghrelin.  Only one study has compared fasting and 
postprandial levels of plasma AG between weight classes and found no correlation [97].  
However, a non-breakfast condition was not a part of the research design.  Because of that and 
due to the fact that the ratio of AG to DG can change while total plasma ghrelin concentrations 
stay the same, it is difficult to conclude that plasma AG levels correlate with BMI. 
Like plasma ghrelin concentrations, research shows that GLP-1 concentrations are lower 
in obese individuals than normal weight individuals.  For example, following a weight loss 
intervention trial on adult men, Verdich et al. reported that the total AUC for GLP-1 was lower 
in obese participants before and after weight loss compared to normal weight participants (P < 
0.05), but following weight loss the response improved in reduced obese participants to 80-88% 
of that of normal weight participants (P = 0.003).  The AUC for GLP-1 increased in a stepwise 
manner when comparing obese to reduced obese to normal weight participants (P = 0.003) [84].  
Examining differences between weight classes in the responses of AG and GLP-1 to breakfast 
consumption is a primary aim of this study.  An equal number of normal weight, overweight, and 
obese participants will be recruited into the study.  Also, in an effort to control for the effect of 
changes in body weight on plasma AG and GLP-1 levels, recruitment will be limited to weight-
stable women who have lost no more than 10 pounds over the six months prior to testing.  The 
  44 
10 pound limit was chosen as it was less than the lower end of the weight reduction range (5.3-
32.7 kg) in the study by Verdich, et al. in which a significant change in the response of GLP-1 
was noted after a six month weight loss intervention [84].  
2.6.4 Frequency of Breakfast Consumption  
Farshchi et al. reported that irregular meal frequency, including variability in breakfast 
consumption, disturbs energy metabolism [21, 105, 106].  This is mainly due to changes in the 
insulin response.  In a randomized crossover study involving normal weight women (mean age 
23.7 ± 7.4 y, mean BMI 22.4 ± 2.4 kg/m2), the investigators reported a greater insulin response 
occurring after irregular meal patterns (a predetermined meal frequency varying between 3-9 
meals/day for 14 days) than after regular meal patterns (6 occasions/day for meals and snacks) (P 
= 0.001) [105, 106].  Specifically to breakfast, they reported that the AUC of insulin profile 
showed a significantly greater response following a breakfast skipping period than after a 
breakfast consumption period [21].  This is important because since GLP-1 is known to have a 
strong incretin effect on glucose-dependent insulin secretion [22, 34], it is possible that an 
irregular breakfast consumption pattern could impact GLP-1 if it is also having an effect on the 
insulin response.  Unfortunately, plasma GLP-1 concentrations were not an observed outcome in 
the Farshchi study.  Based on the research of Farshchi et al., breakfast consumption frequency is 
a factor that needs to be controlled in future research.  Farshchi et al. did not define breakfast 
consumption, but simply stated that only participants who usually ate breakfast were recruited 
for the study.  However, in a cross-sectional study that examined the weight maintenance 
behaviors of NWCR participants who consume breakfast regularly (n = 2645) compared to 
individuals who do not consume breakfast regularly (n = 314), Wyatt et al. identified regular 
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breakfast consumers as those eating breakfast four or more times per week and non-regular 
breakfast consumers as those eating breakfast three or fewer days per week [16].  They reported 
no difference between groups in weight lost (32 vs. 34 kg, respectively, P = 0.14), duration of 
weight-loss maintenance (7.9 vs. 7.7 y, respectively, P = 0.29), or daily energy intake (1394 vs. 
1366 kcals/day, respectively, P = 0.50).   However, regular breakfast consumers did engage in 
slightly more physical activity than non-regular consumers (2657 vs. 2391 kcal/wk, respectively, 
P = 0.05).  Based upon these results, for the proposed study recruitment will be limited to 
participants who consume breakfast at least 4 days per week. 
2.6.5 Blood Sampling Timing 
It is important that blood is sampled at appropriate times to monitor the changes in AG and GLP-
1 concentrations.  Based upon the previously reviewed research [26, 37, 38, 42, 57, 84, 85], AG 
is reported to reach nadir levels and GLP-1 is reported to reach peak levels within one hour of 
meal consumption.  Both have been observed to then trend to preprandial levels within an 
additional hour.  Also, it appears that even though circulating concentrations of AG and GLP-1 
correlate with BMI, the temporal pattern of each is not impacted by body weight.  As an 
example, Cummings et al. reported that although plasma ghrelin levels were greater in the 
normal weight controls than the obese participants, both before and after weight loss, the 
temporal pattern was similar at all time points across all weight class conditions when monitored 
over a 24-hour period [27]. 
In the reviewed literature that examined postprandial changes in ghrelin and GLP-1, 
plasma concentrations were commonly sampled for either two [85, 101, 107] or three hours [26, 
48, 51, 84, 94].   The timing of blood samples varied between studies, occurring as frequently as 
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once every 15 minutes [84] to once per hour [48, 107].  Samples were commonly drawn at 
baseline, 30, 60, 90, and 120 minutes [51, 85, 94].  Based upon the research and the resources 
available to conduct the proposed study, blood will be sampled over two hours, once 
immediately before breakfast consumption and a non-breakfast waiting period and then at 30, 60, 
and 120 minutes after each testing condition. 
2.7 CONCLUSIONS 
It has been observed that individuals who have successfully maintained their body weight 
regularly consume breakfast [7].  It has been hypothesized that the hormonal response to 
breakfast consumption is a plausible mechanism to explain the impact of breakfast consumption 
on body weight [22-52], but this relationship has not been thoroughly examined.  The orexigenic 
gut hormone acylated ghrelin and the anorexigenic gut hormone GLP-1 have been identified as 
two appetite-regulating hormones that are highly responsive to nutrient intake and play a role in 
glucose homeostasis [23, 24, 27, 28, 34, 41, 54, 68, 72-74, 79, 80].  They, therefore, may play a 
significant role in the pathway between breakfast consumption and successful maintenance of 
body weight.  Results of studies examining the influence of breakfast consumption on acylated 
ghrelin and GLP-1 have been mixed, mostly due to differences in research methodology.  This 
study will focus on the acute effect of breakfast consumption on acylated ghrelin and GLP-1.  It 
is hypothesized that plasma AG concentrations will be significantly lower and plasma GLP-1 
concentrations will be significantly higher following breakfast consumption than following a 
non-breakfast condition.  This study will also explore and compare subjective ratings of hunger 
and satiety following both testing conditions and correlate them with plasma acylated ghrelin and 
  47 
GLP-1 concentrations, respectively.  Also, differences in self-reported levels of total daily 
energy intake between testing conditions will be examined as will the impact of BMI on plasma 
acylated ghrelin and GLP-1 concentrations following both testing conditions.  Understanding the 
relationship between breakfast consumption and body weight will provide evidence to support a 
simple strategy to prevent and treat obesity  
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3.0  RESEARCH DESIGN AND METHODS 
3.1 SUBJECTS 
A total of 20 pre-menopausal women between the ages of 18 and 40 years who regularly eat 
breakfast were recruited to participate in this study.  Only women were recruited because a 
gender effect is not a hypothesis of the study and the study was not powered to examine a gender 
effect.  Women were chosen instead of men since 77% of participants in the NWCR are women 
[7].  Sedentary, younger women were used to control for the effects of exercise [39, 96, 108] and 
aging [91, 109] on AG and GLP-1.  The sedentary condition was defined as less than 30 minutes 
of moderate-intensity aerobic exercise per week over the six months prior to recruitment.  Only 
women who reported regular breakfast consumption were used to control for the effect of 
irregular meal frequency on energy metabolism and appetite-regulating hormones [21, 105, 106].  
Regular breakfast consumption was defined as consuming breakfast four or more days per week 
based upon the data reported by Wyatt et al. in their cross-sectional study that described 
breakfast consumption practices of NWCR participants [16].  The independent variable breakfast 
was defined as consuming a food or mixture of foods that equals or exceeds the kilocalorie 
content of one serving of milk between the hours of 5:00 a.m. and 10:00 a.m. on weekdays and 
between 5:00 a.m. and 11:00 a.m. on weekends [11-13, 88].  Seven normal weight (BMI 18.5-
24.9 kg/m2), seven overweight (BMI 25.0-29.9 kg/m2), and six Class I or Class II obese (BMI 
  49 
30.0-39.9 kg/m2) women were recruited so that the exploratory aim investigating the effect of 
BMI on the acute response of plasma AG and GLP-1 following a breakfast and non-breakfast 
condition could be examined, although the study was not powered to identify statistically 
significant differences.   
Exclusionary criteria were: 
1. Breakfast consumption < 4 days per week.  Farshchi et al. have reported disturbances 
in energy metabolism following irregular breakfast consumption patterns, but did not 
define regular breakfast consumption [21, 105, 106].  Other research studies 
comparing breakfast consumption and non-breakfast conditions have considered 
participants who eat breakfast at least four times per week as regular breakfast 
consumers [14, 16, 63, 110].      
2. Working between the hours of midnight and 8:00 a.m.  Waking diurnal patterns may 
impact the response of AG and GLP-1 to meal consumption if monitored at a time 
when participants are normally eating supper than when breakfast is normally 
consumed [101, 111, 112].  Other research has also demonstrated an effect of sleep 
deprivation and daylight influence on plasma ghrelin levels [113, 114]. 
3. History of type 1 or type 2 diabetes.  Both ghrelin and GLP-1 interact with insulin 
and glucose as part of a feedback loop.  Irregular glycemic and insulin responses 
associated with diabetes can impact ghrelin and GLP-1 responses [28, 44, 56, 101, 
102, 115].   
4. Current diagnosis of an eating disorder.  Research has reported an association 
between diagnosed bulimia nervosa [116] and anorexia nervosa [117, 118] and 
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significantly increased basal GLP-1 and basal ghrelin levels, respectively, when 
compared to healthy controls.  
5. Currently pregnant or up to nine weeks post-partum and/or lactating.  Research has 
reported that AG is significantly decreased during pregnancy and the percentage of 
total ghrelin that is AG is significantly greater up to nine weeks post-partum when 
compared to non-pregnant women [119, 120]. 
6. Currently on a weight-loss or weight-gain regimen.  Research has reported that the 
ghrelin and GLP-1 responses are inversely associated with significant changes in 
weight.  Both responses are down-regulated in obese individuals and increase with 
significant weight loss [27, 49, 84, 101, 103].   
7. History of bariatric surgery.  Research has reported that bariatric surgeries, such as 
Roux-en-Y gastric bypass and intragastric balloon, are associated with significantly 
decreased ghrelin responses and significantly increased GLP-1 responses [27, 121, 
122].  
8. Current use of medications that could affect weight or eating patterns (e.g. steroids).  
As above, the ghrelin and GLP-1 responses are inversely associated with significant 
changes in weight [49, 84].   
9. Current diagnosis of a medical condition that could alter metabolism and weight (e.g. 
thyroid disease).  As above, the ghrelin and GLP-1 responses are inversely associated 
with significant changes in weight [49, 84].   
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3.2 RECRUITMENT 
Participants were recruited through internet sources and local flyers.  After giving verbal 
consent, they underwent an initial telephone screening by a staff member of the University of 
Pittsburgh’s Physical Activity and Weight Management Research Center (PAWMRC) to ensure 
eligibility requirements were met.  During the telephone screening, BMI was calculated based on 
the participant’s self-reported height and weight.  Once seven participants were recruited in a 
weight class, additional potential participants within that weight class’ BMI range were 
excluded.  The BMI of each participant was confirmed by measurement of weight and height at 
the PAWMRC prior to testing. 
Each participant attended an orientation session at which details of the study were 
reviewed and an opportunity to have questions answered was provided.  At the session, 
participants completed a medical history questionnaire and a Stunkard and Messick Three-Factor 
Eating Questionnaire [123].  Height and weight were assessed so assignment to the recruited 
weight class could be verified and the kilocalorie amount of the breakfast meal could be planned.  
In addition, waist and hip measurements were taken and body fat was assessed via bioelectrical 
impedance analysis (BIA) for potential future analysis of differences in outcomes between 
weight classes.  Prior to the initiation of in-person screening or experimental procedures, 
participants signed an informed consent document to verify their acknowledgement of the study 
procedures and their understanding of any associated risks with the study procedures.  All study 
procedures were approved by the University of Pittsburgh Institutional Review Board.   
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3.3 STUDY DESIGN 
Participants reported to the PAWMRC on two separate days within a two-week period, separated 
by at least 3 days.  The study used a randomized crossover design in which participants were 
randomly assigned to one of two initial study conditions: breakfast consumption following an 
overnight fast or no breakfast following an overnight fast.  The second testing session took place 
3 to 14 days after the first session.  Testing procedures were the same following each study 
condition.  Both sessions were conducted between days 7 and 21 of the participant’s menstrual 
cycle to control for the effect of hormones on outcome measures.  At least 48 hours prior to the 
first testing session, participants received instructions in writing to refrain from vigorous exercise 
the day before and the morning of each testing session, and to fast for at least 12 hours the night 
before each testing session.  Participants were also instructed to maintain regular eating patterns 
for at least two days prior to each testing visit.  A phone call reminding participants of these 
requirements was made by a staff member from the PAWMRC at least 48 hours before each 
testing session.  
3.3.1 Non-Breakfast Condition 
On the day of testing participants reported to the PAWMRC between the hours of 7:00 a.m. and 
9:00 a.m. having fasted since midnight.  A staff member reviewed the testing procedures and the 
participant provided a urine sample to rule out pregnancy via a urine pregnancy test.  Once it was 
confirmed that the participant was not pregnant, the participant underwent the initial blood draw.  
Immediately following the blood draw, the participant completed a hunger and satiety visual 
analog scale (VAS) questionnaire [124].  This time point was designated as “baseline.”  The 
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participant then was directed to the waiting area and sat for fifteen minutes, an amount of time 
similar to the time that was required to consume the breakfast meal during the breakfast 
consumption visit.  However, the participant continued to fast.  The participant then rested in a 
seated, upright position for two hours, having access to newspapers, magazines, and standardized 
videos that were provided by the investigators.  The participant underwent additional blood 
draws and then completed additional hunger and satiety questionnaires at 30, 60, and 120 
minutes after the 15-minute waiting period.  These time points were designated as 30 minutes 
(30 min.), 60 minutes (60 min.), and 120 minutes (120 min.), respectively.  Two hours after the 
15-minute waiting period and immediately following the last blood draw (120 min.), the 
participant was provided with a standardized snack prior to leaving the PAWMRC.  The 
intention of the snack was to provide a minimal amount of energy to the participant, who had 
fasted since at least midnight.  In an effort to control for the impact of the snack on total daily 
energy intake, it was standardized to provide approximately 180-190 calories for all participants.  
Each participant was required to consume one Luna Bar or one can of Slim Fast Shake and was 
provided with bottled water.  The participant had a variety of options to choose from, such as 
Lemon Zest, Nutz Over Chocolate, Peanut Butter Cookie, and S’mores Luna Bars or Milk 
Chocolate Slim Fast Shakes.  All of the Luna Bars had a similar nutrient profile and provided 
180 calories with 24-26 grams of carbohydrate (51-55% of calories), 8-9 grams of protein (18-
20% of calories), and 5-6 grams of fat (25-30% of calories).  The Slim Fast Shakes had a nutrient 
profile similar to the Luna Bars and provided 190 calories with 23-25 grams of carbohydrate (51-
53% of calories), 10 grams of protein (21-22% of calories), and 6 grams of fat (28-30% of 
calories).  When the participant was finished eating, a staff member of the PAWMRC assisted 
the participant in recording the food eaten during the testing session in a food and physical 
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activity diary.  The staff member then reminded the participant to record all food intake and 
physical activity for the rest of the day in the food and physical activity diary and answered any 
questions the participant had (Figure 3). 
3.3.2 Breakfast Consumption Condition 
During the breakfast consumption visit the participant followed the same procedures as in the 
non-breakfast visit, but instead ate a breakfast meal in the first 15 minutes of the testing period.  
Once the procedures were reviewed and the urine sample was collected for the urine pregnancy 
test, the participant underwent the initial blood draw and completed a hunger and satiety 
questionnaire (baseline).  The participant then was directed to the dining area in which a meal of 
a predetermined kilocalorie amount was provided.  The breakfast meal provided 20% of the 
participant’s estimated daily caloric needs based on resting energy expenditure (REE) multiplied 
by an activity factor of 1.3 for sedentary women [61, 125].  REE was determined using the 
Mifflin-St. Jeor formula with the participant’s actual body weight [126].  The meal consisted of 
approximately 45-55% carbohydrate, 30-35% fat, and 15-20% protein [2].  The participant was 
required to completely eat the breakfast meal within 15 minutes.   
 Upon completion of the breakfast consumption period, the participant rested in a seated, 
upright position for the remainder of the two hours, having access to the same newspapers, 
magazines, and standardized videos that were provided by the investigators during the non-
breakfast condition.  Additional blood draws occurred and additional hunger and satiety 
questionnaires were completed by the participant at 30, 60, and 120 minutes after the breakfast 
consumption period [26, 45, 48, 51, 66, 107, 109].  Two hours after the breakfast consumption 
period and immediately following the last blood draw (120 min.), the participant was provided 
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with the same standardized snack as in the non-breakfast condition prior to leaving the 
PAWMRC.  The snack was provided following the breakfast consumption condition as well in 
order to control for the impact of the snack on total daily energy intake following both testing 
conditions.  Prior to leaving the PAWMRC, a staff member assisted the participant in recording 
the food eaten during the testing session in the food and physical activity diary.  The staff 
member then reminded the participant to record all food intake and physical activity for the rest 
of the day in the food and physical activity diary and answered any questions the participant had 
(Figure 3). 
3.4 COMPENSATION 
Participants were compensated $300 for completing the study.  To be eligible for the $300, the 
participant underwent four blood draws and completed four hunger and satiety questionnaires on 
each testing day.  In addition, the participant recorded and was available to read back all food 
intake and physical activity entered in the two food and physical activity diaries.  A staff member 
from the PAWMRC called the participant the day after each testing day and had the participant 
read back each entry from the diary.  The staff member clarified details on any vague entries so 
that specific foods and activities, and amounts of each, were recorded accurately.  Upon receipt 
of information from the second diary, the staff member thanked the participant for participating 
in the study and $300 was placed in an electronic payment account for the participant. 
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Figure 3. Study design 
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3.5 ASSESSMENT COMPONENTS 
3.5.1 Height 
Height was measured at the end of the orientation session after the participant signed an 
informed consent document.  It was measured using a wall-mounted stadiometer and rounded to 
the nearest 0.1 cm.  Height was used to calculate BMI and REE. 
3.5.2 Body Weight 
Body weight was measured at the end of the orientation session after the participant signed an 
informed consent document.  It was measured using a digital scale and rounded to the nearest 
tenth of a pound.  The participant was weighed in a hospital gown after removing all clothing 
except undergarments.  Body weight was used to calculate BMI and REE. 
3.5.3 Estimated Energy Expenditure 
As has been done in past research that investigated the impact of breakfast on appetite-regulating 
hormones or body weight [25, 51, 61], the energy content of the breakfast test meal in the current 
study provided a percentage of the participant’s estimated daily energy requirement.  This is 
commonly done by using a published predictive formula to calculate estimated basal or resting 
energy expenditure and then multiplying the value by an activity factor.  The breakfast meal in 
this study provided 20% of the participant’s estimated daily caloric needs, calculated as REE 
multiplied by an activity factor of 1.3 for sedentary women [127].  Since a sedentary lifestyle 
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was part of the inclusion criteria for this study, an activity factor of 1.3 was used for all 
participants.  REE was determined using the Mifflin-St. Jeor formula with the participant’s 
actual body weight [126].  The Mifflin-St. Jeor formula for women is [126, 128]: 
(9.99 × actual weight (kg)) + (6.25 × height (cm)) – (4.92 × age (y)) – 161 
While there are limitations in using predictive equations, research has reported that the Mifflin-
St. Jeor formula most accurately measures REE [126, 128, 129].  Although noted limitations 
include underestimations in obese subjects and the elderly, estimations of REE using the Mifflin-
St. Jeor formula matched estimation by indirect calorimetry more closely than other predictive 
equations for all population groups [128, 129].   
 In order to control for the impact of physical activity on energy expenditure, physical 
activity was estimated on both testing days.  Physical activity was self-reported by participants in 
a food and physical activity diary.  The time of day, type of activity, duration of activity, and 
intensity of activity was recorded in the diary.  A staff member from the PAWMRC called the 
participant the day after each testing visit and had the participant read back each entry from the 
diary.  The staff member clarified details on any vague entries so that specific activities and 
amounts were recorded accurately.     
3.5.4 Test Meal 
Participants consumed either a Luna Bar and whole milk or a toasted English muffin, cheddar 
cheese, and apple juice as the breakfast meal.  In an effort to control for meal acceptance, 
participants were able to choose from one of several flavors of Luna Bars: Lemon Zest, Nutz 
Over Chocolate, Peanut Butter Cookie or S’mores.  Each of these flavors has a similar 
macronutrient profile as previously outlined.  One participant who was a vegan was provided 
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with hemp milk, which has a similar macronutrient profile to regular whole milk.  One Luna Bar 
and four ounces of whole milk provided 255 calories and consisted of 30-32 grams of 
carbohydrate (47-50% of calories), 9-10 grams of fat (32-35% of calories), and 12-13 grams of 
protein (19-20% of calories) [130, 131].  For those who chose the toasted English muffin, 
cheddar cheese, and apple juice, one Thomas’ English muffin, 1.25 ounces of cheddar cheese, 
and four ounces of apple juice provided 293 calories and consisted of 38.9 grams of carbohydrate 
(53.1% of calories), 10.4 grams of fat (31.9 % of calories), and 11.1 grams of protein (15.1% of 
calories) [131].  Amounts of the Luna Bar and milk or English muffin, cheddar cheese, and apple 
juice were increased or decreased proportionally by percent of total weight or volume to provide 
20% of each participant’s estimated daily caloric needs [12, 13, 51, 88].  The offerings for the 
breakfast meal were reviewed with participants during the initial telephone screening and at the 
orientation session.   
3.5.5 Total Daily Energy Intake 
Participants kept a detailed record of all foods consumed on each testing day.  A standard food 
and physical activity diary was provided to each participant at each testing visit and a PAWMRC 
staff member instructed them on how to complete it.  A specific description of each food item, 
measured or approximated amounts eaten, and the time at which each item was eaten was 
required.  As detailed previously, on testing days a staff member of the PAWMRC assisted the 
participant in recording the food eaten during the testing session in the food and physical activity 
diary and reminded the participant to record all food intake and physical activity for the rest of 
the day in the diary.  A staff member from the PAWMRC called the participant the day after 
each testing visit and had the participant read back each entry from the diary.  The staff member 
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clarified details on any vague entries so that specific foods and activities and amounts of each 
were recorded accurately.     
3.6 PRIMARY OUTCOME MEASURES 
3.6.1 Blood Analysis 
On each testing day, venous blood was collected and placed in collection tubes containing EDTA 
at each time point (baseline, 30, 60, and 120 min.) to analyze plasma levels of AG and GLP-1.  
For AG, 10 µl of p-hydroxymercuribenzoic acid (PHMB) was added per ml of blood to prevent 
the degradation of AG by protease.  Samples were centrifuged at 1000G for 10 minutes at 4°C.  
The supernatant was transferred to a new tube and 100µl of 1N HCl was added per ml of plasma 
collected.  The sample then was centrifuged at 3500 rpm for 5 minutes at 4°C and 1mL was 
aliquoted into a cryotube and stored at –70°C.  The assay for AG was run using an ELISA kit 
from ALPCO (Salem, NH; cat # A05106). 
The blood sample for GLP-1 was stored on ice and then centrifuged at 1000G for 10 
minutes at 4°C.  One milliliter of plasma then was aliquoted into a cryotube and stored at –70°C.  
The assay for GLP-1 was run using an ELISA kit from ALPCO (Salem, NH; cat # 43-GPTHU-
E01).  Analyses were performed at the Heinz Nutrition Laboratory in the Graduate School of 
Public Health at the University of Pittsburgh.    
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3.6.2 Total Daily Energy Intake 
Self-reported total daily energy intake was compared between the breakfast consumption and 
non-breakfast conditions to investigate if breakfast consumption is associated with changes in 
total daily energy intake.  It was hypothesized that self-reported levels of total daily energy 
intake would be significantly lower following breakfast consumption than following the non-
breakfast condition.  On each of the testing days, energy intake was determined by self-report 
using a 24-hour food and physical activity diary.  To increase accuracy in documenting energy 
intake, prior to leaving the PAWMRC on each testing day a staff member assisted the participant 
in recording the food eaten during the testing session in the diary.  Total energy intake for each 
day recorded was calculated using Diet Analysis Plus, version 10.0 nutrition analysis software 
(Cengage Learning, Independence, KY).  All data was entered by the primary investigator.  
When an exact match was not available on Diet Analysis Plus for a prepared or convenience 
food item, restaurant or manufacturer websites were accessed to attain the information. If 
nutrition information was not available on the manufacturer’s website, the nutrition information 
was first searched on CalorieKing.com and then on LiveStrong.com if necessary.  If the 
information was still not available, the closest approximation to the actual item that was 
available on Diet Analysis Plus was used. 
3.6.3 Hunger and Satiety 
Hunger and satiety were rated on a 100 mm VAS questionnaire [124].  A copy is available in 
Appendix F.  The left end of the scales for questions were anchored with phrases such as, “I am 
not hungry at all” or “I am completely empty,” while the right end of the scales were anchored 
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with phrases such as, “I have never been more hungry” or “I am very satisfied.”   Participants 
were instructed to make a mark across the scale line that best quantified their feelings of hunger 
or satiety.  Quantification of hunger and satiety were determined by measuring the distance from 
the left end of the scale line to the mark made by the participant using a standard tape measure.  
Distances were rounded to the nearest millimeter. 
3.7 STATISTICAL ANALYSIS 
Descriptive analyses were performed for participants’ age, height, weight, BMI, waist girth, hip 
girth, waist/hip ratio, percent body fat, and human eating behavior construct scores as measured 
by the Three-Factor Eating Questionnaire.  For each testing condition, mean and standard 
deviation were calculated for plasma AG and GLP-1 concentrations, calories from energy intake, 
and VAS scores for each of the hunger and satiety questions at each measured time point 
(baseline, 30, 60, and 120 min.) as well as for area under the curve (AUC).  
A 4 × 2 two-way within-subjects repeated measures analysis of variance (ANOVA) 
(Time × Condition) was performed on plasma AG and GLP-1 concentrations as functions of the 
breakfast condition (breakfast consumption, non-breakfast) at each time point (baseline, 30, 60, 
120 min.) to determine if significant differences exist.  Main effects of Condition and Time and 
the interaction effect of Condition × Time are reported.  Simple main effects were examined 
using a Bonferroni adjustment.  The assumption of normality was tested using the Shapiro-Wilk 
test and the assumption of homogeneity of variance was tested using the Brown-Forsythe test.   
Paired samples t-tests were used to examine differences between breakfast consumption 
and non-breakfast conditions for mean daily energy intake and for mean AUC of VAS scores for 
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each hunger and satiety question.  A related-samples Wilcoxan signed rank test was used when 
data were not normally distributed.  Also, to investigate if there was an association between VAS 
scores and plasma AG and GLP-1 concentrations and between VAS scores and daily energy 
intake, bivariate correlation analyses were performed for each testing condition using a Pearson 
correlation.  Spearman rank correlation was performed when data were not normally distributed.    
Although the study was not powered to examine the effect of breakfast consumption 
between BMI groups, a 4 × 2 × 3 three-factor ANOVA was performed on plasma AG and GLP-1 
concentrations as functions of breakfast condition (breakfast consumption, non-breakfast), time 
(baseline, 30, 60, 120 min.) and BMI classification (normal weight, overweight, obese) to 
examine whether the pattern of differences in hormone concentrations between testing conditions 
was significantly different between BMI groups.  The within-subjects independent variables 
were breakfast condition and time, and the between-subjects independent variable was BMI 
class.  Main effects of Condition, Time, and BMI and the interaction effects of Condition × 
Time, Condition × BMI, Time × BMI, and Condition × Time × BMI are reported.  In addition, a 
3 × 2 mixed ANOVA (BMI × Condition) was performed on energy intake as a function of 
breakfast condition and BMI classification to examine whether the pattern of differences in 
energy intake between testing conditions was significantly different between BMI groups.  The 
within-subjects independent variable was breakfast condition and the between-subjects 
independent variable was BMI class.  When a significant interaction effect involving BMI was 
identified in any of the above analyses, the analyses were performed again to compare BMI 
groups two at a time to examine differences between BMI groups.  The assumption of normality 
for each ANOVA analysis was tested using the Shapiro-Wilk test and the assumption of 
homogeneity of variance was tested using the Brown-Forsythe test.  All of the above analyses 
  64 
were performed using SPSS for Windows (version 19.0; SPSS Inc., Chicago, IL) with the alpha 
level set at P < 0.05. 
3.8 POWER ANALYSIS 
The primary aim of this study was to investigate if breakfast consumption had a significant 
impact on the acute response of plasma AG and plasma GLP-1 concentrations over a two hour 
period, as well as an impact on total daily energy intake.  A power analysis was performed to 
estimate an appropriate sample size for the study based on within-subjects, repeated measures 
ANOVA and based on matched pairs, two dependent means t-tests.  In order to detect a moderate 
to large effect size with statistical power set at 0.80 and alpha at 0.05, 19 subjects needed to be 
recruited.  Due to the possibility that participants would have incomplete data, an additional two 
subjects were added to the sample size to ensure adequate statistical power.  Therefore, attempts 
were made to recruit a total of 21 subjects for this study.  However, only 20 participants were 
able to be recruited with the resources available for recruitment. 
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4.0  RESULTS 
4.1 SUBJECTS 
Twenty women (BMI: 26.8 ± 5.9 kg/m2; age: 26.3 ± 6.0 years) consented to participate in the 
study.  Seven participants were classified as normal weight (BMI: 18.5-24.9 kg/m2), seven as 
overweight (BMI: 25.0-29.9 kg/m2) and six as obese (30.0-39.9 kg/m2).  Participants were 
randomized to either the breakfast condition or non-breakfast condition as the first experimental 
session upon entry into the study, with BMI category not considered in the randomization 
scheme.  Thus, 10 participants were randomized to perform the breakfast condition as the first 
experimental session and 8 participants were randomized to receive the non-breakfast condition 
as the first experimental session.  Two participants withdrew from the study.  One normal weight 
participant did not tolerate the blood draw at the first testing session and decided not to continue 
with the study.  One overweight participant became ineligible after venous access could not be 
attained during the baseline blood drawing at the first testing session.  Complete data was 
collected on a total of 18 participants (Figure 4).  
 Descriptive statistics (mean ± standard deviation) for the total sample and for each BMI 
group are shown in Table 1.  A series of one-way analyses of variance (ANOVA) revealed that 
there were no significant differences between the BMI groups for age, height, and cognitive 
restraint, disinhibition and trait hunger constructs as measured by the Stunkard and Messick 
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Three-Factor Eating Questionnaire.  By study design there were significant differences between 
BMI groups for body weight, BMI, waist girth, hip girth, waist-hip ratio, and body composition 
expressed as percent body fat (P < 0.05).  However, differences between BMI groups for waist-
hip ratio measured at the iliac crest level were not statistically significant (P = 0.08).  A series of 
paired- samples t-tests revealed that there were no significant differences between height, weight, 
and body composition measurements for participants between testing visits (Table 2).   
 
 
*Indicates that randomization occurred at the level of N=20 and BMI was not considered in the 
randomization scheme 
 
Figure 4. Study enrollment and randomization 
 
 
20 Subjects 
Recruited 
Normal Weight 
(n=7) 
Overweight 
(n=7) 
Obese 
(n=6) 
6 completed 
(1 withdrew after not 
tolerating blood draw) 
6 completed 
(1 ineligible after could 
not attain venous access) 
6 completed 
Randomized 
to breakfast 
condition as 
the first 
experimental 
session 
(n=3)* 
 
Randomized 
to non-
breakfast 
condition as 
the first 
experimental 
session 
(n=3)* 
 
Randomized 
to breakfast 
condition as 
the first 
experimental 
session 
(n=4)* 
 
Randomized 
to non-
breakfast 
condition as 
the first 
experimental 
session 
(n=2)* 
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to breakfast 
condition as 
the first 
experimental 
session 
(n=3)* 
 
Randomized 
to non-
breakfast 
condition as 
the first 
experimental 
session 
(n=3)* 
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Table 1. Descriptive statistics by total sample and by BMI group (mean ± standard deviation) 
 All groups 
(n=18) 
Normal Wt. 
(n=6) 
Overweight 
(n=6) 
Obese 
(n=6) P-value* 
Age(y) 26.3 ± 6.0 25.7 ± 7.2 23.7 ± 2.1 29.7 ± 6.6 .220 
Height (cm) 164.6 ± 4.4 162.8 ± 2.3 166.8 ± 5.2 164.6 ± 4.6 .283 
Weight (lbs) 159.9 ± 37.7 117.3 ± 7.1 162.7 ± 10.0 198.9 ± 25.6 <.001A,B,C 
BMI (kg/m2) 26.8 ± 5.9 20.2 ± 1.2 26.6 ± 1.3 33.3 ± 3.0 <.001A,B,C 
Waist Girth (cm):  
umbilicusD 
iliac crestE 
 
94.5 ± 17.0 
91.3 ± 15.1 
 
75.7 ± 5.7 
74.6 ± 5.6 
 
96.4 ± 5.1 
91.8 ±5.3 
 
111.3 ± 9.6 
106.1 ± 9.2 
 
<.001A,B,C 
<.001A,B,C 
Hip Girth (cm) 105.4 ± 13.7 91.8 ± 2.1 106.8 ± 3.5 118.4 ± 12.6 <.001A,B 
Waist-Hip Ratio: 
umbilicusD 
iliac crestE 
 
0.89 ± .07 
0.86 ± .06 
 
.83 ± .07 
.81 ± .07 
 
.90 ± .07 
.86 ± .07 
 
.94 ± .04 
.90 ± .04 
 
.016B 
.080 
Body Fat (%) 46.7 ± 4.2 43.1 ± 2.2 46.7 ± 3.8 50.3 ±3.9 .008B 
Human Eating Behavior 
Constructs (score): 
Cognitive Restraint 
Disinhibition 
Hunger 
 
 
6.78 ± 4.3 
5.89 ± 3.3 
6.11 ± 4.0 
 
 
5.83 ± 4.0 
4.33 ± 2.6 
5.67 ± 3.8 
 
 
6.67 ± 3.6 
5.83 ± 4.0 
7.33 ± 4.1 
 
 
7.83 ± 5.6 
7.50 ± 3.1 
5.33 ± 4.4 
 
 
.742 
.274 
.675 
Ethnicity (%): 
 Hispanic/Latino 
Non-Hispanic/Latino  
 
5.6 
94.4 
 
16.7 
83.3 
 
0.0 
100.0 
 
0.0 
100.0 
 
Race (%): 
Asian 
Black/African American 
White 
Other/Mixed 
 
5.6 
16.6 
66.7 
11.1 
 
16.7 
0.0 
66.6 
16.7 
 
0.0 
16.7 
83.3 
0.0 
 
0.0 
33.3 
50.0 
16.7 
 
*One-way ANOVA computed with post-hoc analysis using a Bonferroni adjustment 
A Normal Weight is significantly different than Overweight (P < 0.05) 
B Normal Weight is significantly different than Obese (P < 0.05) 
C Overweight is significantly different than Obese (P < 0.05) 
D Waist girth measured at the level of the umbilicus 
E Waist girth measured at the level of the iliac crest 
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Table 2. Descriptive statistics for breakfast and non-breakfast testing conditions (mean ± standard deviation) 
 
n=18 Non-Breakfast Condition 
Breakfast 
Condition P-value 
Height (cm) 164.6 ± 4.3 164.7 ± 4.3 .178 
Weight (lbs) 160.1 ± 37.9 159.6 ± 37.6 .307 
BMI (kg/m2) 26.8 ± 6.0 26.7 ± 5.8 .270 
Waist Girth (cm): 
umbilicusA 
iliac crestB 
 
93.8 ± 16.4 
90.6 ± 15.3 
 
94.5 ± 16.4 
90.8 ± 14.8 
 
.556 
.744 
Hip Girth (cm) 105.4 ± 13.4 105.6 ± 13.3 .472* 
Waist-Hip Ratio: 
umbilicusA 
iliac crestB 
 
0.89 ± .06 
0.86 ± .06 
 
0.89 ± .08 
0.86 ± .07 
 
.685 
.892 
Body Fat (%) 46.8 ± 4.3 46.7 ± 4.4 .491 
 *Paired-samples Wilcoxan signed rank test used 
A Waist girth measured at the level of the umbilicus 
B Waist girth measured at the level of the iliac crest 
4.2 ANALYSIS OF DATA BY SPECIFIC AIM 
4.2.1 Specific Aim 1: Comparison of Changes in Plasma Acylated Ghrelin 
Concentrations Following Breakfast and Non-Breakfast Testing Conditions 
Three participants had incomplete data for the acylated ghrelin (AG) measurements.  One had a 
missing blood sample at the 60-minute time point of the Breakfast condition due to difficulty 
attaining venous access.  The other two had compromised blood samples that could not be 
properly processed.  Data screening of plasma AG concentrations identified that the assumption 
of normality was violated at the 120-minute time point of the Breakfast condition and at the 30-, 
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60-, and 120-minute time points of the Non-Breakfast condition.  Data screening also identified 
one outlier whose samples deviated from the normal range of values at four different time points.   
A 4 × 2 two-way within-subjects repeated measures ANOVA (Time × Condition) was 
performed on mean plasma AG concentrations.  The three participants with missing data were 
not included in the analysis by the nature of the repeated measures test.  The assumption of 
sphericity was not met for Time (Mauchly’s W = 0.049, P < 0.001) or for Condition × Time 
(Mauchly’s W = 0.090, P < 0.001).  Thus, to examine the main effect of Time and the interaction 
effect, the Huynh-Feldt adjustment was used.  There was a significant Condition × Time 
interaction effect (P = 0.003), indicating that the pattern of change in plasma AG concentrations 
across time differed between the experimental conditions.  Data are presented in Table 3.  
Contributing to this significant interaction effect was the finding that the 30-minute and 60-
minute concentrations of AG for the Breakfast condition were significantly lower than the 
baseline concentration (P < 0.001).  Moreover, there was a significant difference in AG 
concentrations between the Non-Breakfast and Breakfast conditions at the 30-, 60-, and 120-
minute time points (P ≤ 0.001).   
Additional analyses were performed to examine whether these findings were robust.  Due 
to the non-normal distribution of some of the data, the analysis was repeated using transformed 
data (logarithmic transformation and square root transformation), and the pattern of the results 
was unchanged (data not presented).  The analysis was performed again with the outlier 
participant removed from the sample, and the Condition × Time interaction effect and the main 
effect of Condition remained statistically significant (Table 3).   
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Table 3. Differences in plasma acylated ghrelin and GLP-1 concentrations between breakfast and non-
breakfast testing conditions at each measured time point (mean ± standard deviation) 
 
 Experimental Conditions P-values 
Variable Testing Time 
Non-Breakfast 
Condition 
Breakfast 
Condition Condition
 Time Condition 
× Time 
Acylated 
Ghrelin  
(pg/ml) 
(n=15) 
 
Baseline 
30 minutes 
60 minutes 
120 minutes 
100.3 ± 51.8 
110.2 ± 65.4 
117.1 ± 86.4 
124.4 ± 91.5 
110.0 ± 54.7 
64.9 ± 43.4A,C 
57.0 ± 44.6A,C 
90.2 ± 82.0A 
<0.001 0.100 0.003 
Acylated 
Ghrelin  
(pg/ml) 
(n=14)* 
 
Baseline 
30 minutes 
60 minutes 
120 minutes 
97.4 ± 52.4 
97.1 ± 42.4 
97.1 ± 39.9 
103.0 ± 39.8 
100.8 ± 43.3 
58.2 ± 36.2A,D,E 
49.9 ± 36.3A,C,E 
71.4 ± 38.8A 
<0.001 <0.001 <0.001 
GLP-1 
(pm/L) 
(n=17) 
Baseline 
30 minutes 
60 minutes 
120 minutes 
1.6 ± 1.7 
1.4 ± 1.6 
1.4 ± 1.6 
1.4 ± 1.5 
1.8 ± 2.3 
2.3 ± 1.7A 
2.5 ± 1.9A 
2.2 ± 1.6B 
<0.001 0.331 0.042 
GLP-1 
(pm/L) 
(n=16)* 
Baseline 
30 minutes 
60 minutes 
120 minutes 
1.3 ± 0.9 
1.0 ± 0.7 
1.1 ± 0.6 
1.1 ± 0.7 
1.3 ± 0.6 
2.0 ± 1.1A 
2.2 ± 1.5A 
1.9 ± 0.9B 
<0.001 0.031 0.002 
A Indicates that time point for Non-Breakfast condition is significantly different than the same  
   time point for the Breakfast condition at P ≤ 0.001  
B Indicates that time point for Non-Breakfast condition is significantly different than the same  
   time point for the Breakfast condition at P < 0.05 
C Indicates significantly different than baseline at P ≤ 0.001 
D Indicates significantly different than baseline at P < 0.05 
E Indicates significantly different than 120 minutes at P < 0.05 
* Indicates that outlier was removed from the analysis 
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4.2.2 Specific Aim 2: Comparison of Changes in Plasma Glucagon-Like Peptide 1 
Concentrations Following Breakfast and Non-Breakfast Testing Conditions 
As mentioned above, one participant had a missing blood sample at the 60-minute time point of 
the Breakfast condition due to difficulty attaining venous access.  Data screening of plasma 
glucagon-like peptide 1 (GLP-1) concentrations identified that the assumption of normality was 
violated at each time point of both testing conditions.  Data screening also identified one outlier 
whose samples deviated from the normal range of values at each time point of both conditions.   
A 4 × 2 two-way within-subjects repeated measures ANOVA (Time × Condition) was 
performed on mean plasma GLP-1 concentrations.  The participant with missing data was not 
included in the analysis by the nature of the repeated measures test.  The assumption of 
sphericity was not met for Time (Mauchly’s W = 0.389, P = 0.016) or for Condition × Time 
(Mauchly’s W = 0.124, P < 0.001).  Thus, to examine the main effect of Time and the interaction 
effect, the Huynh-Feldt adjustment was used.  There was a significant Condition × Time 
interaction effect (P = 0.042), indicating that the pattern of change in plasma GLP-1 
concentrations across time differed between the experimental conditions.  Data are presented in 
Table 3.  Contributing to this significant interaction effect was the finding that there was a 
significant difference in GLP-1 concentrations between the Non-Breakfast and Breakfast 
conditions at the 30-, 60-, and 120-minute time points (P ≤ 0.05).  
Additional analyses were performed to examine whether these findings were robust.  Due 
to the non-normal distribution of the data, the analysis was repeated using transformed data 
(logarithmic transformation), and the pattern of the results was unchanged (data not presented).  
The analysis was performed again with the outlier participant removed from the sample, and the 
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Condition × Time interaction effect and the main effect of Condition remained statistically 
significant (Table 3).    
4.2.3 Specific Aim 3: Comparison of Changes in Daily Energy Intake Following 
Breakfast and Non-Breakfast Testing Conditions 
Total daily intake was analyzed, which included the breakfast and/or snack provided to 
participants by the researchers on testing days plus all other discretionary intake recorded by 
participants for the rest of each testing day.  Mean breakfast intake was 373 ± 44 kcals.  Data 
screening identified that the assumption of normality was violated for the Non-Breakfast 
condition.  It still was not met after performing logarithmic and square root transformations.  
Data screening also identified two outliers whose total daily intake deviated from the normal 
range of values for the Non-Breakfast condition.  
A related-samples Wilcoxan signed rank test was performed to compare differences in 
total daily intake between testing conditions.  The median of differences of total daily intake 
between conditions was not significant (P = 0.199) (Table 4).  When the two outliers were 
removed from the sample, the assumption of normality was met for the Non-Breakfast condition.  
A paired samples t-test then was performed, and the difference still was not significant (P = 
0.099) (Table 5).  
Snack and discretionary intake was analyzed, which included the snack provided to 
participants by the researchers on testing days plus all other discretionary intake recorded by 
participants for the rest of each testing day, but did not include the breakfast meal provided to 
participants by the researchers.  A related-samples Wilcoxan signed rank test was performed to 
compare differences in snack and discretionary intake between testing conditions.  The median 
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of differences of snack and discretionary intake between conditions was not significant (P = 
0.184) (Table 4).  With the outliers removed from the sample, a paired samples t-test then was 
performed and the difference still was not significant (P = 0.484) (Table 5). 
Snack intake alone was also analyzed.  Although participants were required to consume a 
snack consisting of 180-190 kcals before leaving the research center on each testing day, two 
participants refused the snack and two participants did not completely eat the snack on the 
breakfast testing day, each citing that they were not hungry after consuming breakfast.  On the 
non-breakfast testing day, one participant would not completely eat the snack.  Data screening 
identified that the assumption of normality was violated for both Breakfast and Non-Breakfast 
conditions.  The assumption of normality still was not met after transforming the data and after 
removing the previously mentioned outliers.  Thus, only a related-samples Wilcoxan signed rank 
test was performed to compare differences in snack intake between testing conditions.  The 
median of differences of snack intake between conditions was not significant (P = 0.089) (Table 
4).  
Lastly, discretionary intake was analyzed, which included only the intake recorded by 
participants after leaving the research center each testing day, and did not include intake from the 
breakfast meal and snack provided to the participants by the researchers.  Data screening 
identified that the assumption of normality was violated for the Non-Breakfast condition.  It still 
was not met after performing logarithmic and square root transformations.  Therefore, a related-
samples Wilcoxan signed rank test was performed to compare differences in discretionary intake 
between conditions.  The median of differences of discretionary intake between conditions was 
not significant (P = 0.306) (Table 4).  With the outliers removed from the sample, a paired 
samples t-test was performed and the difference still was not significant (P = 0.620) (Table 5).   
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Table 4. Comparison of energy intake for breakfast and non-breakfast testing conditions using the complete 
sample (median), n=18 
 
   
 *Related-samples Wilcoxan signed rank test computed 
    A Includes breakfast and/or snack provided by researchers and all other  
    discretionary intake 
   B Includes only snack provided by researchers and all other discretionary intake 
   C Includes only snack provided by researchers 
    D Includes only discretionary intake recorded by participants, but not breakfast meal  
    and snack provided by researchers 
 
 
 
 
Table 5. Comparison of energy intake for breakfast and non-breakfast testing conditions using sample 
without outliers (mean ± standard deviation), n=16 
 
   
*Paired-samples t-test computed 
    A Includes breakfast and/or snack provided by researchers and all other  
   discretionary intake 
    B Includes only snack provided by researchers and all other discretionary intake 
    C Includes only discretionary intake recorded by participants, but not breakfast meal  
   and snack provided by researchers 
 
 
Intake Level 
Non-Breakfast 
Condition 
(kcals) 
Breakfast 
Condition 
(kcals) 
P-value* 
Total Daily IntakeA 1,596 1,883 .199 
Snack and Discretionary IntakeB 1,596 1,487 .184 
Snack IntakeC 180 180 .089 
Discretionary IntakeD 1,411 1,355 .306 
Intake Level 
Non-Breakfast 
Condition 
(kcals) 
Breakfast 
Condition 
(kcals) 
P-value* 
Total Daily IntakeA 1,560 ± 221 1,824 ± 555 .099 
Snack and Discretionary IntakeB 1,560 ± 221 1,453 ± 546 .484 
Discretionary IntakeC 1,384 ± 233 1,309 ± 552 .620 
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4.2.4 Specific Aim 4: Comparison of the Influence of Body Mass Index on Changes 
in Plasma Acylated-Ghrelin and GLP-1 Concentrations Following Breakfast and Non-
Breakfast Testing Conditions 
Acylated Ghrelin  
A 4 × 2 × 3 three-factor ANOVA (Time × Condition × BMI) was performed to examine 
whether the pattern of differences in AG concentrations between testing conditions was 
significantly different between BMI groups.  The three participants with missing data were not 
included in the analysis by the nature of the repeated measures test.  Data screening of plasma 
AG concentrations identified that the assumption of normality was violated at the 60-minute and 
120-minute time points of the Non-Breakfast condition for normal weight participants.  The 
assumption of sphericity was not met for Time (Mauchly’s W = 0.047, P < 0.001) or for 
Condition × Time (Mauchly’s W = 0.089, P < 0.001).  Thus, to examine the main effect of Time 
and the interaction effect, the Huynh-Feldt adjustment was used.  As mentioned above there was 
a significant Condition × Time interaction effect (P = 0.001), but no other interaction effects 
were significant.  Data are presented in Table 6.  The analysis was performed again with the 
previously mentioned outlier participant removed from the sample.  The main effect of Time 
then was significant (P < 0.001) as was the main effect of BMI (P = 0.034), but all of the 
interaction effects remained not significant (data not presented).     
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Table 6. Comparison of changes in plasma acylated ghrelin concentrations by BMI group (mean ± standard deviation) 
 
Time Point BMI Class 
Non-
Breakfast 
Condition 
Breakfast 
Condition Condition Time BMI 
Condition 
× Time 
Condition 
× BMI 
Time × 
BMI 
Condition 
× Time  
× BMI 
Acylated 
Ghrelin 
(pg/ml) 
Baseline NWA 
OWB 
OBC 
Total 
87.6 ± 39.5 
145.9 ± 55.2 
67.5 ± 25.3 
100.3 ± 51.8 
122.1 ± 75.6 
130.4 ± 25.4 
77.4 ± 45.9 
110.00 ± 54.7 
<0.001 0.085 0.273 0.001 0.654 0.306 0.233 
30-minute NW 
OW 
OB 
Total 
129.3 ± 96.2 
135.4 ± 30.2 
65.9 ± 33.0 
110.2 ± 65.4 
75.1 ± 52.9 
79.1 ± 32.4 
40.5 ± 40.3 
64.9 ± 43.4 
60-minute NW 
OW 
OB 
Total 
145.2 ± 142.7 
132.4 ± 25.8 
73.7 ± 38.7 
117.1 ± 86.4 
60.5 ± 57.9 
82.9 ± 33.1 
27.7 ± 24.2 
57.0 ± 44.6 
120-minute NW 
OW 
OB 
Total 
155.9 ± 152.2 
133.5 ± 25.4 
83.8 ± 45.7 
124.4 ± 91.5 
126.2 ± 131.6 
98.9 ± 29.2 
45.5 ± 34.2 
90.2 ± 82.0 
A Normal Weight (n=5), B Overweight (n=5), C Obese (n=5) 
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Table 7. Comparison of changes in plasma GLP-1 concentrations by BMI group (mean ± standard deviation) 
 Time Point BMI Class 
Non-
Breakfast 
Condition 
Breakfast 
Condition Condition Time BMI 
Condition 
× Time 
Condition 
× BMI 
Time × 
BMI 
Condition 
× Time  
× BMI 
GLP-1  
(pm/L) 
Baseline NWA 
OWB 
OBC 
Total 
2.5 ± 2.5 
1.2 ± 0.8 
1.0 ± 0.9 
1.6 ± 1.7 
2.9 ± 3.7 
1.4 ± 0.5 
1.2 ± 0.6 
1.8 ± 2.3 
<0.001 0.330 0.272 0.046 0.093 0.270 0.322 
30-minute NW 
OW 
OB 
Total 
2.0 ± 2.6 
1.1 ± 0.8 
1.0 ± 0.8 
1.4 ± 1.6 
3.2 ± 2.2 
1.7 ± 0.9 
1.9 ± 1.3 
2.3 ± 1.7 
60-minute NW 
OW 
OB 
Total 
2.0 ± 2.6 
1.2 ± 0.6 
1.0 ± 0.8 
1.4 ± 1.6 
4.1 ± 2.4 
1.7 ± 0.6 
1.5 ± 1.0 
2.5 ± 1.9 
120-minute NW 
OW 
OB 
Total 
2.0 ± 2.4 
1.2 ± 0.8 
1.0 ± 0.7 
1.4 ± 1.5 
3.0 ± 2.2 
1.8 ± 0.7 
1.7 ± 1.0 
2.2 ± 1.6 
A Normal Weight (n=6), B Overweight (n=5), C Obese (n=6) 
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GLP-1 
Similar analyses were performed on plasma GLP-1 concentrations.  The participant with 
missing data was not included in the analysis by the nature of the repeated measures test.  As 
previously mentioned, data screening of GLP-1 concentrations identified that the assumption of 
normality was violated at each time point of both testing conditions.  The assumption of 
sphericity was not met for Time (Mauchly’s W = 0.233, P = 0.002) or for Condition × Time 
(Mauchly’s W = 0.087, P < 0.001).  Thus, to examine the main effect of Time and the interaction 
effect, the Huynh-Feldt adjustment was used.  As mentioned above there was a significant 
Condition × Time interaction effect (P = 0.046), but no other interaction effects were significant.  
Data are presented in Table 7.   
The analysis was performed again with the previously mentioned outlier participants 
removed from the sample.  The interaction effect of Condition × Time × BMI then was 
significant (P < 0.001), as was the main effect of Time (P = 0.014).  To determine the extent of 
the interaction effect between BMI groups, a 4 × 2 × 2 three-factor ANOVA (Time × Condition 
× BMI) was performed between BMI groups two at a time.  The interaction effect of Condition × 
Time × BMI was significant between normal weight and overweight participants (P = 0.003) and 
between normal weight and obese participants (P = 0.001), but not between overweight and 
obese participants (P = 0.71) (Data not presented). 
 
Energy Intake 
Although not a specific aim of the study, a 3 × 2 mixed ANOVA (BMI × Condition) was 
performed to examine whether the pattern of differences in energy intake between testing 
conditions was significantly different between BMI groups.  A separate analysis was performed 
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on total daily intake, snack and discretionary intake, and discretionary intake only.  Data 
screening identified that the assumption of normality was met for all intake categories for each 
testing condition at each BMI classification level.  There was a significant Condition × BMI 
interaction effect for each intake level (total, P = 0.019; snack and discretionary, P = 0.021; and 
discretionary only, P = 0.019).  To determine the extent of the interaction effect between BMI 
groups, a 2 × 2 mixed ANOVA (BMI × Condition) was performed between BMI groups two at a 
time.  The interaction effect of Condition × BMI was significant between normal weight and 
overweight participants at each intake level (total, P = 0.019; snack and discretionary, P = 0.026; 
and discretionary only, P = 0.025) and between overweight and obese participants at each intake 
level (total, P = 0.045; snack and discretionary, P = 0.038; and discretionary only, P = 0.036), 
but not between normal weight and obese participants (total, P = 0.174; snack and discretionary, 
P = 0.222; and discretionary only, P = 0.193).  Data are presented in Table 8.  Contributing to 
this significant interaction effect was the finding that intake following the Breakfast condition 
was lower or similar to intake following the Non-Breakfast condition for normal weight and 
obese participants, while for overweight participants intake was higher following the Breakfast 
condition than following the Non-Breakfast condition.  However, the main effect of Condition 
was only significant for total daily intake.  The analyses were performed again with the outlier 
participants removed from the sample and the main effect of Condition then was not significant 
for total daily intake (P = 0.087), nor was the interaction effect of Condition × BMI between 
overweight and obese participants for total daily intake (P = 0.060) or discretionary intake only 
(P = 0.052) (Data not presented).   
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Table 8. Comparison of changes in energy intake between breakfast and non-breakfast testing conditions by BMI group (mean ± standard deviation) 
 
 BMI Group-by-Group Interaction Effects 
Intake Level BMI Class 
Non-Breakfast 
Condition 
(kcals) 
Breakfast 
Condition 
(kcals) 
Condition BMI Condition 
× BMI 
NWD vs 
OWE 
NW vs 
OBF 
OW vs 
OB 
Total Daily IntakeA NWD 
OWE 
OBF 
Total 
1,593 ± 226 
1,470 ± 162 
2,049 ± 669 
1,704 ± 469 
1,588 ± 314 
2,236 ± 649 
2,061 ± 856 
1,962 ± 669 
0.036 0.288 0.019 0.019 0.174 0.045 
Snack and Discretionary 
Intake OnlyB 
NW 
OW 
OB 
Total 
1,593 ± 226 
1,470 ± 162 
2,049 ± 669 
1,704 ± 469 
1,267 ± 315 
1,852 ± 637 
1,647 ± 872 
1,589 ± 659 
0.315 0.364 0.021 0.026 0.222 0.038 
Discretionary Intake 
OnlyC 
NW 
OW 
OB 
Total 
1,413 ± 230 
1,290 ± 162 
1,881 ± 669 
1,528 ± 473 
1,100 ± 340 
1,702 ± 640 
1,519 ± 841 
1,440 ± 655 
0.436 0.319 0.019 0.025 0.193 0.036 
   A Includes breakfast and/or snack provided by researchers and all other discretionary intake 
   B Includes only snack provided by researchers and all other discretionary intake 
   C Includes only discretionary intake recorded by participants, but not breakfast meal and snack provided by researchers 
   D NW = Normal Weight (n=6) 
   E OW = Overweight (n=6) 
   F OB = Obese (n=6) 
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4.3 EXPLORATORY ANALYSES 
4.3.1 Comparison of Subjective Ratings of Hunger and Satiety Following 
Breakfast and Non-Breakfast Testing Conditions 
Mean area under the curve (AUC) for scores from each of the five hunger and satiety VAS 
questions were compared between testing days to examine differences in subjective ratings of 
hunger and satiety.  Data screening identified that the assumption of normality was violated for 
question 3 of the Non-Breakfast condition and that there was an outlier whose ratings deviated 
from the normal range on questions 2 and 3 of the Non-Breakfast condition. 
Paired-samples t-tests were performed on AUC scores for questions 1, 2, 4 and 5 and a 
related-samples Wilcoxan signed-rank test was performed on question 3.  Questions 1 and 4 
assessed participants’ feelings of hunger, questions 2 and 3 assessed participants’ feelings of 
satiety, and question 5 assessed participants’ feelings of thirst.  A copy of the questionnaire is 
available in Appendix F.  Mean hunger ratings were significantly lower for the Breakfast 
condition than for the Non-Breakfast condition (P < 0.001, each).  Mean satiety ratings were 
significantly higher for the Breakfast condition than for the Non-Breakfast condition (P < 0.001, 
each).  Lastly, mean ratings of thirst were significantly lower for the Breakfast condition than for 
the Non-Breakfast condition (P = 0.002).  Data are presented on Figure 5.  The analyses were 
performed again with the outlier participant removed from the sample, and the significance of 
the results did not change (data not presented).   
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Figure 5. Comparison of area under the curve (AUC) for scores from subjective hunger and satiety 
questionnaires for breakfast and non-breakfast testing conditions 
 
4.3.2 The Association Between Subjective Ratings of Hunger and Satiety and 
Plasma Acylated-Ghrelin and GLP-1 Concentrations Following Breakfast and Non-
Breakfast Testing Conditions 
Bivariate correlations were performed to investigate if there was a significant association 
between subjective ratings of hunger and satiety and plasma AG and GLP1 concentrations.  
Values were examined at each time point and for AUC.  Because VAS scores were not normally 
distributed at several time points, Spearman correlations were mostly used for the analysis.  The 
Spearman rank coefficient and the Pearson correlation coefficient (r) were not significantly 
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different from zero for all analyses, indicating that there was no relationship between subjective 
feelings of hunger and satiety and the physiological data.  Data are presented in Table 9, and use 
of Spearman correlations is noted.  The analysis was performed again with the previously 
mentioned outlier participants removed from the sample, and the significance of the correlations 
did not change.  
4.3.3 Additional Correlational Analyses 
Bivariate correlations were also performed to investigate if there was a significant association 
between hunger and energy intake.  For each testing condition, mean VAS scores per question at 
the 120 minute time point and for AUC were compared to total energy intake, snack and 
discretionary intake, and discretionary intake.  The Pearson correlation coefficient (r) was 
significantly different from zero for each analysis for the Breakfast condition only, except at the 
120 minute time point for Question 4.  However, at that that time point the Pearson correlation 
coefficient trended toward significance at each level of energy intake.   
Because the assumption of normality was not met for energy intake data for the Non-
Breakfast condition and for scores at the 120 minute time point of Question 2, Spearman rank 
correlation tests were performed for each of these analyses. At each level of energy intake, the 
Spearman rank coefficient was significantly different from zero for scores at the 120 minute time 
point of Question 2 for the Breakfast condition only.  The Spearman rank coefficient was not 
significantly different from zero for all analyses for the Non-Breakfast condition at each level of 
energy intake.  In addition, both Pearson correlation and Spearman rank coefficients were not 
significantly different from zero at the 120 minute time point or for AUC for each testing 
condition and at each level of energy intake for Question 5.  Data are presented in Table 10. 
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Table 9. Correlation of subjective ratings of hunger and satiety and plasma acylated ghrelin and GLP-1 
concentrations for breakfast and non-breakfast testing conditions (Spearman rank coefficient and Pearson 
correlation coefficient (r) reported) 
 
  Acylated Ghrelin GLP-1 
Subjective Rating 
(100 mm scale) Time Point 
Non-
Breakfast 
Condition 
Breakfast 
Condition 
Non-
Breakfast 
Condition 
Breakfast 
Condition 
Question 1: Overall, how 
hungry do you feel? 
Baseline 
30 minute 
60 minute 
120 minute 
AUCB 
.380A 
.227 
.230 
-.040 
.194 
-.092 
.272 
-.046A 
.116 
.123A 
.123 
-.026 
.260 
.140 
.255 
.121 
.018 
.215 
.171 
.045 
Question 2: Overall, how 
satisfied do you feel? 
Baseline 
30 minute 
60 minute 
120 minute 
AUC 
-.403A 
-.366 
-.122 
-.142 
-.304 
-.224A 
-.301 
-.063 
-.164 
-.033A 
-.140 
-.404 
-.242 
-.315 
-.290 
-.223 
-.008 
-.255 
-.117 
.136 
Question 3: Overall, how 
full do you feel? 
Baseline 
30 minute 
60 minute 
120 minute 
AUC 
-.140 
-.339 
-.284 
-.200 
-.275 
-.307 
-.237 
-.094 
-.121 
-.099A 
-.239 
-.365 
-.332 
-.440 
-.409 
-.197 
-.118 
-.303 
-.296 
-.208 
Question 4: Overall, how 
much do you think you 
could eat right now? 
Baseline 
30 minute 
60 minute 
120 minute 
AUC 
.303A 
.308 
-.143 
-.131 
.005 
-.114A 
.106A 
-.181A 
-.062 
-.084A 
-.229 
.000 
-.034 
.051 
-.059 
-.042 
.251 
.277 
.054 
-.004 
Question 5: Overall, how 
thirsty do you feel? 
Baseline 
30 minute 
60 minute 
120 minute 
AUC 
.016A 
.127 
-.064 
-.033 
-.014 
-.242A 
.306A 
.354A 
.086 
.242A 
-.027 
-.213 
-.192 
.021 
-.114 
-.115 
-.408 
-.387 
-.199 
-.270 
  A Pearson correlation computed 
  B AUC = area under the curve for VAS scores from baseline through 120 minutes 
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Table 10. Correlation of subjective ratings of hunger and satiety and energy intake for breakfast and non-
breakfast testing conditions (Pearson correlation coefficient and Spearman rank coefficient (r) reported) 
 
  Total Daily Intake 
(kcals) 
Snack and 
Discretionary Intake 
(kcals) 
Discretionary Intake 
(kcals) 
Subjective Rating 
(100 mm scale) 
Time 
Point 
Non-
Breakfast 
Condition 
DayA 
Breakfast 
Condition 
Day 
Non-
Breakfast 
Condition 
DayA 
Breakfast 
Condition 
Day 
Non-
Breakfast 
Condition 
DayA 
Breakfast 
Condition 
Day 
Question 1: Overall, 
how hungry do you 
feel? 
120 min. .278 .536* .278 .539* .336 .539* 
AUCB -.138 .617* -.138 .635* -.062 .613* 
Question 2: Overall, 
how satisfied do you 
feel? 
120 min.A -.174 -.422* -.174 -.415* -.209 -.407* 
AUC -.160 -.640* -.160 -.646* -.207 -.637* 
Question 3: Overall, 
how full do you feel? 
120 min. .061 -.406* .061 -.410* .020 -.402* 
AUC .124 -.591* .124 -.608* .073 -.593* 
Question 4: Overall, 
how much do you 
think you could eat 
right now? 
120 min. -.017 .375 -.017 .398 .044 .387 
AUC -.271 .492* -.271 .513* -.207 .483* 
Question 5: Overall, 
how thirsty do you 
feel? 
120 min. -.064 .013 -.064 -.019 -.066 .011 
AUC -.085 -.110 -.085 -.136 -.085 -.103 
*P < 0.05  
A Spearman rank correlation computed. 
B AUC = area under the curve for VAS scores from baseline through 120 minutes 
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5.0  DISCUSSION 
5.1 INTRODUCTION 
Two-thirds of adults in the United States are overweight or obese [1].  Increased rates of obesity 
are associated with increased rates of diabetes, cardiovascular disease and cancer, the leading 
causes of death in America [2-4].  With a decrease in the rates of overweight and obesity and the 
maintenance of a healthy body weight, it is likely that a decrease in the rates of these chronic 
diseases will follow.  Regular breakfast consumption has been identified as a lifestyle behavior 
for weight loss maintenance, but the mechanism behind this association is unclear.  
It is possible that eating breakfast initiates a hormonal response that impacts feelings of 
hunger and satiety, which in turn could lead to decreased energy intake later in the day.  
However, results of the current research on this association have been mixed, mainly due to 
differences in research methodology [8-11, 61, 62, 64].  Also, it is not clear if body weight plays 
a role in this relationship.  If there is a relationship between breakfast consumption and daily 
energy intake, the mechanism linking the two needs to be clarified. 
None of the studies reviewed examined within-subject differences in appetite-regulating 
hormones, energy intake, and feelings of hunger between breakfast consumption and non-
breakfast conditions in normal weight, overweight, and obese sedentary women.  Therefore, the 
purpose of the current study was to examine how eating breakfast acutely influenced plasma AG 
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and GLP-1 concentrations, subjective ratings of hunger and satiety, and daily energy intake in 
women compared to a day when breakfast was not eaten, and to explore the role of body weight 
on this influence. 
5.2 SUMMARY OF MAJOR FINDINGS 
5.2.1 The Effect of Breakfast on Acylated Ghrelin Concentrations 
At baseline, plasma AG concentrations were not significantly different between breakfast and 
non-breakfast conditions.  Following breakfast, AG concentrations significantly decreased from 
baseline levels to nadir levels within 60 minutes of eating and then approached baseline levels 
within an additional 60 minutes.  Mean concentrations at the 30-minute and 60-minute time 
points were significantly lower than the baseline mean.  After removing one outlier participant, 
mean concentrations at the 30- and 60-minute time points were also significantly lower than the 
mean at the 120-minute time point.  Following the non-breakfast condition, concentrations 
slightly increased from baseline levels over the two-hour monitoring period, but not 
significantly.  In addition, as hypothesized, concentrations at the 30-, 60-, and 120-minute time 
points following breakfast were significantly lower than those following the non-breakfast 
condition.  These findings are similar to those of previous research done with normal weight and 
mildly overweight individuals [38, 57].  However, to the researchers’ knowledge the current 
study is the only one to demonstrate the response of plasma AG following breakfast and non-
breakfast conditions in normal weight, overweight, and obese sedentary women.   
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 There was a large variability in fasting AG concentrations among reviewed studies [132-
135], with one study reporting a mean fasting concentration of 51.7 pg/ml [135] and another 
reporting a mean fasting concentration of approximately 160.0 pg/ml [132].  These differences 
are likely due to differences in research methodology.  For example, the former study included 
participants between the ages of 18 and 60, while the latter study included only healthy normal 
weight young women.  Mean fasting AG concentrations in the current study (105.2 pg/ml) fell 
within the middle of the range of the reviewed studies.      
 To date, only two studies have examined plasma AG concentrations following breakfast 
and non-breakfast conditions.  Liu et al. used a randomized crossover design similar to the 
current study in eight young, normal weight and mildly overweight men (mean age 24.5 ± 3.7 y, 
mean BMI 24 ± 2.1 kg/m2) and reported a temporal profile of plasma AG concentrations 
following the breakfast condition that was identical to the profile in the current study.  Following 
the non-breakfast condition, though, plasma AG concentrations remained steady in Liu’s study, 
but at levels similar to those of nadir levels following the breakfast condition [38], while in the 
current study concentrations remained steady at levels similar to those of baseline following the 
breakfast condition.  Therefore, Liu et al. observed significantly different concentrations between 
testing conditions at baseline but not at the other measured time points, while the current study 
observed the opposite.  In addition, baseline concentrations of AG in the study by Liu et al. were 
approximately 70% lower on the breakfast testing day and approximately 85% lower on the non-
breakfast testing day than concentrations in the current study.  These differences could be due to 
the fact that sampling of blood began after 37.5 hours of a 61.5 hour fast in the study by Liu et al. 
while in the current study sampling began after a minimum of 12 hours of fasting.  Other 
research has reported that total ghrelin levels significantly decrease with prolonged fasting [111], 
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but none of the reviewed studies examined the temporal profile of AG during a prolonged fast.  It 
is possible that AG levels may also decrease to lower levels, similar to those of a fed-state, 
instead of continuing to increase when the physiological demands of the body can not be met 
with food for a prolonged period of time.  Additional research investigating how AG changes 
over longer periods of time, perhaps up to 24 hours, in fed and fasting conditions could help to 
further explain the influence of AG on appetite regulation and energy intake. 
 The temporal profile of plasma AG concentrations in the current study was more closely 
related to the profile in the study by Lucidi et al [57].   In that randomized crossover study on six 
normal weight adults (male/female ratio 3/3, mean age 36 ± 2 y, mean BMI 23 ± .07 kg/m2), 
concentrations decreased from baseline during the first 60 minutes of monitoring and then 
approached baseline levels within the next 60 minutes of monitoring as they did in the current 
study.  Another similarity was that following the non-breakfast condition, concentrations 
remained steady at levels similar to those of baseline following the breakfast condition.  
However, in the study by Lucidi et al. baseline AG concentrations on each testing day were 
approximately 20% higher than baseline concentrations in the current study.  Although men were 
included in the study by Lucidi et al., a gender effect is unlikely since other research has reported 
higher levels of AG in women than men by as much as 1.8-fold [136, 137].  The differences in 
AG concentrations could be due to differences in body weight between study participants.  The 
current study included normal weight, overweight, and obese women while the study by Lucidi 
et al. included only normal weight men and women.  Previous research has reported that total 
ghrelin concentrations are inversely correlated with BMI, with fasting levels being lower in 
obese individuals [49, 94, 102].  The influence of BMI on study outcomes is discussed further 
below.  The findings of the current study demonstrate that breakfast consumption has a 
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significant effect on AG, an appetite-stimulating hormone.  However, larger randomized 
crossover studies are needed to investigate differences in temporal patterns of AG concentrations 
following breakfast and non-breakfast conditions.  Because many different factors, such as 
gender, age, and body weight, have been reported to affect AG, future studies need to control 
better for the influence of these factors in an effort to understand the role of AG in appetite 
regulation and energy intake.   
5.2.2 The Effect of Breakfast on GLP-1 Concentrations 
At baseline, plasma GLP-1 concentrations were not significantly different between breakfast and 
non-breakfast conditions.  Following breakfast, GLP-1 concentrations increased from baseline 
levels to peak levels within 60 minutes of eating and then approached baseline levels within an 
additional 60 minutes.  At no point were the differences between time points significant, even 
after removing the one outlier participant.  Following the non-breakfast condition, concentrations 
slightly decreased from baseline levels over the two-hour monitoring period, but not 
significantly.  However, as hypothesized, concentrations at the 30-, 60-, and 120-minute time 
points following breakfast were significantly greater than those following the non-breakfast 
condition.   
 As with fasting AG concentrations, there was some variability in fasting GLP-1 
concentrations among reviewed studies [26, 138-141], with one study reporting a mean fasting 
concentration of 2.1 pm/L [26] and another reporting a mean fasting concentration of 4.6 pm/L 
[139].  These differences are likely due to differences in research methodology.  The former 
study included only male participants between the ages of 18 and 26, while the latter study 
included male and female participants between the ages of 20 and 60.  Mean baseline fasting 
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concentrations of GLP-1 in the current study (1.7 pm/L) were lower than the range of the 
reviewed studies.  This may be due to a gender effect, as only women were included in the 
current study, while each of the reviewed studies included men.   
 None of the studies that were reviewed examined differences between endogenous GLP-
1 concentrations following breakfast consumption and non-breakfast conditions in healthy 
adults.  While many examined changes in GLP-1 concentrations following the manipulation of 
the content of a particular macronutrient in the breakfast meal [26, 51, 138-144], only one study 
examined changes in GLP-1 following a standard, mixed-nutrient breakfast.  Unlike the current 
study, though, in that between-subjects study by Verdich et al. differences in the response of 
GLP-1 to breakfast were compared between normal weight (n = 12) and obese men (n = 19) 
before and after the obese men went through a weight loss program.  Also, changes in GLP-1 
following a non-breakfast condition were not part of the study design [84].  After eating 
breakfast, GLP-1 concentrations followed a similar temporal pattern as in the current study, 
increasing and peaking within 60 minutes and then approaching baseline levels within the next 
60 minutes.  This response occurred in normal weight and obese men, and after the obese men 
lost weight.  However, because the aim of the study by Verdich et al. was to examine differences 
between the two groups before and after a weight loss program, the significance of within-
subject differences in GLP-1 concentrations between time points was not discussed by the 
authors.   
Another difference between the studies was that in the study by Verdich et al., GLP-1 
concentrations were nearly 10 times higher than those in the current study at each measured time 
point.  It is possible that this is due to a gender effect as Verdich et al. included only men in their 
study while the current study included only women.  In a study by Carroll et al., men had 
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significantly higher levels of GLP-1 than women over a 60 minute monitoring period.  In that 
study, though, concentrations were only approximately two times higher in men than women 
[145].   It is also possible that differences in outcomes were due to methodological differences in 
laboratory procedures.  The study by Verdich et al. measured GLP-1 against standards of 
synthetic GLP-1 (7-36) amide using an antiserum that does not react with GLP-1-containing 
peptides from the pancreas.  The current study measured GLP-1 using a standard kit.  Results of 
GLP-1 concentration in the current study were similar to GLP-1 concentrations in other studies 
reviewed [37, 77, 83, 85].  The current study is the only one to examine the effect of breakfast 
consumption compared to a non-breakfast condition on the acute response of plasma GLP-1 
concentrations in normal weight, overweight, and obese sedentary women, and the findings 
demonstrate that breakfast consumption has a significant effect on this appetite-suppressing 
hormone.  However, larger studies of a similar design are needed to better understand the effect 
of breakfast on GLP-1.  The influence of gender should also be considered when designing 
future studies.   
5.2.3 The Effect of Breakfast on Daily Energy Intake 
In the current study, daily energy intake was examined as: 1) total daily energy intake, which 
included breakfast and/or the snack provided by researchers plus all other discretionary intake 
recorded by the participants; 2) snack and discretionary intake, which included only the snack 
provided by researchers plus all other discretionary intake recorded by the participants; 3) snack 
intake only; and 4) discretionary intake only.  It was hypothesized that daily energy intake would 
be significantly lower following breakfast consumption than following a non-breakfast 
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condition.  However, no significant difference in energy intake between testing conditions was 
observed at any of the above energy intake levels. 
 Total daily energy intake was higher on the breakfast testing day than on the non-
breakfast testing day by an average of 264 calories, but the difference was not significant.  Even 
though overall intake was slightly higher on the breakfast testing day, on the non-breakfast 
testing day intake of the morning snack provided by the researchers was higher by an average of 
27 calories and all other discretionary intake was higher by an average of 88 calories, but neither 
of these differences was significant.  It appears that participants partially compensated for 
missing breakfast by eating more of the morning snack and by slightly increasing their 
discretionary intake on the non-breakfast testing day, but the increase in intake did not exceed 
the calories they missed by not eating breakfast.  Therefore, a decrease in total daily energy 
intake did not follow breakfast consumption as hypothesized.  This is puzzling since the effect of 
breakfast consumption on the response of AG and GLP-1 concentrations resulted in a pattern that 
was conducive to increased energy intake on the non-breakfast testing day.  It is possible that 
even though significant changes in plasma AG and GLP-1 concentrations between testing 
conditions were observed, concentrations did not reach a threshold at which behavior is 
influenced to increase energy intake.  If such a threshold exists, additional research involving 
endogenous concentrations of each hormone is warranted to explore possible associations with 
energy intake.  It is also possible that even though AG and GLP-1 provided a physiological 
signal for hunger and satiety, that signal did not translate to a positive influence on increased 
energy intake.       
The results of the current study are similar to those of recent research comparing energy 
intake on breakfast and non-breakfast days in children and adults [65, 146].  In a randomized 
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crossover trial that had a research design similar to the current study, Kral et al. showed that 
elementary school children (male/female ratio 6/15, mean age 9.2 ± 0.8 y, mean BMI-for-age 
percentile 57.3 ± 29.4) consumed an average of 362 more calories on the breakfast day than on 
the non-breakfast day, but the difference in that study was significant (P = 0.04) [146].   The 
metabolic differences between growing children and adults, though, complicate comparisons 
between the results of these studies.  For example, it is possible that for children of the body 
weight in the Kral study, the physiological signals that influence increased energy intake are 
beneficial and needed for continued growth, while in adults other factors alter the signals that 
influence energy intake since continued growth is not needed. 
Two other studies found similar results in adults.  In a 10-day prospective analysis of 
food diaries kept by 280 obese (male/female ratio 75/205, mean age 45 ± 0.85 y, mean BMI  
36.6 ± 0.2 kg/m2) and 100 normal weight (male/female ratio 33/67, mean age 42 ± 0.2 y, mean 
BMI  32.5 ± 0.1 kg/m2) participants, Schusdziarra et al. reported that obese participants 
consumed approximately 400 more calories and normal weight participants consumed 
approximately 500 more calories on days breakfast was eaten compared to days it was not eaten.  
Both differences were significant (P < 0.05) [65].  Similarly, Nicklas et al. reported that 504 
young adults (mean age 23 y) consumed 568 more calories on days breakfast was eaten (P < 
0.001) than on days breakfast was skipped [13].  However, neither of these studies involved a 
controlled, non-breakfast condition, therefore making comparison of results to the current study 
difficult.  Regardless, all three studies demonstrated increases in total daily energy intake of 
various amounts on days when breakfast was eaten [13, 65, 146].  It is possible that the other 
studies reported greater energy intake amounts than the current study because they included male 
participants.   
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Only one study reported significantly lower intake following breakfast consumption.  In a 
randomized crossover trial that involved breakfast consumption and non-breakfast conditions, 
participants in a study by Farshchi et al. consumed an average of 91 fewer calories on days when 
breakfast was eaten (P = 0.001) [21].  The design of that study, though, limited discretionary 
eating to four structured meal and snack times during both conditions, even though participants 
were allowed to eat whatever they chose.  This may have limited the free-living conditions that 
were part of the design of the current study and the studies above and may have confounded its 
results.  
 Even though the increase in calories on the breakfast testing day in the current study was 
not clinically significant, it is significant in practice as an increase of approximately 100 calories 
per day every day could equate to a 10 pound weight gain over the course of a year.  However, 
because snack and discretionary intake was slightly higher in the current study on days when 
breakfast was skipped, it might be advantageous for those trying to control their energy intake to 
eat a small breakfast daily.  If calories at breakfast could be kept to a minimum and if eating 
breakfast could also help to limit energy intake at subsequent meals and snacks, it is possible that 
consuming a small breakfast daily could lead to a decrease in total daily energy intake that may 
have a significant beneficial impact on body weight over time. 
 Another factor to consider is that all of the participants in the current study stated that 
they ate breakfast at least four times per week.  It is possible that having a regular breakfast eater 
skip breakfast for one day was not enough to invoke a response that may have led to an increase 
in total daily energy intake.  Perhaps if the participants were followed for a week in which 
breakfast was skipped, an increase in total daily energy intake may have been observed.  
Conversely, an increase in total daily energy intake may have been observed if this same study 
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was conducted with participants who do not regularly eat breakfast.  Additional research is 
warranted to investigate if either the amount of calories consumed at breakfast or if changing 
participants’ established breakfast eating patterns for a longer period of time has a significant 
impact on total daily energy intake.  
5.2.4 The Influence of BMI on Study Outcomes 
Acylated Ghrelin (AG) 
It was hypothesized that AG levels would be significantly higher in overweight participants than 
in normal weight participants and in obese participants than in overweight participants for two 
hours following breakfast consumption than for two hours following the non-breakfast condition.  
No interaction effect was observed, though.  Because ghrelin has been reported to play a role in 
meal initiation, with plasma concentrations increasing to the point of spontaneous feeding [22, 
54, 58], it may seem reasonable to conclude that plasma AG concentrations would be higher in 
individuals in positive energy balance, such as those who are overweight or obese.  A 
relationship has been demonstrated with infusion studies in which energy intake levels increased 
following subcutaneous administration of AG prior to meal consumption [69, 70].  In contrast to 
the above conclusion, though, other research has reported total plasma ghrelin levels to be 
negatively correlated with BMI [49, 94, 102], with fasting levels lower and postprandial 
decreases attenuated in obese individuals when compared with normal weight individuals [49, 
101-104].   These differences have been observed to improve, though, with weight loss [27].  
Therefore, it was proposed that total plasma ghrelin concentrations inversely change with body 
weight to act as part of a negative feedback mechanism to maintain energy homeostasis, with up-
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regulation occurring under conditions of negative energy balance and down-regulation occurring 
under conditions of positive energy balance [101].   
With respect to AG, though, only one study has examined the association between 
plasma AG concentrations and body weight in healthy adults and, as in the current study, found 
no interaction effect [97].  However, the lack of a correlation may be due to the small sample 
sizes in these studies (n = 19 and n = 18, respectively).  Larger randomized crossover trials are 
needed to investigate if body weight is associated with the effects of AG on energy intake.  It is 
also possible that no association was observed in the studies examining AG and body weight 
while an association was observed in studies examining total plasma ghrelin and body weight 
because of the presence of des-acyl ghrelin.  As reviewed above, the ratio of des-acyl ghrelin to 
acylated ghrelin has been reported to change even though total plasma ghrelin levels do not 
change [56].  The significant association reported in the studies examining total plasma ghrelin 
may be due to an effect by des-acyl ghrelin.  It is, therefore, important for future studies to assess 
changes in acylated and des-acyl ghrelin simultaneously when examining associations between 
ghrelin concentrations and body weight. 
 
GLP-1 
It was hypothesized that GLP-1 levels would be significantly lower in overweight participants 
than in normal weight participants and in obese participants than in overweight participants for 
two hours following breakfast consumption than for two hours following the non-breakfast 
condition.  In the final analysis, a significant interaction effect was observed.  Following 
breakfast consumption, plasma GLP-1 concentrations were significantly lower in overweight and 
obese participants than in normal weight participants.  This conclusion would seem reasonable 
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since GLP-1 plays a role in satiety and individuals in positive energy balance, such as those who 
are overweight or obese, would be expected to have lower feelings of fullness after meal 
consumption than those in energy balance, such as normal weight individuals.  Other research 
has supported this conclusion and has also reported an increase in GLP-1 concentrations with 
weight loss [84].  Although GLP-1 is only one of several anorexigenic hormones, the association 
observed between body weight and GLP-1 in the current study supports the importance of its 
role in energy balance. 
 
Daily Energy Intake 
Although it was not a specific aim of the study, the association between body weight and daily 
energy intake was explored.  In the final analysis, a significant interaction effect was observed 
between normal weight and overweight participants, and a weak interaction effect was observed 
between overweight and obese participants, but no interaction effect was observed between 
normal weight and obese participants.  This seems counterintuitive.  However, daily energy 
intake increased following breakfast consumption when compared to the non-breakfast condition 
for overweight participants while it decreased for normal weight and obese participants.  It is 
possible that with a larger sample size these results would not be repeated.  Although, if the 
outcomes were the same, it could be due to a BMI threshold being reached at which the response 
to the physiological stimulation of appetite is blunted.  As reviewed above, the ghrelin system is 
impaired with weight gain.  It is possible that a decrease in sensitivity to the ghrelin response is 
not evident until an individual reaches a certain body weight.  If so, even when preprandial AG 
levels are lower than those of normal weight individuals, overweight individuals may still 
respond by increasing energy intake.  The decrease in sensitivity to the ghrelin response may not 
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be evident at preprandial AG levels higher than those of obese individuals.  It is also possible 
that obese individuals underreported daily intake amounts, therefore resulting in lower daily 
energy intake following breakfast than overweight participants.  Research has reported that 
obesity is significantly associated with underreporting of energy intake [147-150].  Larger 
crossover trials are needed to further elucidate any possible associations between BMI and 
energy intake following breakfast consumption and non-breakfast conditions. 
5.2.5 The Effect of Breakfast on Subjective Ratings of Hunger and Satiety 
Subjective ratings of hunger and satiety were measured using 100 mm visual analog scales 
(VAS).  As hypothesized, subjective ratings of hunger were significantly lower and subjective 
ratings of satiety were significantly higher during the two-hour monitoring period following 
breakfast consumption than following the non-breakfast condition.  For each question, ratings 
were not significantly different between the two testing conditions at baseline, but they were at 
all other time points.  In addition, following breakfast consumption, although the mean rating of 
hunger at 120 minutes was significantly lower than at baseline, it was significantly higher than at 
30 minutes.  Also, on one of the two questions assessing satiety, the mean rating at 120 minutes 
was significantly lower than at 30 minutes, even though it was still significantly higher than at 
baseline.  This suggests that the effect of breakfast consumption on subjective feelings of hunger 
and satiety begins to diminish within two hours of eating breakfast.  By comparison, following 
the non-breakfast condition hunger ratings trended toward being significantly higher and satiety 
ratings trended toward being significantly lower over the two-hour monitoring period, suggesting 
that feelings of hunger increase in the short term when breakfast is skipped. 
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While numerous other studies examined changes in subjective ratings of hunger and 
satiety following the manipulation of macronutrients in a breakfast meal, the previously 
reviewed study by Farshchi et al. was the only study from the reviewed literature to examine 
differences in hunger and satiety ratings between breakfast consumption and non-breakfast 
conditions.  However, the design of Farshchi’s study was to examine changes in subjective 
ratings following a two-week period of daily breakfast consumption compared to a two-week 
period of daily breakfast omission.  At each assessment visit participants were fed breakfast prior 
to completing VAS questionnaires in order to assess the impact of testing conditions on how 
hungry participants felt after eating breakfast [21].  Unfortunately, with respect to measuring 
subjective ratings of appetite, a non-breakfast condition was not part of the study design.  
However, the questions assessing hunger and satiety in that study were the same as the questions 
in the current study.  Comparing the responses between the two studies, following breakfast 
consumption the temporal patterns of the responses to each question were similar in both studies, 
adding support to the conclusion of the current study that the effect of breakfast consumption on 
subjective feelings of hunger and satiety begins to diminish within two hours of eating breakfast.  
To the knowledge of the researchers of the current study, ours is the only one to examine 
differences in subjective ratings of hunger and satiety following breakfast consumption and non-
breakfast conditions.      
5.2.6 The Association between Subjective Ratings of Hunger and Satiety and 
Study Outcomes 
To test the strength of the relationships between subjective feelings of hunger and the other 
dependent variables, VAS scores were correlated with AG concentrations, GLP-1 
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concentrations, and daily energy intake.  With respect to the appetite-regulating hormones, it was 
hypothesized that subjective ratings of hunger would positively correlate with plasma AG 
concentrations and subjective ratings of satiety would positively correlate with plasma GLP-1 
concentrations for the two-hour monitoring period following breakfast consumption and a non-
breakfast conditions.  Surprisingly, this did not occur.  At no point on either testing day did the 
VAS scores for any question significantly correlate with concentrations of either of the appetite-
regulating hormones.   
Although conclusions from the reviewed literature are mixed regarding a relationship, 
there is support for this lack of correlation.  Erdmann et al. concluded in several studies that 
ghrelin concentrations did not correlate with feelings of hunger and satiety following 
carbohydrate-, protein-, or fat-rich breakfast meals [30, 31, 33].  These studies only looked at 
total plasma ghrelin concentrations, though, so it is difficult to compare results with the current 
study.  Blom et al. found a significant relationship between total plasma ghrelin concentrations 
and VAS scores for hunger and satiety following breakfast consumption in one study [25], but in 
another study that examined AG and GLP-1 concentrations following a standard mixed breakfast 
and a high-protein breakfast, a significant relationship was not observed for either condition [26].  
None of the other reviewed studies correlated AG concentrations with VAS scores.     
With respect to GLP-1, most studies only found a significant relationship with subjective 
ratings of hunger and satiety when exogenous GLP-1 was infused.  For example, in a meta-
analysis of nine GLP-1 infusion studies, Verdich et al. reported that differences in plasma GLP-1 
concentrations significantly correlated with differences in subjective ratings of fullness, but not 
with ratings of hunger [52].  However in the previously mentioned study by Verdich et al. that 
examined changes in endogenous GLP-1 concentrations after a weight loss intervention, only a 
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weak correlation between GLP-1 AUC and the AUC of subjective appetite ratings was observed 
[84].  Comparing results from studies examining supraphysiological infused doses and regular 
endogenous concentrations of GLP-1, Verdich et al. concluded that endogenous plasma GLP-1 
concentrations may not be enough to stimulate a subjective satiety response [84].   
The discrepancy in the significance of results from the latter study by Verdich et al. and 
the current study may be due to the fact that the monitoring of the dependent variables in the 
Verdich study lasted 180 minutes, while in the current study monitoring lasted only 120 minutes.  
Adding to this disparity, in a study by Adam et al. in which monitoring also lasted 120 minutes, a 
significant correlation was observed between increased postprandial concentrations of GLP-1 
and subjective ratings of satiety at 60 and 90 minutes following consumption of a breakfast meal 
with a preload of water.  The correlation was not significant, though, following a breakfast meal 
with a preload of a galactose and guar gum beverage [85], which suggests that a macronutrient 
component may mediate the association.  Given the monitoring times in the above studies [84, 
85], though, it is also possible that a significant relationship between changes in GLP-1 and 
subjective ratings of hunger and satiety is only realized over longer periods of time.  Lastly, it is 
also possible that since GLP-1 is only one of several anorexigenic peptides, other hormones may 
play a role in the relationship that confound the correlation between GLP-1 and subjective 
ratings of hunger and satiety.  Although four of the above studies examined other anorexigenic 
hormones along with GLP-1, none reported that the other hormones were included as covariates 
when analyzing the relationship between GLP-1 concentrations and VAS scores [26, 42, 75, 84]. 
Although not a specific aim of the study, VAS scores were correlated with total daily 
energy intake, snack and discretionary intake, and discretionary intake only.  Following breakfast 
consumption, daily intake at each intake level significantly correlated with subjective ratings of 
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hunger and satiety.  However, there was not a significant relationship with either hunger or 
satiety following the non-breakfast condition.  Only one of the reviewed studies examined the 
relationship between subjective ratings of hunger and satiety and energy intake and found no 
correlation between the difference in ad libitum energy intake and difference in both fullness and 
hunger ratings [52].  In the current study, it is interesting that a significant correlation was 
observed following breakfast consumption but not following the non-breakfast condition.  This 
could suggest that in a fed state participants were more perceptive of the physiological drive and 
better able to identify feelings of hunger and satiety with corresponding changes in AG and 
GLP-1 than they were in a fasted state.  Subjective feelings of hunger and satiety may be 
interpreted better when AG and GLP-1 are trending toward levels of a fed state.  If accurate, this 
may explain how breakfast consumption influences physiological mechanisms that contribute to 
hunger, satiety, and eating behavior.   
5.3 LIMITATIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH 
Only sedentary but otherwise healthy women between the ages of 18 and 40 were included in the 
current study.  Caution should be taken before generalizing the results of this study to other 
individuals.  In addition, the following are limitations of the current study that may have 
contributed to the observed findings: 
1. Although it was determined that 19 participants were needed in order to detect a 
moderate to large effect size in differences of studied outcomes, only 18 participants were 
included in most analyses.  Due to missing data or values outside of the normal range, 
some of the analyses included as few as 14 participants.  While including 18 participants 
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is still enough to detect a large effect size with the statistical analyses used, analyses 
performed with fewer than 15 participants would not be powered to detect significant 
differences in outcomes.  Also, this study was underpowered to examine differences in 
AG and GLP-1 concentrations and energy intake between BMI groups.  A significant 
Condition × Time × BMI interaction was observed with GLP-1 concentrations and a 
Condition × BMI interaction was observed with daily energy intake.  Although these 
findings suggest that body weight may influence appetite regulation and energy intake, 
additional, properly powered studies should be conducted to fully examine any 
associations.  
2. As the previously reviewed research has observed, the macronutrient content of the 
breakfast meal may influence AG and GLP-1 concentrations as well as subjective ratings 
of hunger and satiety.  In the current study, a standardized, mixed meal was used that 
provided commonly proportioned amounts of carbohydrate, protein, and fat in an effort to 
control for this influence.  In the final analysis, though, daily energy intake did not 
significantly change following breakfast consumption when compared to a non-breakfast 
condition.  Because of the conflicting results in research examining the impact of 
macronutrients on ghrelin and GLP-1 responses and subjective ratings of hunger and 
satiety, additional research is needed that includes a non-breakfast condition as part of its 
study design.  If the role of breakfast in energy balance is beneficially influenced by a 
particular macronutrient, identifying the macronutrient and exploring the physiological 
mechanism of its action could be advantageous to those trying to achieve a healthy body 
weight. 
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3. Only AG and GLP-1 were examined in this study because both are gut-based hormones 
that are particularly responsive to food intake.  However, as previously reviewed, they are 
only two of many appetite-regulating polypeptides.  Other orexigenic peptides, including 
neuropeptide Y and agouti-related protein, and anorexigenic peptides, including leptin, 
cholecystokinin, and peptide YY, all play a role in appetite regulation and often work in 
tandem, sometimes influencing or inhibiting the secretion of one another.  In addition, 
changes in body weight influence concentrations of many of these peptides.  Therefore, it 
is quite possible that the findings of the current study were influenced by changes in these 
other appetite-regulating polypeptides. 
4. Although it was hypothesized in the current study that total daily energy intake would be 
significantly lower following breakfast consumption than following a non-breakfast 
condition, energy intake was not significantly different between conditions.  It is possible 
that differences in subsequent energy intake may be observed following meal 
consumption and non-meal conditions involving lunch or dinner.  Research of a design 
similar to the current study should be conducted on lunch and dinner consumption to 
explore possible effects they may have on subsequent energy intake.  
5. As with other research examining energy intake in free-living situations, energy intake 
data relied on self-report by the participants.  Under- and over-reporting of energy intake 
is common when research participants are asked to be conscious of the food choices they 
make.  Because analyses of energy intake were of a within-subjects design, and because 
the specific hypotheses of the study were not shared with the participants, the potential 
error associated with self-reported energy intake may have been reduced. 
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6. Blood samples were taken via a needle stick at four time points for each testing condition.  
With four participants, multiple attempts were required which slightly delayed the timing 
of the blood draws.  Although the delay in obtaining the blood samples should not affect 
the findings of the current study, it is a possibility.  Future studies should consider using 
an angiocatheter to reduce the difficulty in drawing blood and to improve the accuracy of 
timed blood draws. 
5.4 CONCLUSIONS 
Breakfast consumption has been identified as a strategy for achieving energy balance and 
maintaining weight loss, but mechanisms to explain its effects have not been fully explored.  
Results from research investigating the association between breakfast consumption and energy 
balance have been conflicting, mainly due to differences in research design.  Findings from the 
current study indicate that even though a significant acute hormonal response was observed 
following breakfast consumption when compared to a non-breakfast condition, total daily energy 
intake between conditions was not significantly different.  However, observed, statistically 
insignificant changes in energy intake following breakfast consumption could translate into 
energy balance over time.  In addition, findings from our study suggest that body weight may 
play a role in the pathway by which breakfast consumption may impact energy intake.  Finally, 
subjective feelings of hunger significantly correlated with energy intake following breakfast 
consumption but not following the non-breakfast condition, suggesting that perceptions of the 
physiological drivers of appetite may be more sensitive following breakfast consumption than 
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when breakfast is skipped.  Additional studies with a larger sample size should be conducted to 
further investigate these associations.   
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DESCRIPTION: 
 
Excess body weight is associated with increased risk for developing heart disease, diabetes, and some forms of 
cancer.  Maintaining a healthy body weight can improve the risk for these conditions.  Once a healthy body weight is 
achieved, the goal in maintaining it is to match calories eaten to calories burned and to be in a state of energy 
balance.  Research has identified regular breakfast consumption as a strategy to achieve energy balance.  However, 
it is not fully understood how this occurs.  The purpose of this study is to examine the effect of breakfast consumption 
on hormones that have been shown to affect appetite.  It will also examine the effect of breakfast on feelings of 
hunger and fullness and on how much you eat the rest of the day.   
   
You are being invited to take part in this research study because you are a woman who regularly eats breakfast and 
does not engage in regular physical activity.  People invited to participate in this study are women between 18-40 
years of age.  The study is being performed on a total of 21 individuals and will be conducted at a University of 
Pittsburgh facility. 
 
If you decide to take part in this research study, you will be asked to attend one orientation session and two testing 
sessions.  At the orientation session, details of the study will be reviewed and an opportunity to have questions 
answered will be provided.  In addition, you will be asked to complete some questionnaires and undergo some 
screening and experimental procedures if you are considered eligible to participate.  The orientation session will last 
approximately 60 minutes.   
 
The following procedures that are not part of your standard medical care will be conducted at the orientation session 
and the testing sessions: 
 
 Screening Procedures: 
 
Procedures to determine if you are eligible to take part in a research study are called “screening 
procedures”.   For this research study, the screening procedures include: 
 
Completion of a questionnaire about eating behaviors (Three-Factor Eating Questionnaire) and a detailed 
medical history.  These will take approximately 30 minutes to complete and will allow the investigators to 
determine if you have any significant medical conditions that may affect the outcomes of this study.   
 
Pregnant women, women who have been pregnant within nine weeks of starting the study, or women who 
are currently breast-feeding an infant will not be allowed to take part in this study.  A urine pregnancy test 
will be used to determine pregnancy status at each testing session prior to its start. 
 
 Experimental Procedures: 
 
If you qualify to take part in this research study, you will be asked to undergo assessments of height, weight, 
waist and hip measurements, body composition, and resting energy expenditure.  These assessments will 
take place at the Physical Activity and Weight Management Research Center in Birmingham Towers (South 
Side of Pittsburgh) at the University of Pittsburgh.  These assessments will be completed in approximately  
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90 minutes.  A brief explanation of each follows: 
  
A. Body Weight and Height (5 minutes):  Your body weight will be measured using a standard medical  
 scale.  Your height will be measured with a ruler that is attached to a flat wall.  These will be measured  
 at the orientation visit and prior to the two testing sessions. 
 
B. Waist and Hip Measurements (5 minutes):  Your waist and hips will be measured by an investigator  
 using a standard tape measure.  They will be measured at the orientation visit and prior to the two  
 testing sessions. 
 
C. Body Composition (20 minutes):  Your body composition is the amount of fat weight and lean weight  
 (muscle and bone) that you have on your body.  Your body composition will be measured using a  
 technique known as Bioelectric Impedance Analysis (BIA).  This procedure requires that a small  
 electrode be placed on your hand, wrist, ankle, and foot.  A low-level signal that is not harmful to you  
 and that you will not feel is transmitted between the electrodes.  BIA will be measured at the orientation  
       visit and prior to the two testing sessions. 
 
D. Resting Energy Expenditure (50 minutes):  Your resting energy expenditure (REE), or the number of 
 calories that you burn at rest, will be measured on each of the testing days.  For this procedure, you will  
 be asked to lie quietly in a room for approximately 30 minutes to ensure that your body is in a rested  
 state.  Then, a plastic canopy will be placed over your upper body, and the air that you breathe in and  
 out will be analyzed for a period of 20 minutes.  REE will only be measured prior to the two testing  
 sessions.   
 
If your are currently a subject in another ongoing research study at the Physical Activity and Weight Management 
Research Center and you have already completed assessments of height, weight, waist and hip measurements, 
body composition, and resting energy expenditure within 4 weeks of signing this consent document, and if those tests 
utilized the same procedures as described above, you grant the investigators permission to use the results from the 
previously completed tests so that you do not need to perform these tests again for this current study. 
Breakfast Consumption and Non-Breakfast Sessions: 
At an orientation meeting, you will be asked to schedule two visits to the Physical Activity and Weight Management 
Research Center.  One visit will require you to consume a breakfast provided by the investigators and the other will 
require that you do not eat breakfast.  These visits will be separated by at least 3 days and be within days 7 and 21 of 
your menstrual cycle.  The order in which these visits take place will be randomly determined using a method similar 
to flipping a coin.  A more detailed description of each of these visits is shown below. 
 
A.  Breakfast Consumption Condition:  On this day of testing you will report to the research center between 
the hours of 7:00 a.m. and 9:00 a.m. having fasted for 12 hours.  You should eat no food during the 12 
hour fasting period, but drinking water is permitted.  All testing procedures will be reviewed and the 
following will occur over a total of approximately 4 hours: 
 a.   The above experimental procedures (height, weight, waist and hip measurements, body  
         composition, and resting energy expenditure ) will be performed. 
b.   You will be asked to complete a questionnaire related to your feelings of hunger and fullness  
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immediately prior to eating breakfast and at 30, 60, and 120 minutes after finishing breakfast. 
c.   Blood will be taken 4 times throughout the course of the testing session via a needle stick.  A sample 
will be taken immediately prior to eating breakfast and at 30, 60, and 120 minutes after finishing 
breakfast.  Each blood sample will be approximately 1 tablespoon of blood, with a total of 
approximately 4 tablespoons of blood being collected during this entire session.  Your blood will be 
analyzed to measure levels of acylated-ghrelin and glucagon-like peptide 1 (GLP-1) which are 
biomarkers of metabolism and digestion that are thought to be involved in weight control.  Serum 
insulin and glucose will also be analyzed.  Blood samples will be obtained by a trained phlebotomist 
or medical technician.  In addition, at the time of each blood draw, your blood glucose level will be 
measured using a standard glucometer to ensure that your blood glucose does not drop too low.  If it 
does, the test will be terminated. 
     d.   You will be provided with a choice of breakfast meals.  Each will include the same amount of  
calories and provide 20% of your estimated daily needs based upon your height, weight, and age.  
You will be required to completely eat the breakfast meal within 15 minutes.  You will be able to 
choose from either a Luna Bar and whole milk or a toasted English muffin, cheddar cheese, and 
apple juice as the breakfast meal.  You will be able to choose from one of several flavors of Luna 
Bars.  If you are lactose intolerant you will be provided with Lactaid milk.       
e.   Upon completion of breakfast you will be brought to a separate room in which you will be asked to  
rest quietly in a seated position for 2 hours.  During this time, you will have access to newspapers, 
magazines, books, and a video that you can watch.  The additional blood samples will be collected 
and the additional questionnaires will be completed during this time as detailed above at 30, 60, and  
120 minutes following breakfast.  
  f.    Prior to leaving the research center, you will be required to consume a small snack and water.  
  g.   To keep track of the foods you ate and the physical activity you engaged in on the day of testing, you  
        will be required to document all foods consumed and all physical activity in a food and physical  
    activity diary that you will be provided with.  Prior to leaving the research center, a staff member will  
    assist you in recording the food eaten during the testing session in the diary.  The staff member then  
    will remind you to record all foods eaten and all physical activity for the rest of the day in the food and  
    physical activity diary and will answer any questions you have.  On the day after your testing session, 
    a staff member will call you to review the entries in your diary.  You will be asked to schedule a time  
    for the staff member to call you and provide him/her with a phone number at which you can be  
    reached prior to leaving the research center. 
 
B.   Non-Breakfast Condition: On this day of testing you will report to the research center between the hours 
of 7:00 a.m. and 9:00 a.m. having fasted for 12 hours.  You should eat no food during the 12 hour fasting 
period, but drinking water is permitted.  All testing procedures will be reviewed and the following will 
occur over a total of approximately 3 hours: 
 a.   The above experimental procedures (height, weight, waist and hip measurements, body  
      composition, and resting energy expenditure) will be performed. 
b.   You will be asked to complete a questionnaire related to your feelings of hunger and fullness  
 immediately after the procedures are reviewed with you and at 30, 60, and 120 minutes after a 15-
minute waiting period during which you will sit quietly without eating. 
 c.   Blood will be taken 4 times throughout the course of the testing session via a needle stick.  A sample 
  will be taken immediately after the procedures are reviewed with you and at 30, 60, and 120 minutes 
after a 15-minute waiting period during which you will sit quietly without eating.  Each blood sample  
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will be approximately 1 tablespoon of blood, with a total of approximately 4 tablespoons of blood 
being collected during this entire session.  Your blood will be analyzed to measure levels of acylated-
ghrelin and GLP-1 which are biomarkers of metabolism and digestion that are thought to be involved 
in weight control.  Serum insulin and glucose will also be analyzed.  Blood samples will be obtained 
by a trained phlebotomist or medical technician.  In addition, at the time of each blood draw, your 
blood glucose level will be measured using a standard glucometer to ensure that your blood glucose 
does not drop too low.  If it does, the test will be terminated. 
d.   You then will be brought to a separate room in which you will be asked to rest quietly in a seated  
position for 2 hours.  During this time, you will have access to newspapers, magazines, books, and a 
video that you can watch.  The additional blood samples will be collected and the additional 
questionnaires will be completed during this time as detailed above at 30, 60, and 120 minutes 
following the 15-minute waiting period.  
  e.   Prior to leaving the research center, you will be required to consume a small snack and water.  
   f.   To keep track of the foods you ate and the physical activity you engaged in on the day of testing, you 
        will be required to document all foods consumed and all physical activity in a food and physical  
        activity diary that you will be provided with.  Prior to leaving the research center, a staff member will   
 assist you in recording the food eaten during the testing session in the diary.  The staff member then 
 will remind you to record all foods eaten and all physical activity for the rest of the day in the food and   
 physical activity diary and will answer any questions you have.  On the day after your testing session,  
 a staff member will call you to review the entries in your diary.  You will be asked to schedule a time  
 for the staff member to call you and provide him/her with a phone number at which you can be  
 reached prior to leaving the research center. 
 
RISKS and BENEFITS: 
 
The possible risks of this research study may be due to the foods you are asked to eat and the assessments that will  
be performed. 
 
  Risks 
         
        A.  Risk of Bioelectrical Impedance Analysis (BIA):  You may experience skin irritation or skin redness from  
             electrodes being placed on your skin.  The risk of this happening to you is likely because this occurs in  
             more than 25% of people (more than 25 out of 100 people). 
  
              B.  Risk of Measuring Resting Energy Expenditure:  The measurement of resting energy expenditure will be 
             done using a ventilated hood.  The only adverse factor associated with this is that you may experience a  
             feeling of claustrophobia.  The risk of this happening to you is infrequent because it occurs in less than  
             1-10% of people (1 to 10 out of 100 people).  A person will be bedside at all times and check to see if you  
             are comfortable.  The transparent hood can be easily removed if necessary. 
 
 C.   Risk Associated with Completion of Questionnaires:  You may experience non-physical risks such as 
       boredom, frustration, stress, and time constraints when completing the questionnaires.  The risk of this  
       happening to you is likely because this occurs in more than 25% of people (more than 25 out of 100  
       people).  You may also experience the rare occurrence of breach of confidentiality with regard to  
       information provided by you on the questionnaires.  The risk of this happening is low because it occurs  
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in less than 1% of people (less than 1 out of 100 people). 
 
 D.  Risk of Drawing Blood:   The risks of drawing blood from a vein include discomfort at the site of  
      puncture and possible bruising and swelling around the puncture site.  The risks of this happening to you  
      are likely because they occur in more than 25% of people (more than 25 out of 100 people).  Although  
      rare, it is possible that you may develop an infection or experience faintness from the procedure.  The  
      risk of an infection or fainting occurring is rare because they occur in less than 1% of people (less than 1  
      out of 100 people).  You may also experience the rare occurrence of breach of confidentiality with regard  
      to stored blood samples.  The risk of this happening is low because it occurs in less than 1% of people  
      (less than 1 out of 100 people). 
 
 E.  Risk of Consuming a Solid or Liquid Meal Replacement:  Among the options for the breakfast meal and  
      snacks provided for you to consume during the testing sessions are meal replacement bars and shakes.   
      There is a possibility that you may not like the taste of the meal replacement.  Also, consuming some of  
      them may result in bloating, gas, and indigestion.  This is rare and occurs in less than 1% of people (less  
      than 1 out of 100 people). 
 
 Benefits 
 
 There are no direct benefits that you will receive from participating in this study.  However, knowledge  
 gained from this study may provide a future benefit, for example, to those who may want to lose or maintain  
 weight. 
  
NEW INFORMATION: 
 
You will be promptly notified if any new information develops during the conduct of this research study which may 
cause you to change your mind about continuing to participate. 
 
COSTS and PAYMENTS: 
 
Neither you, nor your insurance provider, will be charged for the costs of any of the procedures performed for the 
purpose of this research study.  These costs will be paid by the sponsor of this research study.   
 
You will be paid $300 upon completion of all testing procedures which include an orientation session, the breakfast 
consumption session, and the non-breakfast session described above.  You will be paid $100 after you complete the 
first testing session, $100 after you complete the second testing session and an additional $100 if you complete both 
testing sessions and follow-up phone interviews the day after each testing session.  Thus, a total of $300 can be 
earned for your complete participation in the study.   
 
COMPENSATION FOR INJURY: 
 
University of Pittsburgh researchers and their associates who provide services at the University of Pittsburgh Medical 
Center (UPMC) recognize the importance of your voluntary participation in their research studies.  These individuals 
and their staffs will make reasonable efforts to minimize, control, and treat any injuries that may arise as a result of 
this research.  If you believe that the research procedures have resulted in an injury to you, immediately contact the  
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Principal Investigator who is listed on the first page of this form.  
 
Emergency medical treatment for injuries solely and directly related to your participation in this research study will be 
provided to you by the hospitals of UPMC. Your insurance provider may be billed for the costs of this emergency 
treatment, but none of those costs will be charged directly to you. If your research-related injury requires medical 
care beyond this emergency treatment, you will be responsible for the costs of this follow-up care. At this time, there 
is no plan for any additional financial compensation. 
 
CONFIDENTIALITY: 
 
Any information about you obtained from this research will be kept as confidential (private) as possible.  All records 
related to your involvement in this research study will be stored in a locked file cabinet.  Your identity on these 
records will be indicated by a case number rather than by your name, and the information linking these case numbers 
with your identity will be kept separate from the research records.  If you should withdraw from participation in this 
study prior to its completion, any collected data and any biological specimens collected will be de-identified and 
rendered anonymous.  They will be retained in this format and any identifiable data will be destroyed at this point.  
You will not be identified by name in any publication of the research results unless you sign a separate consent form 
giving your permission (release). 
 
 Blood Samples 
 
 At this point, funding is only available to analyze your blood samples for acylated-ghrelin, GLP-1, insulin and  
 glucose.  However, stored samples of your blood will be used to examine other biomarkers that may affect  
 hunger and satiety as additional funding becomes available.  Therefore, obtained blood samples will be  
 stored indefinitely in a locked freezer in the Physical Activity and Weight Management Research Center.   
 Your identity on these blood samples will be indicated by a case number rather than by your name.  The  
 information linking the case number to your name will be stored separately in a secure location.  Samples of  
 your blood may be shared with secondary investigators.  However, the samples will only be identified by  
 case number and not by your name. 
 
 Your biological sample or genetic material may lead, in the future, to new inventions or products. If the 
 research investigators are able to develop new products from the use of your biological sample or genetic  
 material, there are currently no plans to share with you any money or other rewards that may result from the  
 development of the new product. 
 
In addition to the investigators listed on the first page of this authorization (consent) form and their research staff, the 
following individuals will or may have access to identifiable information (which may include your identifiable medical 
information) related to your participation in this research study:  
 
 Authorized representatives of the University of Pittsburgh Research Conduct and Compliance Office may   
   review your identifiable research information (which may include your identifiable medical information) for 
 the purpose of monitoring the appropriate conduct of this research study.  
 
In unusual cases, the investigators may be required to release identifiable information (which may include 
your identifiable medical information) related to your participation in this research study in response to an  
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order from a court of law.  If the investigators learn that you or someone with whom you are involved is in 
serious danger or potential harm, they will need to inform, as required by Pennsylvania law, the appropriate 
agencies.   
 
If we should find out about a medical condition you were unaware of, with your written permission, this 
information will be shared with the doctor of your choice.  
 
The investigators may continue to use and disclose, for the purposes described above, identifiable information (which 
may include your identifiable medical information) related to your participation in this research study for a minimum of 
six years after final reporting or publication of a project.  
 
RIGHT TO PARTICIPATE or WITHDRAW FROM PARTICIPATION: 
 
Your participation in this research study, to include the use and disclosure of your identifiable information for the 
purposes described above, is completely voluntary.  (Note, however, that if you do not provide your consent for the  
use and disclosure of your identifiable information for the purposes described above, you will not be allowed to 
participate in the research study.)  Whether or not you provide your consent for participation in this research study 
will have no effect on your current or future relationship with the University of Pittsburgh.  Whether or not you provide 
your consent for participation in this research study will have no effect on your current or future medical care at a 
UPMC hospital or affiliated health care provider or your current or future relationship with a health care insurance 
provider. 
 
You may withdraw, at any time, your consent for participation in this research study, to include the use and disclosure 
of your identifiable information for the purposes described above.  (Note, however, that if you withdraw your consent 
for the use and disclosure of your identifiable medical record information for the purposes described above, you will 
also be withdrawn, in general, from further participation in this research study.)  Any identifiable research or medical 
information recorded for, or resulting from, your participation in this research study prior to the date that you formally 
withdrew your consent may continue to be used and disclosed by the investigators for the purposes described above.  
Any collected data and any biological specimens collected will be de-identified and rendered anonymous.  They will 
be retained in this format and any identifiable data will be destroyed at this point.      
        
To formally withdraw your consent for participation in this research study you should provide a written and dated 
notice of this decision to the principal investigator of this research study at the address listed on the first page of this 
form.  
 
Your decision to withdraw your consent for participation in this research study will have no effect on your current or 
future relationship with the University of Pittsburgh.  Your decision to withdraw your consent for participation in this 
research study will have no effect on your current or future medical care at a UPMC hospital or affiliated health care 
provider or your current or future relationship with a health care insurance provider. 
 
It is possible that you may be removed from the research study by the researchers if, for example, your health status 
changes and it does not appear that is safe for you to reduce your food intake or if you should become pregnant 
during the study 
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************************************************************************ 
VOLUNTARY CONSENT 
 
The above information has been explained to me and all of my current questions have been answered.  I understand 
that I am encouraged to ask questions about any aspect of this research study during the course of this study, and 
that such future questions will be answered by a qualified individual or by the investigator(s) listed on the first page of 
this consent document at the telephone number(s) given. I understand that I may always request that my questions, 
concerns or complaints be addressed by a listed investigator.   
 
I understand that I may contact the Human Subjects Protection Advocate of the IRB Office, University of Pittsburgh 
(1-866-212-2668) to discuss problems, concerns, and questions; obtain information; offer input; or discuss situations 
that have occurred during my participation.   
 
By signing this form, I agree to participate in this research study.  A copy of this consent form will be given to me. 
 
____________________________  ____________________________  ____________ 
Participant’s Signature   Printed Name of Participant  Date 
 
 
CERTIFICATION of INFORMED CONSENT 
 
I certify that I have explained the nature and purpose of this research study to the above-named individual(s), and I 
have discussed the potential benefits and possible risks of study participation.  Any questions the individual(s) have 
about this study have been answered, and we will always be available to address future questions as they arise.  I 
further certify that no research component of this protocol was begun until after this consent form was signed.  
 
___________________________________  ________________________ 
Printed Name of Person Obtaining Consent  Role in Research Study 
 
_________________________________  ____________ 
Signature of Person Obtaining Consent  Date  
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APPENDIX B 
BASELINE VISIT DATA COLLECTION FORM 
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 IRB# PRO09120437: The Effect of Breakfast Consumption on Acylated-Ghrelin and GLP-1 
 PI: Tom Hritz, MS, RD, LDN 
 
 Subject ID________________________  Date consent signed______________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Signature______________________________________________    Date_________________________ 
 
Baseline Study Procedures Performed per Protocol and Documented? Y/N 
Telephone screening Date_______________ 
By  ________________ 
 
Orientation session Date_______________ 
By  ________________ 
 
Eating Inventory questionnaire 
completed 
  
Medical history questionnaire 
completed 
  
Height, Weight, BMI Hgt_________cm.  Wgt__________lbs.   
BMI________kg/m2 
 
Waist/Hip measurements Waist (umbilicus)_____cm  _____cm  _____cm 
Waist (iliac crest)_____cm  _____cm  _____cm 
Hips______cm  ______cm  ______cm 
 
Bioelectric Impedance Analysis 
(BIA) 
Resistance______________ohms 
Reactance_______________ohms 
 
Schedule Visit 1 and Visit 2 within 7-
21 days of onset of menstrual cycle 
Date of  LMP_________________   
Date of Visit 1________________ 
Date of Visit 2________________ 
Randomized to:  Breakfast   Non-breakfast 
 
Selection for breakfast visit  Luna bar & milk   English muffin, cheese,  
                                           apple juice 
 
Prep for next visit: 
• Fast for at least 12 hours 
• Abstain from vigorous PA day 
before visit 
• Avoid OTC meds. day before visit 
• Arrive to visit by vehicle 
Reviewed with subject? 
Comments: 
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APPENDIX C 
NON-BREAKFAST CONDITION DATA COLLECTION FORM 
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 IRB# PRO09120437: The Effect of Breakfast Consumption on Acylated-Ghrelin and GLP-1 
 PI: Tom Hritz, MS, RD, LDN 
 
 Subject ID_______________ Acrostic_______________       Date consent signed________________ 
 
  
Signature_________________________________________    Date_________________________ 
Non-Breakfast Testing Session 
Date:____________________________ 
 
Performed per Protocol and Documented? Y/N 
Confirm: 
• Fasted for at least 12 hours 
• Abstained from vigorous PA day before 
visit 
• Avoided OTC meds. day before visit 
• Arrived to visit by vehicle 
  
Urine pregnancy test NegativePositive (if positive, stop testing)  
Resting Energy Expenditure Time done:________________ 
Rested for 30 mins. in supine position in dark 
room 
     Start time________________ 
     End time_________________ 
Steady state measurement under canopy 
(complete test after REE stable for 5 minutes) 
     Start time________________ 
     End time_________________ 
 
Height, Weight, BMI Hgt_________cm.  Wgt__________lbs.   
BMI________kg/m2 
 
Waist/Hip measurements Waist (umbilicus)_____cm  _____cm  _____cm 
Waist (iliac crest)_____cm  _____cm  _____cm 
Hips______cm  ______cm  ______cm 
 
Bioelectric Impedance Analysis (BIA) Resistance______________ohms 
Reactance_______________ohms 
 
Baseline blood draw & hunger/satiety 
questionnaire 
Blood sample:                          Questionnaire: 
Baseline____________           ______________ 
By________________ 
 
Waiting period Start time____________ 
End time_____________ 
 
Rested quietly for next 2 hours with 
standardized video and periodicals 
 
Blood draw and hunger/satiety questionnaire 
completion at 30, 60 and 120 minutes 
following completion of waiting period 
Resting start___________     End____________ 
 
Blood samples:                         Questionnaire: 
30 mins.____________           ______________ 
60 mins.____________           ______________ 
120 mins.___________           ______________ 
By_____________________ 
 
Completion: 
• Snack prior to leaving 
• Record food eaten in food & PA diary 
• Schedule time to call & review diary entries 
• Confirm next testing visit date (if 
applicable) 
Snack choice: 
Luna Bar & H2O    Slim Fast Shake & H2O 
 
Scheduled phone call time:_______________ 
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APPENDIX D 
BREAKFAST CONDITION DATA COLLECTION FORM 
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 IRB# PRO09120437: The Effect of Breakfast Consumption on Acylated-Ghrelin and GLP-1 
 PI: Tom Hritz, MS, RD, LDN 
 
 Subject ID_______________ Acrostic_______________         Date consent signed_______________ 
 
 
Signature______________________________________________    Date_________________________ 
Breakfast Testing Session 
Date:____________________________ 
 
Performed per Protocol and Documented? Y/N 
Confirm: 
• Fasted for at least 12 hours 
• Abstained from vigorous PA day before 
visit 
• Avoided OTC meds. day before visit 
• Arrived to visit by vehicle 
  
Urine pregnancy test NegativePositive (if positive, stop testing)  
Resting Energy Expenditure Time done:________________ 
Rested for 30 mins. in supine position in dark 
room 
     Start time________________ 
     End time_________________ 
Steady state measurement under canopy 
(complete test after REE stable for 5 minutes) 
     Start time________________ 
     End time_________________ 
 
Height, Weight, BMI Hgt_________cm.  Wgt__________lbs.   
BMI________kg/m2 
 
Waist/Hip measurements Waist (umbilicus)_____________cm. 
Waist (iliac crest)_____________cm. 
Hips________________________cm. 
 
Bioelectric Impedance Analysis (BIA) Resistance______________ohms 
Reactance_______________ohms 
 
Baseline blood draw & hunger/satiety 
questionnaire 
Blood sample:                          Questionnaire: 
Baseline____________           ______________ 
By________________ 
 
Breakfast consumed Luna bar & milk  English muffin, cheese,  
                                           apple juice 
Start time____________ 
End time_____________ 
 
Rested quietly for next 2 hours with 
standardized video and periodicals 
 
Blood draw and hunger/satiety questionnaire 
completion at 30, 60 and 120 minutes 
following completion of breakfast 
Resting start___________    End____________ 
 
Blood samples:                         Questionnaire: 
30 mins.____________           ______________ 
60 mins.____________           ______________ 
120 mins.___________           ______________ 
By_____________________ 
 
Completion: 
• Snack prior to leaving 
• Record food eaten in food & PA diary 
• Schedule time to call & review diary entries 
• Confirm next testing visit date (if 
applicable) 
Snack choice: 
Luna Bar & H2O    Slim Fast Shake & H2O 
 
Scheduled phone call time:_______________ 
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APPENDIX E 
BREAKFAST CONDITION DATA SHEET 
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 IRB# PRO09120437: The Effect of Breakfast Consumption on Acylated-Ghrelin and GLP-1 
 PI: Tom Hritz, MS, RD, LDN 
 
Breakfast Testing Session Data Sheet 
 
 
 Subject ID:________________________  Date of Visit:_______________________ 
 
 
 Body Wt:__________lb.  Ht:___________cm          Age___________y 
 
 
 Basal Energy Expenditure*:______ kcals  x 1.3 (activity factor) =  Est. daily needs:______kcals 
 
 
 Est. daily needs   x   0.20  =   
 
 
 
 Meal Selection:           Luna Bar & milk             English muffin, cheddar cheese, apple juice 
 
 
 
 
 
 Breakfast start time:____________________          Breakfast end time:_____________________ 
 
 
 Resting start time:______________________         Resting end time:_______________________ 
 
 
 
 
 *Basal Energy Expenditure calculated using the Mifflin-St. Jeor formula 
 
Food Item Portion Size Kcals 
Luna Bar 
(flavor:_______________________) 
__________________oz  
Whole milk:  regular     Lactaid __________________fl 
oz 
 
   Total:_______________ 
English muffin __________________oz  
Cheddar cheese __________________oz  
Apple juice __________________fl 
oz 
 
 Total:_______________ 
Breakfast kcal needs:____________kcals 
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APPENDIX F 
HUNGER AND SATIETY VAS QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   127 
Hunger and Satiety Visual Analogue Scales (VAS) 
 
 
 
 
 For each question below place a single vertical slash through the line at the point that best  
 describes how you feel right now. 
 
 
Overall, how hungry do you feel? 
I am not          I have never been  
hungry at all         more hungry 
 ____________________________________________________ 
 
 
Overall, how satisfied do you feel? 
I am            
completely empty         I am very satisfied 
 ____________________________________________________ 
 
 
Overall, how full do you feel? 
Not at all full         Totally full 
 ____________________________________________________ 
 
 
Overall, how much do you think you could eat right now? 
Nothing at all         A lot 
 ____________________________________________________ 
 
 
Overall, how thirsty do you feel? 
I am not          I have never been so  
thirsty at all         thirsty 
 ____________________________________________________ 
  
 
 
 
 
 
 
To be completed by staff 
 
Date:____________      ID Number:____________           Time:____________ 
 
 
 Baseline      30 minute   60 minute      120 minute 
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APPENDIX G 
GRAPHS DEMONSTRATING CHANGES IN ACYLATED GHRELIN AND GLUCAGON-LIKE 
PEPTIDE 1 (GLP-1) BETWEEN BREAKFAST AND NON-BREAKFAST CONDITIONS 
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Changes in Acylated Ghrelin between Breakfast and Non-Breakfast Conditions (n=15)
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APPENDIX H 
GRAPH OF DIFFERENCES IN DAILY ENERGY INTAKE BETWEEN BREAKFAST 
AND NON-BREAKFAST CONDITIONS 
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Differences in Daily Energy Intake between Breakfast and Non-Breakfast Conditions
1528 1440
176
373
149
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400
2600
2800
Non-Breakfast Testing Day Breakfast Testing Day
Testing Condition
En
er
gy
 In
ta
ke
 (k
ca
ls
/d
ay
)
Breakfast Intake
Snack Intake
Discretionary Intake
 
   132 
BIBLIOGRAPHY 
1. Ogden, C.L., et al., Prevalence of overweight and obesity in the United States, 1999-
2004. Jama, 2006. 295(13): p. 1549-55. 
2. Dietary Guidelines for Americans, 2005. 6th Edition. U.S. Department of Health and 
Human Services and U.S. Department of Agriculture, 2005. 
3. The Burden of Chronic Diseases and Their Risk Factors: National and State 
Perspectives. U.S. Department of Health and Human Services. Washington, DC: U.S. 
Government Printing Office, 2004. 
4. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep 
Ser, 2003. 916: p. i-viii, 1-149, backcover. 
5. Harnack, L.J., R.W. Jeffery, and K.N. Boutelle, Temporal trends in energy intake in the 
United States: an ecologic perspective. Am J Clin Nutr, 2000. 71(6): p. 1478-84. 
6. Wing, R.R. and J.O. Hill, Successful weight loss maintenance. Annu Rev Nutr, 2001. 21: 
p. 323-41. 
7. Wing, R.R. and S. Phelan, Long-term weight loss maintenance. Am J Clin Nutr, 2005. 
82(1 Suppl): p. 222S-225S. 
8. Song, W.O., et al., Is consumption of breakfast associated with body mass index in US 
adults? J Am Diet Assoc, 2005. 105(9): p. 1373-82. 
9. Cho, S., et al., The effect of breakfast type on total daily energy intake and body mass 
index: results from the Third National Health and Nutrition Examination Survey 
(NHANES III). J Am Coll Nutr, 2003. 22(4): p. 296-302. 
10. Berteus Forslund, H., et al., Meal patterns and obesity in Swedish women-a simple 
instrument describing usual meal types, frequency and temporal distribution. Eur J Clin 
Nutr, 2002. 56(8): p. 740-7. 
11. Affenito, S.G., et al., Breakfast consumption by African-American and white adolescent 
girls correlates positively with calcium and fiber intake and negatively with body mass 
index. J Am Diet Assoc, 2005. 105(6): p. 938-45. 
12. Haines, P.S., D.K. Guilkey, and B.M. Popkin, Trends in breakfast consumption of US 
adults between 1965 and 1991. J Am Diet Assoc, 1996. 96(5): p. 464-70. 
13. Nicklas, T.A., et al., Impact of breakfast consumption on nutritional adequacy of the diets 
of young adults in Bogalusa, Louisiana: ethnic and gender contrasts. J Am Diet Assoc, 
1998. 98(12): p. 1432-8. 
14. Berkey, C.S., et al., Longitudinal study of skipping breakfast and weight change in 
adolescents. Int J Obes Relat Metab Disord, 2003. 27(10): p. 1258-66. 
15. Carels, R.A., et al., Skipping meals and alcohol consumption. The regulation of energy 
intake and expenditure among weight loss participants. Appetite, 2008. 51(3): p. 538-45. 
   133 
16. Wyatt, H.R., et al., Long-term weight loss and breakfast in subjects in the National 
Weight Control Registry. Obes Res, 2002. 10(2): p. 78-82. 
17. Tai, M.M., P. Castillo, and F.X. Pi-Sunyer, Meal size and frequency: effect on the 
thermic effect of food. Am J Clin Nutr, 1991. 54(5): p. 783-7. 
18. LeBlanc, J., I. Mercier, and A. Nadeau, Components of postprandial thermogenesis in 
relation to meal frequency in humans. Can J Physiol Pharmacol, 1993. 71(12): p. 879-83. 
19. Johnston, C.S., C.S. Day, and P.D. Swan, Postprandial thermogenesis is increased 100% 
on a high-protein, low-fat diet versus a high-carbohydrate, low-fat diet in healthy, young 
women. J Am Coll Nutr, 2002. 21(1): p. 55-61. 
20. Timlin, M.T. and M.A. Pereira, Breakfast frequency and quality in the etiology of adult 
obesity and chronic diseases. Nutr Rev, 2007. 65(6 Pt 1): p. 268-81. 
21. Farshchi, H.R., M.A. Taylor, and I.A. Macdonald, Deleterious effects of omitting 
breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J 
Clin Nutr, 2005. 81(2): p. 388-96. 
22. Ahima, R.S. and D.A. Antwi, Brain regulation of appetite and satiety. Endocrinol Metab 
Clin North Am, 2008. 37(4): p. 811-23. 
23. Baggio, L.L. and D.J. Drucker, Biology of incretins: GLP-1 and GIP. Gastroenterology, 
2007. 132(6): p. 2131-57. 
24. Beasley, J.M., et al., Associations between macronutrient intake and self-reported 
appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient 
Intake Trial to Prevent Heart Disease. Am J Epidemiol, 2009. 169(7): p. 893-900. 
25. Blom, W.A., et al., Postprandial ghrelin responses are associated with the intermeal 
interval in time-blinded normal weight men, but not in obese men. Physiol Behav, 2009. 
96(4-5): p. 742-8. 
26. Blom, W.A., et al., Effect of a high-protein breakfast on the postprandial ghrelin 
response. Am J Clin Nutr, 2006. 83(2): p. 211-20. 
27. Cummings, D.E., et al., Plasma ghrelin levels after diet-induced weight loss or gastric 
bypass surgery. N Engl J Med, 2002. 346(21): p. 1623-30. 
28. D'Alessio, D.A. and T.P. Vahl, Glucagon-like peptide 1: evolution of an incretin into a 
treatment for diabetes. Am J Physiol Endocrinol Metab, 2004. 286(6): p. E882-90. 
29. Date, Y., et al., Ghrelin, a novel growth hormone-releasing acylated peptide, is 
synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and 
humans. Endocrinology, 2000. 141(11): p. 4255-61. 
30. Erdmann, J., et al., Food intake and plasma ghrelin response during potato-, rice- and 
pasta-rich test meals. Eur J Nutr, 2007. 46(4): p. 196-203. 
31. Erdmann, J., et al., Ghrelin response to protein and carbohydrate meals in relation to 
food intake and glycerol levels in obese subjects. Regul Pept, 2006. 135(1-2): p. 23-9. 
32. Erdmann, J., F. Lippl, and V. Schusdziarra, Differential effect of protein and fat on 
plasma ghrelin levels in man. Regul Pept, 2003. 116(1-3): p. 101-7. 
33. Erdmann, J., et al., Postprandial response of plasma ghrelin levels to various test meals 
in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab, 2004. 
89(6): p. 3048-54. 
34. Hameed, S., W.S. Dhillo, and S.R. Bloom, Gut hormones and appetite control. Oral Dis, 
2009. 15(1): p. 18-26. 
35. Kojima, M., et al., Ghrelin is a growth-hormone-releasing acylated peptide from 
stomach. Nature, 1999. 402(6762): p. 656-60. 
   134 
36. le Roux, C.W., et al., Gut hormones as mediators of appetite and weight loss after Roux-
en-Y gastric bypass. Ann Surg, 2007. 246(5): p. 780-5. 
37. Lejeune, M.P., et al., Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, 
and energy and substrate metabolism during a high-protein diet and measured in a 
respiration chamber. Am J Clin Nutr, 2006. 83(1): p. 89-94. 
38. Liu, J., et al., Novel ghrelin assays provide evidence for independent regulation of ghrelin 
acylation and secretion in healthy young men. J Clin Endocrinol Metab, 2008. 93(5): p. 
1980-7. 
39. Mackelvie, K.J., et al., Regulation of appetite in lean and obese adolescents after 
exercise: role of acylated and desacyl ghrelin. J Clin Endocrinol Metab, 2007. 92(2): p. 
648-54. 
40. Matsuda, K., et al., Regulation of food intake by acyl and des-acyl ghrelins in the 
goldfish. Peptides, 2006. 27(9): p. 2321-5. 
41. Mayorov, A.V., et al., Catalytic antibody degradation of ghrelin increases whole-body 
metabolic rate and reduces refeeding in fasting mice. Proc Natl Acad Sci U S A, 2008. 
105(45): p. 17487-92. 
42. Raben, A., et al., Meals with similar energy densities but rich in protein, fat, 
carbohydrate, or alcohol have different effects on energy expenditure and substrate 
metabolism but not on appetite and energy intake. Am J Clin Nutr, 2003. 77(1): p. 91-
100. 
43. Rask, E., et al., Impaired incretin response after a mixed meal is associated with insulin 
resistance in nondiabetic men. Diabetes Care, 2001. 24(9): p. 1640-5. 
44. Reimer, R.A. and J.C. Russell, Glucose tolerance, lipids, and GLP-1 secretion in 
JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring), 2008. 16(1): p. 40-
6. 
45. Sedlackova, D., et al., Simultaneous decrease of plasma obestatin and ghrelin levels after 
a high-carbohydrate breakfast in healthy women. Physiol Res, 2008. 57 Suppl 1: p. S29-
37. 
46. Seeley, R.J., et al., The role of CNS glucagon-like peptide-1 (7-36) amide receptors in 
mediating the visceral illness effects of lithium chloride. J Neurosci, 2000. 20(4): p. 1616-
21. 
47. Shughrue, P.J., M.V. Lane, and I. Merchenthaler, Glucagon-like peptide-1 receptor 
(GLP1-R) mRNA in the rat hypothalamus. Endocrinology, 1996. 137(11): p. 5159-62. 
48. Tentolouris, N., et al., Differential effects of high-fat and high-carbohydrate content 
isoenergetic meals on plasma active ghrelin concentrations in lean and obese women. 
Horm Metab Res, 2004. 36(8): p. 559-63. 
49. Tschop, M., et al., Circulating ghrelin levels are decreased in human obesity. Diabetes, 
2001. 50(4): p. 707-9. 
50. Turton, M.D., et al., A role for glucagon-like peptide-1 in the central regulation of 
feeding. Nature, 1996. 379(6560): p. 69-72. 
51. Veldhorst, M.A., et al., Effects of high and normal soyprotein breakfasts on satiety and 
subsequent energy intake, including amino acid and 'satiety' hormone responses. Eur J 
Nutr, 2009. 48(2): p. 92-100. 
52. Verdich, C., et al., A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide 
on ad libitum energy intake in humans. J Clin Endocrinol Metab, 2001. 86(9): p. 4382-9. 
   135 
53. Cummings, D.E., et al., A preprandial rise in plasma ghrelin levels suggests a role in 
meal initiation in humans. Diabetes, 2001. 50(8): p. 1714-9. 
54. Crowley, V.E., Overview of human obesity and central mechanisms regulating energy 
homeostasis. Ann Clin Biochem, 2008. 45(Pt 3): p. 245-55. 
55. Muccioli, G., et al., Binding of 125I-labeled ghrelin to membranes from human 
hypothalamus and pituitary gland. J Endocrinol Invest, 2001. 24(3): p. RC7-9. 
56. Toshinai, K., et al., Upregulation of Ghrelin expression in the stomach upon fasting, 
insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res 
Commun, 2001. 281(5): p. 1220-5. 
57. Lucidi, P., et al., Meal intake similarly reduces circulating concentrations of octanoyl 
and total ghrelin in humans. J Endocrinol Invest, 2004. 27(5): p. RC12-5. 
58. Gardiner, J.V., C.N. Jayasena, and S.R. Bloom, Gut hormones: a weight off your mind. J 
Neuroendocrinol, 2008. 20(6): p. 834-41. 
59. Healthy People 2010 (Group) and United States. Dept. of Health and Human Services., 
Healthy people 2010. 2nd ed. 2000, Washington, DC: U.S. Dept. of Health and Human 
Services. 
60. National Heart Lung and Blood Institute. and National Institute of Diabetes and Digestive 
and Kidney Diseases (U.S.), Clinical guidelines on the identification, evaluation, and 
treatment of overweight and obesity in adults : the evidence report. NIH publication ; no. 
98-4083. 1998, [Bethesda, Md.?]: National Heart, Lung, and Blood Institute in 
cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases. 
xxx, 228 p. 
61. Keim, N.L., et al., Weight loss is greater with consumption of large morning meals and 
fat-free mass is preserved with large evening meals in women on a controlled weight 
reduction regimen. J Nutr, 1997. 127(1): p. 75-82. 
62. van der Heijden, A.A., et al., A prospective study of breakfast consumption and weight 
gain among U.S. men. Obesity (Silver Spring), 2007. 15(10): p. 2463-9. 
63. Ma, Y., et al., Association between eating patterns and obesity in a free-living US adult 
population. Am J Epidemiol, 2003. 158(1): p. 85-92. 
64. Niemeier, H.M., et al., Fast food consumption and breakfast skipping: predictors of 
weight gain from adolescence to adulthood in a nationally representative sample. J 
Adolesc Health, 2006. 39(6): p. 842-9. 
65. Schusdziarra, V., et al., Impact of breakfast on daily energy intake--an analysis of 
absolute versus relative breakfast calories. Nutr J. 10: p. 5. 
66. Kim, H.H., et al., Post-prandial plasma ghrelin levels in people with different breakfast 
hours. Eur J Clin Nutr, 2004. 58(4): p. 692-5. 
67. Soares, J.B. and A.F. Leite-Moreira, Ghrelin, des-acyl ghrelin and obestatin: three pieces 
of the same puzzle. Peptides, 2008. 29(7): p. 1255-70. 
68. Chen, C.Y., et al., At the cutting edge: ghrelin gene products in food intake and gut 
motility. Neuroendocrinology, 2009. 89(1): p. 9-17. 
69. Druce, M.R., et al., Subcutaneous administration of ghrelin stimulates energy intake in 
healthy lean human volunteers. Int J Obes (Lond), 2006. 30(2): p. 293-6. 
70. Wren, A.M., et al., Ghrelin enhances appetite and increases food intake in humans. J 
Clin Endocrinol Metab, 2001. 86(12): p. 5992. 
71. Asakawa, A., et al., Stomach regulates energy balance via acylated ghrelin and desacyl 
ghrelin. Gut, 2005. 54(1): p. 18-24. 
   136 
72. Qader, S.S., et al., Proghrelin-derived peptides influence the secretion of insulin, 
glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse 
and rat pancreas. Regul Pept, 2008. 146(1-3): p. 230-7. 
73. Blundell, J.E. and E. Naslund, Glucagon-like peptide-1, satiety and appetite control. Br J 
Nutr, 1999. 81(4): p. 259-60. 
74. D'Alessio, D., Intestinal hormones and regulation of satiety: the case for CCK, GLP-1, 
PYY, and Apo A-IV. JPEN J Parenter Enteral Nutr, 2008. 32(5): p. 567-8. 
75. Blom, W.A., et al., Effects of gastric emptying on the postprandial ghrelin response. Am 
J Physiol Endocrinol Metab, 2006. 290(2): p. E389-95. 
76. Moran, T.H., et al., Peptide YY(3-36) inhibits gastric emptying and produces acute 
reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol, 
2005. 288(2): p. R384-8. 
77. Naslund, E., et al., Energy intake and appetite are suppressed by glucagon-like peptide-1 
(GLP-1) in obese men. Int J Obes Relat Metab Disord, 1999. 23(3): p. 304-11. 
78. Lachey, J.L., et al., The role of central glucagon-like peptide-1 in mediating the effects of 
visceral illness: differential effects in rats and mice. Endocrinology, 2005. 146(1): p. 458-
62. 
79. Flint, A., et al., Glucagon-like peptide 1 promotes satiety and suppresses energy intake in 
humans. J Clin Invest, 1998. 101(3): p. 515-20. 
80. Drucker, D.J., The biology of incretin hormones. Cell Metab, 2006. 3(3): p. 153-65. 
81. Eissele, R., et al., Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas 
of rat, pig and man. Eur J Clin Invest, 1992. 22(4): p. 283-91. 
82. Edwards, C.M., et al., Glucagon-like peptide 1 has a physiological role in the control of 
postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes, 
1999. 48(1): p. 86-93. 
83. Gutzwiller, J.P., et al., Glucagon-like peptide-1: a potent regulator of food intake in 
humans. Gut, 1999. 44(1): p. 81-6. 
84. Verdich, C., et al., The role of postprandial releases of insulin and incretin hormones in 
meal-induced satiety--effect of obesity and weight reduction. Int J Obes Relat Metab 
Disord, 2001. 25(8): p. 1206-14. 
85. Adam, T.C. and M.S. Westerterp-Plantenga, Nutrient-stimulated GLP-1 release in 
normal-weight men and women. Horm Metab Res, 2005. 37(2): p. 111-7. 
86. Rubio, I.G., et al., Oral ingestion of a hydrolyzed gelatin meal in subjects with normal 
weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and 
insulin. Eat Weight Disord, 2008. 13(1): p. 48-53. 
87. Ruxton, C.H. and T.R. Kirk, Breakfast: a review of associations with measures of dietary 
intake, physiology and biochemistry. Br J Nutr, 1997. 78(2): p. 199-213. 
88. Siega-Riz, A.M., B.M. Popkin, and T. Carson, Trends in breakfast consumption for 
children in the United States from 1965-1991. Am J Clin Nutr, 1998. 67(4): p. 748S-
756S. 
89. Mahan, L.K. and S. Escott-Stump, Krause's food, nutrition, & diet therapy. 10th ed. 
2000, Philadelphia: W.B. Saunders. xxxiv, 1194. 
90. Callahan, H.S., et al., Postprandial suppression of plasma ghrelin level is proportional to 
ingested caloric load but does not predict intermeal interval in humans. J Clin 
Endocrinol Metab, 2004. 89(3): p. 1319-24. 
   137 
91. Di Francesco, V., et al., Effect of age on the dynamics of acylated ghrelin in fasting 
conditions and in response to a meal. J Am Geriatr Soc, 2008. 56(7): p. 1369-70. 
92. Schutte, A.E., et al., Aging influences the level and functions of fasting plasma ghrelin 
levels: the POWIRS-Study. Regul Pept, 2007. 139(1-3): p. 65-71. 
93. Makovey, J., et al., Gender differences in plasma ghrelin and its relations to body 
composition and bone - an opposite-sex twin study. Clin Endocrinol (Oxf), 2007. 66(4): 
p. 530-7. 
94. Greenman, Y., et al., Ghrelin secretion is modulated in a nutrient- and gender-specific 
manner. Clin Endocrinol (Oxf), 2004. 60(3): p. 382-8. 
95. Broom, D.R., et al., Exercise-induced suppression of acylated ghrelin in humans. J Appl 
Physiol, 2007. 102(6): p. 2165-71. 
96. Cheng, M.H., et al., Appetite regulation via exercise prior or subsequent to high-fat meal 
consumption. Appetite, 2009. 52(1): p. 193-8. 
97. Unick, J.L., et al., Acute effect of walking on energy intake in overweight/obese women. 
Appetite. 55(3): p. 413-9. 
98. Chanoine, J.P., et al., GLP-1 and appetite responses to a meal in lean and overweight 
adolescents following exercise. Obesity (Silver Spring), 2008. 16(1): p. 202-4. 
99. O'Connor, A.M., et al., Circulating gastrointestinal hormone changes in marathon 
running. Int J Sports Med, 1995. 16(5): p. 283-7. 
100. O'Connor, A.M., et al., The gastroenteroinsular response to glucose ingestion during 
postexercise recovery. Am J Physiol Endocrinol Metab, 2006. 290(6): p. E1155-61. 
101. Shiiya, T., et al., Plasma ghrelin levels in lean and obese humans and the effect of 
glucose on ghrelin secretion. J Clin Endocrinol Metab, 2002. 87(1): p. 240-4. 
102. Yin, X., et al., Ghrelin fluctuation, what determines its production? Acta Biochim 
Biophys Sin (Shanghai), 2009. 41(3): p. 188-97. 
103. Erdmann, J., et al., Differential association of basal and postprandial plasma ghrelin 
with leptin, insulin, and type 2 diabetes. Diabetes, 2005. 54(5): p. 1371-8. 
104. Marzullo, P., et al., Predictors of postabsorptive ghrelin secretion after intake of different 
macronutrients. J Clin Endocrinol Metab, 2006. 91(10): p. 4124-30. 
105. Farshchi, H.R., M.A. Taylor, and I.A. Macdonald, Regular meal frequency creates more 
appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency 
in healthy lean women. Eur J Clin Nutr, 2004. 58(7): p. 1071-7. 
106. Farshchi, H.R., M.A. Taylor, and I.A. Macdonald, Decreased thermic effect of food after 
an irregular compared with a regular meal pattern in healthy lean women. Int J Obes 
Relat Metab Disord, 2004. 28(5): p. 653-60. 
107. Guo, Z.F., et al., Circulating preprandial ghrelin to obestatin ratio is increased in human 
obesity. J Clin Endocrinol Metab, 2007. 92(5): p. 1875-80. 
108. Martins, C., L. Morgan, and H. Truby, A review of the effects of exercise on appetite 
regulation: an obesity perspective. Int J Obes (Lond), 2008. 32(9): p. 1337-47. 
109. Serra-Prat, M., et al., Effect of age and frailty on ghrelin and cholecystokinin responses to 
a meal test. Am J Clin Nutr, 2009. 89(5): p. 1410-7. 
110. Schlundt, D.G., et al., The role of breakfast in the treatment of obesity: a randomized 
clinical trial. Am J Clin Nutr, 1992. 55(3): p. 645-51. 
111. Natalucci, G., et al., Spontaneous 24-h ghrelin secretion pattern in fasting subjects: 
maintenance of a meal-related pattern. Eur J Endocrinol, 2005. 152(6): p. 845-50. 
   138 
112. Sanchez, J., et al., Diurnal rhythms of leptin and ghrelin in the systemic circulation and 
in the gastric mucosa are related to food intake in rats. Pflugers Arch, 2004. 448(5): p. 
500-6. 
113. Dzaja, A., et al., Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am 
J Physiol Endocrinol Metab, 2004. 286(6): p. E963-7. 
114. Tolle, V., et al., Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding 
behavior, and sleep-wake patterns in rats. Endocrinology, 2002. 143(4): p. 1353-61. 
115. Bewick, G.A., et al., Mice with hyperghrelinemia are hyperphagic and glucose intolerant 
and have reduced leptin sensitivity. Diabetes, 2009. 58(4): p. 840-6. 
116. Brambilla, F., P. Monteleone, and M. Maj, Glucagon-like peptide-1 secretion in bulimia 
nervosa. Psychiatry Res, 2009. 169(1): p. 82-5. 
117. Monteleone, P., et al., Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are 
increased in underweight patients with anorexia nervosa but not in symptomatic patients 
with bulimia nervosa. J Clin Endocrinol Metab, 2008. 93(11): p. 4418-21. 
118. Prince, A.C., et al., Systematic review and meta-analysis of the baseline concentrations 
and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr, 
2009. 89(3): p. 755-65. 
119. Damjanovic, S.S., et al., Relationship between basal metabolic rate and cortisol secretion 
throughout pregnancy. Endocrine, 2009. 35(2): p. 262-8. 
120. Tham, E., et al., Acylated ghrelin concentrations are markedly decreased during 
pregnancy in mothers with and without gestational diabetes: relationship with 
cholinesterase. Am J Physiol Endocrinol Metab, 2009. 296(5): p. E1093-100. 
121. Doucet, E., et al., Total peptide YY is a correlate of postprandial energy expenditure but 
not of appetite or energy intake in healthy women. Metabolism, 2008. 57(10): p. 1458-64. 
122. Konopko-Zubrzycka, M., et al., The effect of intragastric balloon on plasma ghrelin, 
leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab, 
2009. 94(5): p. 1644-9. 
123. Stunkard, A.J. and S. Messick, The three-factor eating questionnaire to measure dietary 
restraint, disinhibition and hunger. J Psychosom Res, 1985. 29(1): p. 71-83. 
124. Flint, A., et al., Reproducibility, power and validity of visual analogue scales in 
assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab 
Disord, 2000. 24(1): p. 38-48. 
125. Fricker, J., et al., Circadian rhythm of energy intake and corpulence status in adults. Int J 
Obes, 1990. 14(5): p. 387-93. 
126. Mifflin, M.D., et al., A new predictive equation for resting energy expenditure in healthy 
individuals. Am J Clin Nutr, 1990. 51(2): p. 241-7. 
127. American Dietetic Association., ADA nutrition care manual. 2005, American Dietetic 
Association (ADA): [Chicago]. 
128. Frankenfield, D.C., et al., Validation of several established equations for resting 
metabolic rate in obese and nonobese people. J Am Diet Assoc, 2003. 103(9): p. 1152-9. 
129. Frankenfield, D., L. Roth-Yousey, and C. Compher, Comparison of predictive equations 
for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J 
Am Diet Assoc, 2005. 105(5): p. 775-89. 
130. SlimFast Products.   [cited September 14, 2009]; Available from: http://www.slim-
fast.com/products/products.aspx. 
   139 
131. Bowes, A.d.P., et al., Bowes & Church's food values of portions commonly used. 17th ed. 
1998, Philadelphia: Lippincott. xxx, 481 p. 
132. Al Awar, R., et al., Postprandial acylated ghrelin status following fat and protein 
manipulation of meals in healthy young women. Clin Sci (Lond), 2005. 109(4): p. 405-11. 
133. Broom, D.R., et al., Influence of resistance and aerobic exercise on hunger, circulating 
levels of acylated ghrelin, and peptide YY in healthy males. Am J Physiol Regul Integr 
Comp Physiol, 2009. 296(1): p. R29-35. 
134. Gruendel, S., et al., Increased acylated plasma ghrelin, but improved lipid profiles 24-h 
after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br J 
Nutr, 2007. 98(6): p. 1170-7. 
135. Martins, C., et al., The effects of exercise-induced weight loss on appetite-related 
peptides and motivation to eat. J Clin Endocrinol Metab. 95(4): p. 1609-16. 
136. Akamizu, T., et al., Separate measurement of plasma levels of acylated and desacyl 
ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab, 
2005. 90(1): p. 6-9. 
137. Chan, J.L., et al., Ghrelin levels are not regulated by recombinant leptin administration 
and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab, 2004. 89(1): p. 
335-43. 
138. Adam, T.C. and M.S. Westerterp-Plantenga, Glucagon-like peptide-1 release and satiety 
after a nutrient challenge in normal-weight and obese subjects. Br J Nutr, 2005. 93(6): p. 
845-51. 
139. Veldhorst, M.A., et al., Effects of complete whey-protein breakfasts versus whey without 
GMP-breakfasts on energy intake and satiety. Appetite, 2009. 52(2): p. 388-95. 
140. Veldhorst, M.A., et al., Comparison of the effects of a high- and normal-casein breakfast 
on satiety, 'satiety' hormones, plasma amino acids and subsequent energy intake. Br J 
Nutr, 2009. 101(2): p. 295-303. 
141. Willbond, S.M. and E. Doucet, Individually timing high-protein preloads has no effect on 
daily energy intake, peptide YY and glucagon-like peptide-1. Eur J Clin Nutr. 65(1): p. 
55-62. 
142. Juntunen, K.S., et al., Postprandial glucose, insulin, and incretin responses to grain 
products in healthy subjects. Am J Clin Nutr, 2002. 75(2): p. 254-62. 
143. Nieuwenhuizen, A.G., et al., Acute effects of breakfasts containing alpha-lactalbumin, or 
gelatin with or without added tryptophan, on hunger, 'satiety' hormones and amino acid 
profiles. Br J Nutr, 2009. 101(12): p. 1859-66. 
144. Willis, H.J., et al., Increasing doses of fiber do not influence short-term satiety or food 
intake and are inconsistently linked to gut hormone levels. Food Nutr Res. 54. 
145. Carroll, J.F., et al., Influence of BMI and gender on postprandial hormone responses. 
Obesity (Silver Spring), 2007. 15(12): p. 2974-83. 
146. Kral, T.V., et al., Effects of eating breakfast compared with skipping breakfast on ratings 
of appetite and intake at subsequent meals in 8- to 10-y-old children. Am J Clin Nutr. 
93(2): p. 284-91. 
147. Ferrari, P., et al., Evaluation of under- and overreporting of energy intake in the 24-hour 
diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). 
Public Health Nutr, 2002. 5(6B): p. 1329-45. 
148. Heitmann, B.L., L. Lissner, and M. Osler, Do we eat less fat, or just report so? Int J Obes 
Relat Metab Disord, 2000. 24(4): p. 435-42. 
   140 
149. Mendez, M.A., et al., Under- and overreporting of energy is related to obesity, lifestyle 
factors and food group intakes in Jamaican adults. Public Health Nutr, 2004. 7(1): p. 9-
19. 
150. Tooze, J.A., et al., Psychosocial predictors of energy underreporting in a large doubly 
labeled water study. Am J Clin Nutr, 2004. 79(5): p. 795-804. 
 
 
